<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>ClinicalTrials.gov: updated in the last 5 days</title>
    <link>https://clinicaltrials.gov/ct2/results/rss.xml?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;count=10000&amp;amp;show_rss=Y</link>
    <description>Studies found on ClinicalTrials.gov by a search of: updated in the last 5 days</description>
    <language>en-us</language>
    <pubDate>Thu, 30 Jun 2016 09:46:54 EDT</pubDate>
    <ttl>1440</ttl>
    <item>
      <title>Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821221?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Japanese Encephalitis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®)&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Institute of Hygiene and Epidemiology, Vietnam;   Sanofi Pasteur, a Sanofi Company&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821221</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Analgesia in Pediatric Laparoscopy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820610?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Analgesia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Dexmedetomidine;   Drug: Magnesium Sulfate;   Drug: Control group&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Assiut University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820610</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of the Implication of Omega-3 Polyunsaturated Fatty Acids in Retinopathy of Prematurity in New-born Infants</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820662?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Retinopathy of Prematurity&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: RETCAM;   Biological: Blood samples&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Centre Hospitalier Universitaire Dijon&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820662</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Quality Improvement in Infection COntrol and Sepsis Management in MOdel Regions</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820675?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Sepsis;   Severe Sepsis;   Septic Shock&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: structured case analysis;   Other: strucured screening &quot;every patient, every shift&quot;&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Center for Sepsis Control and Care, Germany;   German Federal Ministry for Education adn Research;   Vivantes Berlin Hospitals;   Nuremberg Hospital;   Sana Clinics;   Augsburg Hospital;   Central Hospital Bad Berka;   Armed Forces Hospital Berlin;   Bonn University Hospital;   Bremen City Hospitals;   MediClin Hospital Coswig;   Lippe Hospitals;   Hospital Dresden Friedrichstadt;   Dueren Hospital;   Duesseldorf University Hospital;   St. Georg Hospital Eisenach;   Rudolf Elle Hospital Eisenberg;   Hans Susemihl Hospital Emden;   Trauma Center Frankfurt Main;   SRH Hospital Gera;   Asklepios Clinics;   Greifswald University Hospital;   German Red Cross Clinics;   Halle University Hospital;   Hannover University Hospital;   University Hospitals of Schleswig-Holstein;   St. Elisabeth Hospital Cologne;   Leipzig University Hospital;   Magdeburg University Hospital;   Mannheim University Hospital;   Munich University Hospital Rechts der Isar;   Trauma Center Murnau;   Havelland Hospitals;   Nordhausen South Harz Hospital;   Oldenburg Hospital;   Rostock Southern City Hospital;   Saarbruecken Hospital;   Siegen Diakonie Hospital;   Stuttgart Hospital;   SRH Central Hospital Suhl;   MediClin Mueritz Hospital Waren;   Werdau Pleissetal Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820675</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Ultrasound Evaluation of OMT for Sacral Base Asymmetry</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820701?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Manipulation, Osteopathic&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: OMT&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    A.T. Still University of Health Sciences&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820701</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Pilot Study of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820714?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Constipation&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: BLI801 Laxative&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Braintree Laboratories&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820714</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of Journey II BCS Total Knee System Compared to Other Posterior Stabilized Total Knee Systems in a Physical Therapy Setting</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820766?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Osteoarthritis;   Degenerative Arthritis;   Traumatic Arthriti&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Smith &amp; Nephew, Inc.&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820766</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Crossover Study of the LMA Protector Versus Ambu AuraGain</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820792?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Airway Morbidity&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: function tests;   Device: LMA ProtectorTM;   Device: Ambu AuraGainTM&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Schulthess Klinik&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820792</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Bronchopulmonary Dysplasia: From Neonatal Chronic Lung Disease to Early Onset Adult COPD</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820818?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Premature Birth;   Obstructive Lung Disease;   Bronchopulmonary Dysplasia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    St. Justine's Hospital&lt;br/&gt;&lt;b&gt;Enrolling by invitation&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820818</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Anesthesia Geriatric Evaluation and Quality of Life After Peripheral Vascular Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820831?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Quality of Life&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    St. Antonius Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820831</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820844?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Urinary Bladder, Overactive&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: GSK1358820;   Drug: Placebo;   Drug: Antibiotic therapy;   Other: Bladder diary;   Other: King's Health Questionnaire (KHQ);   Other: Overactive Bladder Symptom Score (OABSS);   Other: Treatment Benefit Scale (TBS)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820844</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820857?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Neuroendocrine Carcinomas&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Folfiri-bevacizumab;   Drug: Folfiri&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Hospices Civils de Lyon&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820857</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Feasibility of Posterior Nasal Nerve Cryomodulation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820597?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Rhinitis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Arrinex Device&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Arrinex, Inc.&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820597</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820896?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Alzheimer's Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Placebo;   Drug: RO7105705&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Genentech, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820896</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Interest of the Ultrasound Guidance for the Laying of Femoral Arterial and Venous Catheters in Intensive Care Unit</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820909?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Severely Traumatized Patients in Emergency Wards&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: venous and arterial catheter set-up using ultrasound guidance;   Procedure: Anatomical guidance.&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Hospices Civils de Lyon&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820909</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibition and Induction on the Pharmacokinetics of CC-220 in Healthy Subjects</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820935?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pharmacokinetics&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: CC-220;   Drug: Rifampin;   Drug: Itraconazole&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Celgene Corporation&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820935</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Effect of Vitamin E Ointment on Incisional SSI in Colorectal Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820948?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Surgical Site Infection&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Vitamin E ointment application&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Hospital General Universitario Elche&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820948</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820961?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Breast Cancer;   Estrogen Receptor Positive Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: entinostat;   Drug: exemestane&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Syndax Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820961</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820987?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Septic Shock&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: MEROPENEM;   Drug: PIPERACILLIN-TAZOBACTAM;   Drug: CEFEPIME&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Centre Hospitalier Universitaire de Besancon&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified January 2016</description>
      <guid isPermaLink="false">NCT02820987</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety and Efficacy Study of Pembrolizumab (MK-3475) in Chinese Participants With Locally Advanced or Metastatic Melanoma (MK-3475-151/Keynote-151)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821000?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Melanoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Pembrolizumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Merck Sharp &amp; Dohme Corp.&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821000</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Estimating Blood Concentrations of Anaesthetics During One-Lung Ventilation (OLV)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821455?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    One-Lung Ventilation&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: Lung Surgery with One-Lung Ventilation&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Edinburgh;   NHS Lothian&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821455</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Duration of Anti-PD-1 Therapy in Metastatic Melanoma (STOP-GAP)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821013?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Unresectable/Metastatic Melanoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Intermittent PD-1 inhibitor therapy;   Other: Continuous PD-1 inhibitor therapy&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Canadian Cancer Trials Group&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821013</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821039?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Idiopathic Pulmonary Fibrosis;   Usual Interstitial Pneumonia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Turkish Thoracic Society&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821039</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ryzodeg®</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821052?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Diabetes&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: insulin degludec/insulin aspart&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novo Nordisk A/S&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821052</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Evaluation of 4D Magnetic Resonance Flow Sequence at Hepatic Level</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821078?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Magnetic Resonance Imaging&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: 4D flow imaging sequence&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Centre Hospitalier Universitaire, Amiens&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821078</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Biomechanics Research in the Effects of Interactive Dynamic Balance Training on Postural and Gait Control in Older Adults</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821091?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Older Adults, Balance&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Interactive Dynamic Balance Training&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Taiwan University Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821091</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Bioavailability Crossover Study of Two Formulations of Lamotrigine Extended Release Tablets in Healthy Subjects</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821338?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Lamotrigine Extended Release&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Food and Drug Administration (FDA);   Vince &amp; Associates Clinical Research, Inc.;   Algorithme Pharma Inc&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821338</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Complement and Cardiovascular Risk in Adolescents</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821104?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Cardiovascular Disease;   Type 2 Diabetes&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Ohio State University;   American Heart Association&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821104</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Impact of Telemedicine to Support Palliative Care Resident in Nursing Home</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821143?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Palliative Care&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: usual palliative care;   Other: Telemedicine consultation&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University Hospital, Toulouse&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821143</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821169?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pain&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: ropivacaine;   Drug: saline solution 0.9%&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University Hospital, Lille&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821169</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Identification of Anaphylactogenic Antibodies in Peanut Allergy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821286?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Peanut Allergy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Observational study&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Zurich;   University Children's Hospital, Zurich&lt;br/&gt;&lt;b&gt;Enrolling by invitation&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821286</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of Sanofi Pasteur's DTaP-IPV Hep B-PRP-T Combined Vaccine in Infants Who Previously Received Hepatitis B Vaccine</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821195?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Hepatitis B;   Haemophilus Influenzae Type b&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Biological: DTaP-IPV-Hep B-PRP-T combined vaccine (Hexaxim™)&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Institute of Hygiene and Epidemiology, Vietnam;   Sanofi Pasteur, a Sanofi Company&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821195</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Clinical Evaluation of the Efficacity of Epilepsy Surgery in Infants and Children</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821260?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Epilepsy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Fondation Ophtalmologique Adolphe de Rothschild&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821260</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820883?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Staphylococcus Aureus Infection&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Staphylococcus aureus vaccine (60µg/per protein);   Biological: Staphylococcus aureus vaccine (30µg/per protein);   Biological: Staphylococcus aureus vaccine (15µg/per protein)&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Jiangsu Province Centers for Disease Control and Prevention;   Chengdu Olymvax Biopharmaceuticals Inc.;   Third Military Medical University&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820883</guid>
      <pubDate>Wed, 29 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Brain and Cognitive Reserve</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819167?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Brain Ischemia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: neurologic and neuropsychological evaluation&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Hospices Civils de Lyon&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819167</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02818998?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Macular Edema&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Bayer;   Regeneron Pharmaceuticals&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02818998</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Impact of a Therapeutic Education Program of Patient on the Evolution of the Cardiovascular Chronic Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819791?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Stroke;   Myocardial Infarction&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Optimized conventional therapy alone;   Behavioral: Optimized conventional therapy with therapeutic education&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University Hospital, Bordeaux&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819791</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Corticosteroid Mediates Acute Respiratory Distress Syndrome</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819453?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Respiratory Distress Syndrome&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Dexamethasone&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Shanghai Pulmonary Hospital, Shanghai, China&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819453</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Concomitant High-resolution Recording of Haemodynamic and Electrical Activities of Children With Typical or Atypical Absence Seizures</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819427?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Epilepsy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: Near Infra Red Spectroscopy (NIRS);   Device: Electroencephalography (EEG)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Centre Hospitalier Universitaire, Amiens&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819427</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Using Mother's Raw Milk Could Improve Breastfeeding in Hospitalized Neonates</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819193?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Breastfeeding&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: raw mother's own milk&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Hospices Civils de Lyon&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819193</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Paracetamol Treatment of the Borderline Significant PDA</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819414?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Patent Ductus Arteriosus&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Paracetamol drops;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Shaare Zedek Medical Center&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819414</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Effectiveness and Safety of Electroacupuncture on Poststroke Urinary Incontinence</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819336?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Urinary Incontinence;   Stroke, Complication&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: Electroacupuncture (EA);   Device: Sham electroacupuncture&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Kyunghee University;   Wonkwang University Gwangju Medical Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819336</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Comparison of Propofol, Propofol-remifentanil and Propofol-ketamine Anesthesia During Electroconvulsive Therapy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819375?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Anesthesia;   Electroconvulsive Therapy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Propofol;   Drug: Propofol+Remifentanil;   Drug: Propofol+Ketamine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Inonu University&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819375</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine - FLU-02-IB</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819180?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Influenza&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Butantan Influenza Trivalent, Fragmented and Inactivated vaccine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Butantan Institute&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819180</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of the Social and Psychological Consequences of ICU Hospitalization</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819154?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Intensive Care Units&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: phone call to evaluate the social changes, emotional, professional a cohort of patients following ICU stay&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Groupe Hospitalier Paris Saint Joseph&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819154</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Evaluation of the Interest of the Instillation of Saline Intraperitoneally (INSI ) Versus Instillation of Naropin the Surgical Site Versus Lung Recruitment Maneuvers ( PVM ) in the Management of Pain After Laparoscopic Cholecystectomy in Ambulatory Care</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819544?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Surgery;   Pain&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Sodium chloride administration;   Drug: Ropivacaine administration&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Centre Hospitalier Universitaire, Amiens&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819544</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819310?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Constipation;   Chronic Idiopathic Constipation;   CIC&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: BLI400 Laxative&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Braintree Laboratories&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819310</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>First-in-Human Safety, PK, and Food Effect Study of Single Ascending Doses of G1T38 in Healthy Volunteers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821624?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy Volunteers&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: G1T38 (CDK 4/6 Inhibitor);   Biological: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    G1 Therapeutics, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821624</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819297?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Constipation;   Chronic Idiopathic Constipation;   CIC&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: BLI400 Laxative;   Drug: BLI400 Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Braintree Laboratories&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819297</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Benefit of a Diagnostic MRI in Case of Pathological Nipple Discharge With Normal Mammography / Ultrasound</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819362?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Breast Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: MRI&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Institut Bergonié;   Société d'Imagerie de la Femme&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819362</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Texting for Relapse Prevention</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819349?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Schizophrenia;   Schizoaffective Disorder&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Texting for Relapse Prevention (T4RP)&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Center for Innovative Public Health Research;   Community Psychiatry Program, Johns Hopkins Hospital&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819349</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Combination Effect of Statin Plus Metformin on Relapse-free</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819869?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hepatocellular Carcinoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Statin and Metformin use&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Taipei Medical University WanFang Hospital&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified January 2016</description>
      <guid isPermaLink="false">NCT02819869</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819011?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Accidental Falls;   Fall Due to Loss of Equilibrium;   High Risk of Falls Due to Mobility Limitation;   Diabetes;   Arthritis;   Cancer;   Peripheral Arterial Disease;   Parkinson's Disease;   End Stage Renal Failure on Dialysis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: AFO;   Other: Control&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Bijan Najafi;   Orthotic Holdings Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819011</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Side Specific Withdrawal Times for Colonoscopy: Impact on Adenoma Detection in the Proximal and Distal Colon</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819492?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Colon Adenoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Technische Universität München&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819492</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Analgesia in Knee Arthroscopic Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02818985?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Analgesia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Dexamethasone;   Drug: Dexmedetomidine;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Assiut University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02818985</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819115?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Influenza&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Butantan Fragmented Inactivated Trivalent Influenza Vaccine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Butantan Institute&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819115</guid>
      <pubDate>Tue, 28 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>PCT REveals Good Recovery After Acute Diverticulitis: the PREGRAD Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02817854?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Diverticulitis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Measure PCT, CRP and WBC at admission;   Procedure: Measure PCT, CRP and WBC 1 day after admission;   Procedure: Measure PCT, CRP and WBC 2 days after admission&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Roma La Sapienza&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02817854</guid>
      <pubDate>Mon, 27 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Frequency Of MCP-1 And CCR2 Gene Polymorphisms And Its Effect On Gene Expression In Patients With AgP</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02817568?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Aggressive Periodontitis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Drawing Blood&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Abant Izzet Baysal University;   Selcuk University&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02817568</guid>
      <pubDate>Mon, 27 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Intranasal Ketamine for Acute Traumatic Pain</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02817477?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Pain&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Ketamine Hydrochloride;   Drug: Morphine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Tel Aviv Medical Center&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02817477</guid>
      <pubDate>Mon, 27 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Effects of Blue-light Blocking Lens on Visual Functions</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821403?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Effects of Blue-light Blocking Lens on Visual Functions&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Three spectacle lens designs: 1) clear lens with regular coating; 2) regular coating lens with yellow tint; 3) clear lens with blue-light blocking coating&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    The Hong Kong Polytechnic University&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821403</guid>
      <pubDate>Mon, 27 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Enhancing Patient Ability to Understand and Utilize Complex Information Concerning Medication Self-management</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820038?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Rheumatoid Arthritis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Medication Guides;   Behavioral: SMART Program;   Behavioral: Drug Facts Boxes&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of North Carolina, Chapel Hill;   The University of Texas at Dallas;   University of Alabama at Birmingham;   University of Texas Southwestern Medical Center;   University of Pittsburgh;   Global Healthy Living Foundation;   Dartmouth-Hitchcock Medical Center;   Cornell University&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820038</guid>
      <pubDate>Mon, 27 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Studies of Neuregulin/ERBB Signaling in Human Heart</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820233?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Heart Disease;   Vascular Disease;   Heart Failure&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Maine Medical Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820233</guid>
      <pubDate>Mon, 27 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>FreeStyle Libre Glucose Monitoring System Paediatric Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821117?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Diabetes Mellitus&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: FreeStyle Libre Flash Glucose Monitoring System&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Abbott Diabetes Care&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821117</guid>
      <pubDate>Mon, 27 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Relay PRO Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02818972?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Aortic Aneurysm, Thoracic&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Relay PRO&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Bolton Medical&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02818972</guid>
      <pubDate>Mon, 27 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Improving Renal Complications in Adolescents With Type 2 Diabetes Through REsearch Cohort Study (National iCARE Study)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02818192?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Type 2 Diabetes;   Proteinuria;   Stress;   Nephropathy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Manitoba;   Canadian Institutes of Health Research (CIHR)&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02818192</guid>
      <pubDate>Mon, 27 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Initial Versus Delayed PDT Combination With Conbercept in PCV</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821520?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Polypoidal Choroidal Vasculopathy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Initial PDT Combination with Conbercept;   Drug: Delayed PDT Combination with Conbercept&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    The Eye Hospital of Wenzhou Medical University&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821520</guid>
      <pubDate>Sat, 25 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Effects of a Six-week Exercise Programme Undertaken by Women With Rheumatoid Arthritis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819830?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Rheumatoid Arthritis;   Physical Activity&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Exercise Intervention&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Siobhan Graham;   University of Bath&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819830</guid>
      <pubDate>Sat, 25 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Water for Reducing Pain in Negative Pressure Wound Therapy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820272?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Treatment&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: NPWT with cold water;   Procedure: NPWT with normal saline room temp;   Procedure: NPWT without other intervention&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Chulalongkorn University&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820272</guid>
      <pubDate>Fri, 24 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>PGS on Blastocysts From Vitrified and Fresh Oocytes</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820415?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Increase the Number of Blastocyst to Biopsy for Preimplantation Genetic Testing&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: chromosomal status of blastocysts from fresh and vitrified/warmed oocytes&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Unità di Medicina della Riproduzione, Italy&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820415</guid>
      <pubDate>Fri, 24 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Vocal Intervention in Systemic Sclerosis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821663?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Systemic Sclerosis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: vocal intervention&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Medical University of Vienna&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821663</guid>
      <pubDate>Fri, 24 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Oral Glucocorticoids Effect on Post Endodontic Pain</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819648?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pulpitis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Prednisolone;   Other: Control&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Cairo University&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819648</guid>
      <pubDate>Fri, 24 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study Assessing Evaluation of the Interest of Serum S100B Protein Determination in the Management of Pediatric Mild Traumatic Brain Injury</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819778?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Craniocerebral Trauma;   Pediatrics&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: usual care;   Procedure: S100B&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University Hospital, Clermont-Ferrand&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819778</guid>
      <pubDate>Fri, 24 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Sun Protection Factor Assay (SPF Assay 19010)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02815241?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Sunscreening Agents&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: BAY987517&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Bayer&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02815241</guid>
      <pubDate>Fri, 24 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Knowledge and Perceptions Regarding JSSK and RBSK in Patients and Nurses: A Comparative Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820220?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Knowledge Maternal-Child Health Services&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Lady Hardinge Medical College&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820220</guid>
      <pubDate>Fri, 24 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Sun Protection Factor Assay (SPF Assay 19009)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02815228?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Sunscreening Agents&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: BAY987517&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Bayer&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02815228</guid>
      <pubDate>Fri, 24 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Sun Protection Factor Assay (SPF Assay 19008)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02815202?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Sunscreening Agents&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: BAY987517&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Bayer&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02815202</guid>
      <pubDate>Fri, 24 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Surfactant Administration in Preterm Infants</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821273?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Modified INSURE Technique&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Modified INSURE technique;   Other: INSURE technique&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Daping Hospital and the Research Institute of Surgery of the Third Military Medical University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821273</guid>
      <pubDate>Fri, 24 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Dexamethasone as an Adjuvant to Ropivacaine for the Interscalene Brachial Plexus Block: a Dose-finding</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02818491?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Postoperative Pain&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Placebo;   Drug: Dexamethasone 1 mg;   Drug: Dexamethasone 2 mg;   Drug: Dexamethasone 3 mg;   Drug: Dexamethasone 4 mg;   Drug: Ropivacaine 0.5%&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Centre Hospitalier Universitaire Vaudois&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02818491</guid>
      <pubDate>Thu, 23 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Effectivity and Safety of Endoscopic Ultrasonography-guided Laser Ablation for Refractory Neoplasms</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02816944?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Refractory Neoplasms&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: EUS-guided laser ablation for refractory neoplasms&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    First Affiliated Hospital of Zhejiang University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02816944</guid>
      <pubDate>Thu, 23 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Metabolic Effects of Furosemide +HSS in Refractory Ascites</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821377?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Ascites;   Cirrhosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: intravenous furosemide;   Drug: Hypertonic saline solutions;   Procedure: Seriated paracentesis&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Palermo&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821377</guid>
      <pubDate>Thu, 23 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>MicroCutter Assisted Thoracic Surgery Hemostasis Registry</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02816671?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Lobectomy;   Segmentectomy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Surgical Stapler&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Dextera Surgical Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02816671</guid>
      <pubDate>Thu, 23 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Brain Function in Children With Congenital Heart Disease (CHD)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02814539?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Congenital Heart Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Bea Latal;   University of Zurich;   Mäxi Foundation&lt;br/&gt;&lt;b&gt;Enrolling by invitation&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02814539</guid>
      <pubDate>Thu, 23 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Triglyceride-rich Lipoprotein and Development of Dementia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02814422?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Dementia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Taiwan University Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02814422</guid>
      <pubDate>Thu, 23 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of the Role Des Fc Gamma Receptors in Immune Thrombocytopenic Purpura (ITP)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821572?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Purpura Immunological Thrombopenia (PTI)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: blood sample;   Procedure: spleen sample&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Centre Hospitalier Universitaire Dijon&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821572</guid>
      <pubDate>Thu, 23 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821715?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Narcolepsy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: THN102;   Drug: Modafinil&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Theranexus&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821715</guid>
      <pubDate>Thu, 23 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>ACT DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821351?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Paroxysmal Atrial Fibrillation&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Radio frequency (RF) Cardiac ablation&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Advanced Cardiac Therapeutics&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02821351</guid>
      <pubDate>Wed, 22 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Somatostatin Receptor Imaging in Cardiac Sarcoidosis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02812849?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cardiac Sarcoidosis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Cu-64 DOTATATE&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Rigshospitalet, Denmark&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02812849</guid>
      <pubDate>Wed, 22 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Effects of the Proprioceptive Neuromuscular Facilitation for Promoting Muscular Irradiation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821598?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Motor Disorders&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Upper Limb pattern with flexion - abduction - external rotation;   Other: Lower Limb pattern with flexion - adduction - external rotation with knee flexion;   Other: Lower Limb pattern with flexion - abduction - internal rotation with knee flexion;   Other: Lifting to the right;   Other: Sit to Stand&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Federal University of Health Science of Porto Alegre&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821598</guid>
      <pubDate>Wed, 22 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Assessment of a Novel Tracheostomy Tie</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820181?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Tracheostomy Complication&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: novel tracheostomy bi-ties;   Device: traditional Tracheostomy ties&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    The First Affiliated Hospital of Shanxi Medical University&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820181</guid>
      <pubDate>Wed, 22 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820116?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Non-small Cell Lung Cancer(NSCLC)&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Icotinib&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Beijing Haidian Hospital;   Peking University People's Hospital;   307 Hospital of PLA;   309th Hospital of Chinese People's Liberation Army&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02820116</guid>
      <pubDate>Wed, 22 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study to Test the Impact of an Improved Chulha on Respiratory Health of Women and Children in Indian Slums</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821650?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Signs and Symptoms, Respiratory;   Air Pollution, Indoor&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: TEJ (Traditional stove to Efficient stove in Jhuggi)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Maastricht University&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821650</guid>
      <pubDate>Tue, 21 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821689?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Dermatopolymyositis;   Interstitial Lung Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Pirfenidone&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    RenJi Hospital&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821689</guid>
      <pubDate>Tue, 21 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Impact of an Effort Rehabilitation Program for Overweight/Obese Children/Teens on Quality of Life and Wellbeing</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821637?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pediatric Obesity&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Eurofit Tests of Physical Fitness (Eurofit);   Behavioral: Child Health Questionnaire (CHQ);   Other: Effort rehabilitation program&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Groupe Hospitalier de la Region de Mulhouse et Sud Alsace&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821637</guid>
      <pubDate>Mon, 20 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Identification of Carotid Plague Vulnerability by Contrast Enhanced Ultrasound: Correlation With Plague Histopathology</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820207?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Carotid Artery Plaque;   Ultrasonic Diagnosis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Beijing Tsinghua Chang Gung Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820207</guid>
      <pubDate>Mon, 20 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Clinical Trial to Evaluate Drug-drug Interactions Between Darunavir/Cobicistat and Etravirine in Hiv- Infected Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02818348?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    HIV-1 Infection&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: darunavir/cobicistat;   Drug: etravirine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Fundacio Lluita Contra la SIDA&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02818348</guid>
      <pubDate>Mon, 20 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Effect of Yoghurts Enriched With XXS (Mixture of Natural Polyphenolic Compounds and Plant Extracts) on the Evolution of Weight in Overweight Subjects</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02810041?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Obesity;   Overweight&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Dietary Supplement: yoghurts enriched with XXS;   Dietary Supplement: yoghurts non enriched with XXS&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Centre Hospitalier Universitaire Dijon&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02810041</guid>
      <pubDate>Mon, 20 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819882?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Breast Neoplasms&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: No intervention&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Spanish Breast Cancer Research Group;   Hoffmann-La Roche;   Novartis;   AstraZeneca;   Pfizer;   Celgene&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819882</guid>
      <pubDate>Mon, 20 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Impact of a Nutritional Intervention on Type1 Diabetes Adult With Metabolic Syndrome</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821585?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Type 1 Diabetes;   Metabolic Syndrome&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Nutritional Counseling&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Institut de Recherches Cliniques de Montreal&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821585</guid>
      <pubDate>Mon, 20 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821312?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Overactive Bladder&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: DA-8010;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Dong-A ST Co., Ltd.&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821312</guid>
      <pubDate>Sun, 19 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>11C or 18F-Choline PET/CT and Whole Body MRI for Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02815033?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostate Cancer Metastatic&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Enzalutamide;   Procedure: 11C or 18F-Choline PET/CT;   Procedure: Whole body MRI;   Procedure: Bone scan&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    The European Uro-Oncology Group;   Centre for Human Drug Research, Netherlands&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02815033</guid>
      <pubDate>Sat, 18 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>18F-FDG PET/CT and Whole Body MRI for Staging and Response Prediction in Castration-resistant Prostate Cancer Patients Receiving Enzalutamide</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02814968?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostate Cancer Metastatic&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Enzalutamide;   Device: 18-FDG PET/CT;   Device: Whole body MRI;   Device: Bone scan&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    The European Uro-Oncology Group;   Centre for Human Drug Research, Netherlands&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02814968</guid>
      <pubDate>Sat, 18 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Lacto-ovo-vegetarian Diet Riched in Omega-3 Fatty Acids in Menopausal Women</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02816814?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Menopause;   Metabolic Syndrome;   Hepatic Steatosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Diet rich in omega-3 fatty acids;   Other: Diet with extra virgin olive oil&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis&lt;br/&gt;&lt;b&gt;Enrolling by invitation&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02816814</guid>
      <pubDate>Fri, 17 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02809092?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Myeloid Leukemia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: NK Cells + Chemotherapy Starting&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Hospital de Clinicas de Porto Alegre&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02809092</guid>
      <pubDate>Fri, 17 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study on the Efficacy and Safety of Gelaspan</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02808325?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hypovolemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Gelaspan 4%;   Drug: Gelofusine 4%&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    B. Braun Medical LLC&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02808325</guid>
      <pubDate>Fri, 17 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic Asthmatics</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821416?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Asthma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Benralizumab;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    AstraZeneca&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821416</guid>
      <pubDate>Fri, 17 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Fertility Post Placenta Accrete</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821702?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Fertility&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: Vaginal ultrasound;   Biological: Blood sample&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Sheba Medical Center&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821702</guid>
      <pubDate>Fri, 17 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Monitoring HDR Brachytherapy for Cervical Cancer by Optic and Thermal Imaging</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02818179?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    MALIGNANCY&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Radiation: THERMOGRAPHY IMAGING&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Sheba Medical Center&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02818179</guid>
      <pubDate>Thu, 16 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Tolerance of a Calorically Dense Enteral Nutrition Formula</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02806427?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Enteral Feeding&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Enteral Formula&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Nestlé&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02806427</guid>
      <pubDate>Thu, 16 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Subjects</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02814656?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Chronic Obstructive Pulmonary Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: AZD8871;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    AstraZeneca;   Parexel&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02814656</guid>
      <pubDate>Thu, 16 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02807025?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    IPF;   Sarcoidosis;   Tuberculosis;   Asthma;   COPD;   Healthy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Imperial College Healthcare NHS Trust&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02807025</guid>
      <pubDate>Thu, 16 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Anterior Cruciate Ligament Radiology Follow-up Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02816606?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Anterior Cruciate Ligament Rupture&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Flexible reamers;   Procedure: 70-degree arthroscope&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Royal Devon and Exeter NHS Foundation Trust&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02816606</guid>
      <pubDate>Wed, 15 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02803203?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Non-small Cell Lung Cancer;   EGFR-mutant Lung Cancers&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: osimertinib;   Drug: Bevacizumab&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Memorial Sloan Kettering Cancer Center;   AstraZeneca;   Genentech, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02803203</guid>
      <pubDate>Tue, 14 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02804763?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Systemic Lupus Erythematosus (SLE)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Placebo;   Drug: Dapirolizumab pegol (DZP)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    UCB Biopharma S.P.R.L.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02804763</guid>
      <pubDate>Tue, 14 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820324?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Pain&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Oliceridine;   Drug: Placebo;   Drug: Morphine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Trevena Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820324</guid>
      <pubDate>Thu, 09 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Clinical Evaluation of Laryngeal Transplantation: Study of 3 Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821299?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Laryngeal Transplantation&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Laryngeal transplantation&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Hospices Civils de Lyon&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821299</guid>
      <pubDate>Thu, 09 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02798250?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Type 1 Diabetes&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Dual-hormone closed-loop;   Drug: Insulin;   Drug: Glucagon;   Device: Dexcom G4 Platinum glucose sensor;   Device: Accu Chek Combo insulin pump&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Institut de Recherches Cliniques de Montreal&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02798250</guid>
      <pubDate>Thu, 09 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02814864?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Pelvic Radiation Therapy;   Radiation-induced Hemorrhagic Cystitis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Mesenchymal Stromal Cell (MSC) injections&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Assistance Publique - Hôpitaux de Paris&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02814864</guid>
      <pubDate>Thu, 09 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Stereotactic Radiotherapy for Renal Cancers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02811250?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Renal Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Radiation: Stereotactic radiotherapy 4 x 8 Gy;   Radiation: Stereotactic radiotherapy 5 x 8 Gy;   Radiation: Stereotactic radiotherapy 4 x 10 Gy;   Radiation: Stereotactic radiotherapy 4 x 12 Gy&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Hospices Civils de Lyon&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02811250</guid>
      <pubDate>Wed, 08 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Oral Probiotics for the Treatment and Prevention of Vulvovaginal Infections in Pregnancy - Double-blind, Randomized, Placebo-controlled Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02795845?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Bacterial Vaginosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Dietary Supplement: Probiotic Capsule containing L. acidophilus, L. Paracasei, L. Rhamnosus, streptococcus thermophilus and Bifidobacterium bifidum;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    HaEmek Medical Center, Israel&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02795845</guid>
      <pubDate>Tue, 07 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Cell Therapy by Autologous BMC for Large Bone Defect Repair</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02803177?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Humerus Fracture Displaced Proximal&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: BMC2012;   Device: beta-TCP Chronos® Synthes&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Goethe University;   LOEWE CGT&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02803177</guid>
      <pubDate>Tue, 07 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RDX5791 in Healthy Volunteers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819687?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: RDX5791;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Ardelyx&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819687</guid>
      <pubDate>Tue, 07 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Chemoembolization for Hepatocellular Carcinoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821533?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hepatocellular Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: TACE;   Drug: Cisplatin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Chinese University of Hong Kong&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821533</guid>
      <pubDate>Tue, 07 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02794467?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Adenomyosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Epelsiban;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02794467</guid>
      <pubDate>Mon, 06 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Evaluation of the Evolution of Imaging Markers of Cartilage Degradation in Patients With Knee Osteoarthritis Receiving DROGLICAN</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821468?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Osteoarthritis, Knee&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Droglican;   Drug: Paracetamol or oral NSAIDs excluding COX2 inhibitors&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Bioiberica;   Artialis&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821468</guid>
      <pubDate>Mon, 06 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Perioperative Three Dimensional Right Ventricular Function</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820727?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Heart Diseases&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University Hospital Tuebingen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820727</guid>
      <pubDate>Mon, 06 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02794519?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Asthma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Sirukumab;   Drug: Placebo;   Drug: Rescue medication&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02794519</guid>
      <pubDate>Mon, 06 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Long Term Effect of Early Iron Supplementation and Psychosocial Stimulation on Growth and Development of Iron-deficient Anaemic Infants</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02801721?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Anaemia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: psycho social stimulation&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    International Centre for Diarrhoeal Disease Research, Bangladesh&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02801721</guid>
      <pubDate>Sun, 05 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Project FACTS (Fidelity Accuracy: Comparing Three Strategies)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820623?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Assess Fidelity to Cognitive-behavioral Therapy for Youth&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Self-report;   Behavioral: Chart-Stimulated Recall;   Behavioral: Behavioral Rehearsal&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Pennsylvania&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820623</guid>
      <pubDate>Fri, 03 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Phase I Single and Multiple Escalating Dose Study of RGN1016 in Healthy Male Subjects</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820155?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: RGN1016;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Taiwan University Hospital;   National Taiwan University&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820155</guid>
      <pubDate>Fri, 03 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Clinical Trial In Healthy Volunteers And Health Elderly Volunteers To Evaluate The Safety, Tolerability And Blood Concentration After Single And Multiple Escalating Oral Doses Of PF-06751979.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02793232?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy Subjects&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: PF-06751979 single dose;   Drug: Placebo single dose;   Drug: PF-06751979 multiple ascending dose;   Drug: Placebo multiple ascending dose;   Drug: PF-06751979 multiple dose;   Drug: Placebo multiple elderly dose&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Pfizer&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02793232</guid>
      <pubDate>Fri, 03 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Hespecta Vaccination in HPV+ Head and Neck Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821494?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Head and Neck Neoplasms&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Hespecta&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Leiden University Medical Center;   ISA Pharmaceuticals;   Dutch Cancer Society;   Top Institute Pharma&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02821494</guid>
      <pubDate>Thu, 02 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Phase III Study of GSK1278863 in Japanese Non-dialysis and Peritoneal Dialysis Subjects With Renal Anemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02791763?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Anaemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: 1 to 4 mg tablets of GSK1278863;   Drug: 6 mg GSK1278863 tablet;   Drug: Epoetin beta pegol&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02791763</guid>
      <pubDate>Thu, 02 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Comparison of Two Antibiotic Prophylactic Protocols in Preterm Premature Rupture of the Membranes</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819570?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Premature Rupture of Membrane&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: I.V cefuroxime 750 mg*3/d for 2 days;   Drug: I.V ampicillin 2 gram x4/d for 2 days;   Drug: P.O cefuroxime 500 mgx2/d for 5 days;   Drug: P.O roxithromycin 150 mg*2/d for 7 days;   Drug: P.O moxypen 500 mgx3/d for 5 days&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Western Galilee Hospital-Nahariya&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819570</guid>
      <pubDate>Thu, 02 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02795676?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Fabry Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: PRX-102;   Biological: Agalsidase beta&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Protalix&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02795676</guid>
      <pubDate>Thu, 02 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Neurofunctional Predictors of Escitalopram Treatment Response in Adolescents With Anxiety</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02818751?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Anxiety&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Escitalopram;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Cincinnati;   National Institute of Mental Health (NIMH)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02818751</guid>
      <pubDate>Thu, 02 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Clinical Relevance of P16INK4A Expressing CTCs Detection Comparing With HPV Infection in Cancer Tissue in HNSCC Patients.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02791607?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrence;   Metastasis;   Death&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Chang Gung Memorial Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02791607</guid>
      <pubDate>Wed, 01 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02791334?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Solid Tumor&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: LY3300054;   Drug: Ramucirumab;   Drug: Necitumumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Eli Lilly and Company&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02791334</guid>
      <pubDate>Wed, 01 Jun 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>PECI/SPB vs Intercostal Nerve Block for the Management of Postoperative Pain in Latissimus Dorsi Flap Reconstruction</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821676?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: PECI/SPB Block with Active Anesthetic + Placebo Multilevel Intercostal Nerve Block followed by Latissimus Dorsi Flap Breast Reconstruction;   Procedure: Placebo PEC/SPB Block + Multilevel Intercostal Nerve Block with Active Anesthetic followed by Latissimus Dorsi Flap Breast Reconstruction&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Ottawa Hospital Research Institute&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821676</guid>
      <pubDate>Tue, 31 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Predictive Effect of the Inflammatory Response on the Evacuation of Mechanical Ventilation and the Mechanism</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820090?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Systemic Inflammatory Response Syndrome;   Ventilator Weaning&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Beijing Chao Yang Hospital&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820090</guid>
      <pubDate>Tue, 31 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Latin American Study of 24-hs Symptoms in Chronic Obstructive Pulmonary Disease (COPD) Patients; LASSYC Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02789540?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Stable COPD Patients&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    AstraZeneca&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02789540</guid>
      <pubDate>Mon, 30 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV[Delta]G-ZEBOV-GP) for Pre-Exposure Prophylaxis (PREP) in People at Potential Occupational Risk for Ebola Virus Exposure</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02788227?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy Volunteers&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: rVSVdeltaG-ZEBOV GP (2X 107 pfu/mL)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02788227</guid>
      <pubDate>Sat, 28 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Vedolizumab (Anti- 4 &lt;=7) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02788175?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    HIV&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Entyvio (Vedolizumab)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02788175</guid>
      <pubDate>Sat, 28 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Aggressive Fluid Hydration for the Prevention of Post-ERCP Pancreatitis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821546?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pancreatitis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Lactated Ringer's solution&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Mahidol University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821546</guid>
      <pubDate>Fri, 27 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02788409?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostatic Neoplasms&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Not applicable for study&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Bayer;   RTI Health Solutions&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02788409</guid>
      <pubDate>Fri, 27 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02786927?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pulmonary Disease, Chronic Obstructive&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Placebo ELLIPTA device;   Drug: Placebo capsules for use in HANDIHALER device;   Other: Inhaler Preference Questionnaire Version 1;   Other: Inhaler Preference Questionnaire Version 2&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02786927</guid>
      <pubDate>Thu, 26 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02787551?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Type 2 Diabetes Mellitus&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: insulin glargine/lixisenatide fixed ratio combination;   Drug: liraglutide;   Drug: exenatide;   Drug: exenatide extended-release;   Drug: albiglutide;   Drug: dulaglutide;   Drug: metformin;   Drug: pioglitazone&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Sanofi&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02787551</guid>
      <pubDate>Thu, 26 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02799472?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Arthritis, Rheumatoid&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: GSK3196165;   Drug: Placebo;   Drug: MTX;   Drug: Folic (or folinic) acid&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    GlaxoSmithKline;   Parexel&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02799472</guid>
      <pubDate>Thu, 26 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Sensor Controlled Compliance Evaluation of Compressive Elastic Stockings</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02792907?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Disorder of Ankle Joint&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Compressive stocking&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Balgrist University Hospital&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02792907</guid>
      <pubDate>Wed, 25 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02785900?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Myeloid Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: 33A;   Drug: placebo;   Drug: azacitidine;   Drug: decitabine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Seattle Genetics, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02785900</guid>
      <pubDate>Wed, 25 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>RITCH: Reducing Disparities in Tobacco Cessation Outcomes</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02785536?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Smoking Cessation&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: RITCh Treatment;   Behavioral: Standard Treatment&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    The City College of New York;   Virginia Tech Carilion Research Institute&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02785536</guid>
      <pubDate>Wed, 25 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Effect and Mechanism of Respiratory Stimulant Doxapram on Facilitating Emergence</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820025?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Anesthesia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: doxapram;   Other: saline&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    General Hospital of Ningxia Medical University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified January 2016</description>
      <guid isPermaLink="false">NCT02820025</guid>
      <pubDate>Wed, 25 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Universal Cancer Peptide-based Vaccination in Metastatic NSCLC</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02818426?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Metastatic Non-small Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: UCPVax&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Centre Hospitalier Universitaire de Besancon;   Invectys&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02818426</guid>
      <pubDate>Fri, 20 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Chinese Early-onset Hypertension Study (CEHS)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819674?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hypertension&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    China National Center for Cardiovascular Diseases&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819674</guid>
      <pubDate>Fri, 20 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study on the Use of Inhaled NO (iNO)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821156?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pulmonary Hypertension&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Air Liquide Santé International;   EURAXI Pharma&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821156</guid>
      <pubDate>Fri, 20 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>[Trial of device that is not approved or cleared by the U.S. FDA]</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02782117?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    [Redacted]&lt;br/&gt;&lt;b&gt;Withheld&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT02782117</guid>
      <pubDate>Thu, 19 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>PANORAMA - Real World Molecular Testing, Treatment Patterns, and Clinical Outcomes EGFR Mutation-Positive NSCLC</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02777658?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Carcinoma, Non-Small-Cell Lung&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    AstraZeneca;   iOMEDICO AG, Freiburg, Germany&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02777658</guid>
      <pubDate>Tue, 17 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02795429?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Advanced Hepatocellular Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: PDR001;   Drug: INC280&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novartis Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02795429</guid>
      <pubDate>Tue, 17 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02776735?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Juvenile Idiopathic Arthritis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Sarilumab SAR153191 (REGN88)&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Sanofi;   Regeneron Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02776735</guid>
      <pubDate>Mon, 16 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02793154?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Diabetes Mellitus, Type 2&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Exenatide;   Drug: Albiglutide&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    GlaxoSmithKline;   Wake Forrest Baptist Health&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02793154</guid>
      <pubDate>Mon, 16 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Closed-loop Control of Postprandial Glucose Levels After Meals With Different Macronutrients Content in Adults With Type 1 Diabetes</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02774876?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Type 1 Diabetes&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: Patient's insulin pump;   Drug: Insulin;   Device: Dexcom G4 Platinum glucose sensor;   Other: Single-hormone closed-loop&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Institut de Recherches Cliniques de Montreal&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02774876</guid>
      <pubDate>Fri, 13 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02773979?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Plasmodium Falciparum Infection&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Chloroquine;   Other: Placebo;   Biological: PfSPZ&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02773979</guid>
      <pubDate>Thu, 12 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>PfSPZ Challenge in Non-immune Adults in Baltimore, USA</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02780154?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Plasmodium Falciparum Infection&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: PfSPZ (NF54);   Biological: PfSPZ (7G8)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02780154</guid>
      <pubDate>Thu, 12 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in Greece</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821247?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Choroidal Neovascularization;   Macular Degeneration&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: VEGF-Trap-Eye (BAY86-5321)&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Bayer;   Regeneron Pharmaceuticals&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821247</guid>
      <pubDate>Wed, 11 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Optimal Vitamin D3 Supplementation Strategies for Acute Fracture Healing</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02786498?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Fracture&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Vitamin D3;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Maryland;   McMaster University&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02786498</guid>
      <pubDate>Wed, 11 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Managing Infliximab Reinduction After Temporary Discontinuation of Drug</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02771457?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Inflammatory Bowel Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Infliximab at weeks 0,2, and 6;   Drug: Infliximab at weeks 0,4, and 8;   Drug: Infliximab at weeks 0 and 8&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    New York University School of Medicine&lt;br/&gt;&lt;b&gt;Withdrawn&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02771457</guid>
      <pubDate>Mon, 09 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02766478?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostate Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Genistein;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Emory University&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02766478</guid>
      <pubDate>Fri, 06 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02767557?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Unresectable Pancreatic Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Tocilizumab;   Drug: Gemcitabine;   Drug: nab-Paclitaxel&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Herlev Hospital;   Celgene;   Roche Pharma AG&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02767557</guid>
      <pubDate>Fri, 06 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Bright 1 Bodies Weight Management Program</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02768987?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Diabetes Mellitus, Type 1&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Bright 1 Bodies&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Yale University;   University of the West of Scotland;   Texas A&amp;M University&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02768987</guid>
      <pubDate>Wed, 04 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Cabozantinib-S-Malate, Crizotinib, Volitinib, or Sunitinib Malate in Treating Patients With Locally Advanced or Metastatic Kidney Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02761057?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent Renal Cell Carcinoma;   Stage III Renal Cell Cancer;   Stage IV Renal Cell Cancer;   Type 1 Papillary Renal Cell Carcinoma;   Type 2 Papillary Renal Cell Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cabozantinib S-malate;   Drug: Crizotinib;   Other: Laboratory Biomarker Analysis;   Drug: Sunitinib Malate;   Drug: Volitinib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02761057</guid>
      <pubDate>Mon, 02 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Effects of Propofol and Sevoflurane on Early POCD in Elderly Patients With Metabolic Syndrome</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02766062?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Postoperative Complications&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: metabolic syndrome&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    General Hospital of Ningxia Medical University&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified January 2016</description>
      <guid isPermaLink="false">NCT02766062</guid>
      <pubDate>Sun, 01 May 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>eXalt3: Study Comparing X-396 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02767804?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Non-small Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: X-396;   Drug: crizotinib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Xcovery Holding Company, LLC&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02767804</guid>
      <pubDate>Sat, 30 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Long-term Safety Study of Intranasal Esketamine in Treatment-resistant Depression</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02782104?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Depressive Disorder, Treatment-Resistant&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Intranasal Esketamine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Janssen Research &amp; Development, LLC&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02782104</guid>
      <pubDate>Fri, 29 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Medtronic Transcatheter Aortic Valve Implant System (CoreValve System Family) Post Marketing Surveillance (PMS) (CoreValve India PMS)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02759237?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Symptomatic Aortic Stenosis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: CoreValve System Family&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Medtronic Cardiovascular;   Medtronic&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02759237</guid>
      <pubDate>Fri, 29 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Pathophysiological Study of Adipose Tissue of Patients Infected With HIV</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02820337?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    HIV&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02820337</guid>
      <pubDate>Fri, 29 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02817789?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Aortic Valve Stenosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Ticagrelor alone;   Drug: Combination lysine acetylsalicylate - clopidogrel&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University Hospital, Bordeaux&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02817789</guid>
      <pubDate>Fri, 29 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Bilastine and Montelukast in Patients With Seasonal Allergic Rhinoconjunctivitis (SARC) and Asthma : Efficacy of Concomitant Administration</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02761252?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Seasonal Allergic Rhinoconjunctivitis;   Asthma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Bilastine 20mg;   Drug: Montelukast 10mg;   Drug: Placebo Bilastine 20mg;   Drug: Placebo Montelukast 10mg&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Menarini International Operations Luxembourg SA&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02761252</guid>
      <pubDate>Thu, 28 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects &gt;=50 Years</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02757963?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostatic Hyperplasia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Benign prostatic enlargement (BPE)/Benign prostatic obstruction (BPO) screening tool;   Other: International Prostate Symptom Score (IPSS) screening tool&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02757963</guid>
      <pubDate>Thu, 28 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02756962?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Myeloid Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cytarabine;   Procedure: Allogeneic stem cell transplant;   Procedure: Bone marrow aspiration;   Procedure: Punch skin biopsy&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Washington University School of Medicine&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02756962</guid>
      <pubDate>Wed, 27 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Evaluation of the Efficacy of Diafert in Predicting Embryos' Potential to Develop to the Blastocyst Stage</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02788617?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Infertility&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Diafert&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Forest Laboratories&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02788617</guid>
      <pubDate>Tue, 26 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Venetoclax and Ibrutinib in Patients With Chronic Lymphocytic Leukemia (CLL)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02756897?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Leukemia;   Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Ibrutinib;   Drug: Venetoclax&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   AbbVie&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02756897</guid>
      <pubDate>Tue, 26 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study to Evaluate the Efficacy of Venetoclax in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL) Including Those With 17p Deletion or TP53 Mutation or Those Who Are Refractory or Intolerant to B-cell Receptor Inhibitors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02756611?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Chronic Lymphocytic Leukemia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Venetoclax&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    AbbVie&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02756611</guid>
      <pubDate>Tue, 26 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Tremelimumab (Anti-CTLA-4) Plus MEDI4736 (Anti-PD-L1) in Resectable Colorectal Cancer Liver Metastases.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02754856?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Colorectal Cancer;   Liver Metastases&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Tremelimumab;   Drug: Fluorouracil;   Drug: Leucovorin;   Drug: Oxaliplatin;   Drug: Bevacizumab;   Drug: MEDI4736;   Procedure: Liver Resection&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   MedImmune LLC&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02754856</guid>
      <pubDate>Tue, 26 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Maggot Debridement Therapy Versus Conventional Dressing Therapy to Treat Diabetic Foot Ulcers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02816749?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Diabetic Foot Ulcers&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Maggot debridement therapy;   Procedure: Conventional Dressing Therapy&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    The First Affiliated Hospital of Dalian Medical University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02816749</guid>
      <pubDate>Tue, 26 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Evaluation of Trima Version 7.0 Platelets in 100% Plasma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02754492?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy Volunteers&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Trima Accel System with Version 7.0 Software&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Terumo BCT&lt;br/&gt;&lt;b&gt;Suspended&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02754492</guid>
      <pubDate>Tue, 26 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Evaluation of Trima Version 7.0 Platelets in PAS</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02754440?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy Volunteers&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Trima Accel System with Version 7.0 Software&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Terumo BCT&lt;br/&gt;&lt;b&gt;Suspended&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02754440</guid>
      <pubDate>Tue, 26 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type.PERSEIDA Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02792478?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    RAS Wild Type mCRC&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Amgen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02792478</guid>
      <pubDate>Tue, 26 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study to Access if ABP798 is Safe &amp; Effective in Treating Moderate or Severe Rheumatoid Arthritis Compared to Rituximab</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02792699?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Arthritis, Rheumatoid&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: ABP 798;   Drug: Rituximab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Amgen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02792699</guid>
      <pubDate>Mon, 25 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02760316?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Rheumatoid Arthritis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: AZD9567 10 mg;   Drug: AZD9567 20 mg;   Drug: AZD9567 40 mg;   Drug: AZD9567 80 mg;   Drug: Prednisolone 20 mg&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    AstraZeneca&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02760316</guid>
      <pubDate>Mon, 25 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Intra-articular Volumetric Assessment After Total Knee Arthroplasty</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821325?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hematoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: MRI&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Loma Linda University;   Pacira Pharmaceuticals, Inc&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821325</guid>
      <pubDate>Mon, 25 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Carbon Dioxide Insufflation Versus Conventional Air Insufflation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02790359?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Abdominal Pain&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Air;   Other: Carbon dioxide&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Medical College of Wisconsin&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02790359</guid>
      <pubDate>Mon, 25 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>LACTIN-V Study for Recurrent Bacterial Vaginosis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02766023?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Bacterial Vaginosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Lactobacillus crispatus CTV-05;   Other: Placebo;   Drug: Metronidazole&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02766023</guid>
      <pubDate>Thu, 21 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Relationship Between Left Ventricular Remodeling, Coronary Endothelial Function and Myocardial Fibrosis Using Positron Emission Tomography in Patients With ST-elevation Myocardial Infarction</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02789098?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    ST Elevation Myocardial Infarction&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: (15)-O water positron emission tomography and Biomarkers&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University Hospital, Caen;   Société Française de Cardiologie&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02789098</guid>
      <pubDate>Thu, 21 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Evaluation of Furosap in Human Volunteers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02748005?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hypogonadism&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Dietary Supplement: Fenugreek seeds extract 500 mg&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Chemical Resources&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified August 2015</description>
      <guid isPermaLink="false">NCT02748005</guid>
      <pubDate>Wed, 20 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Effect of NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in the Spine in Ankylosing Spondylitis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02758782?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Ankylosing Spondylitis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Golimumab;   Drug: Celecoxib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Charite University, Berlin, Germany&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02758782</guid>
      <pubDate>Wed, 20 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Student Stress Levels and Management Through Meditation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821611?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Stress, Psychological&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Meditation Group&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    California State University, Northridge&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821611</guid>
      <pubDate>Mon, 18 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02745392?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Migraine&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: ZP-Zolmitriptan;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Zosano Pharma Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02745392</guid>
      <pubDate>Thu, 14 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02750930?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Diabetes Mellitus, Type 2&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Albiglutide;   Device: Auto-injector&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02750930</guid>
      <pubDate>Thu, 14 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Philadelphia Immediate Transport in Penetrating Trauma Trial</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821364?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Hemorrhagic Shock;   Peritonitis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Advanced Life Support&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Temple University&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821364</guid>
      <pubDate>Wed, 13 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Tumor-educated Platelets in Venous Thromboembolism</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02739867?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Neoplasms;   Venous Thromboembolism&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02739867</guid>
      <pubDate>Tue, 12 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Probiotics for the Prevention of Antibiotic-Associated Diarrhea</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02817165?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Diarrhea&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Dietary Supplement: Probiotic (BioK+);   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    The Hospital for Sick Children;   McMaster University&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02817165</guid>
      <pubDate>Tue, 12 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Randomized Sitagliptin Withdrawal Study (MK-0431-845)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02738879?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Type 2 Diabetes Mellitus&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Sitagliptin;   Drug: Placebo to stiagliptin;   Drug: Metformin;   Drug: Metformin XR;   Drug: Insulin glargine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Merck Sharp &amp; Dohme Corp.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02738879</guid>
      <pubDate>Mon, 11 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>the Sequential Therapy of CD19-targeted and CD20-targeted CAR-T Cell Therapy for Diffuse Large B Cell Lymphoma(DLBCL)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02737085?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Lymphoma, Large B-Cell, Diffuse&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Anti-CD19 CAR-T cells and Anti-CD20 CAR-T cells&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Southwest Hospital, China&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02737085</guid>
      <pubDate>Fri, 08 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Changes in Inflammatory Markers During Pulmonary Rehabilitation Based on Exacerbation States in COPD</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02740686?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Chronic Obstructive Pulmonary Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Sample collection&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Lincoln;   National Health Service, United Kingdom&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02740686</guid>
      <pubDate>Fri, 08 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Auranofin Trial for GI Protozoa</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02736968?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Amoebic Dysentery;   Giardiasis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Auranofin;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02736968</guid>
      <pubDate>Thu, 07 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Coronary Physiology and Its Relationship to Anatomy in Patients With Diabetes Mellitus</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02745821?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Diabetes Mellitus;   Coronary Artery Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Pressure Wire Certus, St. Jude Medical, USA&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Ottawa Heart Institute Research Corporation&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02745821</guid>
      <pubDate>Mon, 04 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Visual Performances of a Progressive Multifocal Intraocular Lens With Extended Depth of Focus</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02740010?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Vision Disorders&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: IOL MINI WELL&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    SIFI MedTech Srl;   Opera Contract Research Organization SRL&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified March 2014</description>
      <guid isPermaLink="false">NCT02740010</guid>
      <pubDate>Mon, 04 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study Comparing the Closed Triple Therapy, Open Triple Therapy and a Dual Therapy for Effect on Lung Function in Subjects With Chronic Obstructive Pulmonary Disease (COPD)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02731846?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pulmonary Disease, Chronic Obstructive&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Fluticasone furoate 100 mcg + Umeclidinium 62.5 mcg+Vilanterol 25 mcg;   Drug: Fluticasone furoate 100 mcg + Vilanterol 25 mcg;   Drug: Umeclidinium 62.5 mcg;   Device: Placebo ELLIPTA inhaler;   Drug: Albuterol/Salbutamol&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02731846</guid>
      <pubDate>Mon, 04 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Community-based Neuroendocrine Tumor (NET) Research Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02730104?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Gastroenteropancreatic Neuroendocrine Tumors&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Ipsen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02730104</guid>
      <pubDate>Fri, 01 Apr 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Postprandial Response After Intake of Meals With Different Fatty Acid Composition</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02729857?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Healthy;   Familial Hypercholesterolemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Dietary Supplement: SFA muffin;   Dietary Supplement: PUFA muffin&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Oslo;   Oslo University Hospital;   Mills DA&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02729857</guid>
      <pubDate>Thu, 31 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Physiological and Psychological Effects of Testosterone During Severe Energy Deficit and Recovery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02734238?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Caloric Restriction;   Exercise&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Sesame Oil;   Drug: testosterone enanthate&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Pennington Biomedical Research Center;   United States Army Research Institute of Environmental Medicine;   MyoSyntax;   Defence Research and Development Canada;   United States Department of Defense&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02734238</guid>
      <pubDate>Thu, 31 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Hypnosis Efficacy for the Prevention of Anxiety During a Coronary Angiography</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02818101?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Coronary Angiography&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Hypnosis session&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Centre Hospitalier Régional Metz-Thionville&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02818101</guid>
      <pubDate>Wed, 30 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02725593?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Type 2 Diabetes&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Dapagliflozin;   Drug: Dapagliflozin placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    AstraZeneca;   Parexel;   Q2 solutions;   PRA Health Sciences;   Covance Laboratories, Inc&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02725593</guid>
      <pubDate>Tue, 29 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821559?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Metastatic Colorectal Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: TOMOX;   Drug: Bevacizumab&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Centre Hospitalier Universitaire de Besancon;   Hospira, Inc.&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02821559</guid>
      <pubDate>Tue, 29 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Pilot Study of Fecal Transplantation Using a Unique Diet for Donor and Recipient in Moderate to Severe Treatment Refractory Colitis in Inflammatory Bowel Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02734589?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Ulcerative Colitis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Fecal transplantation;   Other: Unique novel Diet for UC and Unique novel Diet for the donor + FMT;   Other: Unique novel Diet for UC&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Wolfson Medical Center&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02734589</guid>
      <pubDate>Mon, 28 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02737332?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostate Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Zytiga® (Abiraterone Acetate);   Drug: SoluMatrix™ (Abiraterone Acetate)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Churchill Pharmaceutical LLC&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02737332</guid>
      <pubDate>Fri, 25 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02730351?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Asthma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Fluticasone furoate/ Vilanterol 100 mcg/25 mcg;   Drug: Fluticasone propionate 250 mcg;   Drug: Placebo via ELLIPTA inhaler;   Drug: Placebo via DISKUS / ACCUHALER&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02730351</guid>
      <pubDate>Thu, 24 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Dose Escalation and Expansion Study of GSK3359609 in Subjects With Selected Advanced Solid Tumors (INDUCE-1)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02723955?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: GSK3359609 IV infusion;   Drug: Pembrolizumab 200 mg IV infusion&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02723955</guid>
      <pubDate>Thu, 24 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02734615?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Advanced or Metastatic ER+ Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: LSZ102;   Drug: LEE011;   Drug: BYL719&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novartis Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02734615</guid>
      <pubDate>Wed, 23 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Protein Recommendation to Increase Muscle</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02788955?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Colorectal Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Dietary counselling;   Other: Dietary Protein&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Alberta;   Canada Foundation for Innovation;   Government of Alberta;   Nestlè Health Science;   Olymel;   Cargill&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02788955</guid>
      <pubDate>Wed, 23 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of Combinations of Nivolumab, Elotuzumab, Pomalidomide and Dexamethasone in Multiple Myeloma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02726581?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Multiple Myeloma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Nivolumab;   Biological: Elotuzumab;   Drug: Pomalidomide;   Drug: Dexamethasone&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Bristol-Myers Squibb;   AbbVie&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02726581</guid>
      <pubDate>Wed, 23 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Conventional, Overdenture and Palateless Overdenture Oral Health Impact Comparison Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02731703?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Jaw, Edentulous&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Overdenture treatment&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of North Carolina, Chapel Hill;   Dentsply Implants&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02731703</guid>
      <pubDate>Tue, 22 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02718937?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Respiratory Syncytial Virus (RSV) Infection&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: BTA-C585 oral capsule;   Drug: Matching placebo capsules&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Biota Pharma Europe Limited&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02718937</guid>
      <pubDate>Mon, 21 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>[Trial of device that is not approved or cleared by the U.S. FDA]</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02727842?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    [Redacted]&lt;br/&gt;&lt;b&gt;Withheld&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT02727842</guid>
      <pubDate>Thu, 17 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Thoracic MRI Imaging in Children</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02714933?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pulmonary Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: MRI sequence Advanced ZTE&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Assistance Publique - Hôpitaux de Paris&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02714933</guid>
      <pubDate>Wed, 16 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02713256?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Graves' Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: CFZ533&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novartis Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02713256</guid>
      <pubDate>Tue, 15 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02710708?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Contraception&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Ethinyl Estradiol 20 (EE20)/DRSP (YAZ, BAY86-5300)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Bayer&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02710708</guid>
      <pubDate>Mon, 14 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study Will Evaluate the Efficacy of Etanercept Treatment in Subjects Who Have Failed Therapy With Apremilast</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02749370?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Plaque Psoriasis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Etanercept&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Amgen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02749370</guid>
      <pubDate>Mon, 14 Mar 2016 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of N91115 in CF Patients Who Are Heterozygous for F508del-CFTR and a Gating Mutation and Being Treated With Ivacaftor</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02724527?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cystic Fibrosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: N91115;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Nivalis Therapeutics, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02724527</guid>
      <pubDate>Fri, 11 Mar 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02709005?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Bacterial Vaginosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Placebo;   Drug: 5% Monolaurin Vaginal Gel&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02709005</guid>
      <pubDate>Thu, 10 Mar 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Cefixime / Azithromycin pK Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02708992?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Gonorrhoea&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Azithromycin;   Drug: Cefixime&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified February 2016</description>
      <guid isPermaLink="false">NCT02708992</guid>
      <pubDate>Thu, 10 Mar 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02718495?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cystic Fibrosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: PTI-428;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Proteostasis Therapeutics, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02718495</guid>
      <pubDate>Thu, 10 Mar 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02723773?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Herpes Zoster&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Herpes Zoster Vaccine GSK1437173A&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02723773</guid>
      <pubDate>Thu, 10 Mar 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02713828?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Squamous Cell Carcinoma of the Lung&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Glembatumumab Vedotin;   Drug: Glembatumumab Vedotin&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    PrECOG, LLC.;   Celldex Therapeutics&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02713828</guid>
      <pubDate>Tue, 08 Mar 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02710084?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Phelan-McDermid Syndrome&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Oxytocin;   Drug: Saline&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Alexander Kolevzon&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02710084</guid>
      <pubDate>Mon, 07 Mar 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Dynamic Allocation Modular Sequential Trial of Approved and Promising Therapies in Men With Metastatic Castrate Resistant Prostate Cancer (DynaMO)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02703623?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostate Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Abiraterone acetate;   Drug: Prednisone;   Drug: ARN509;   Drug: Ipilimumab;   Drug: Cabazitaxel;   Drug: Carboplatin&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Bristol-Myers Squibb;   Janssen, LP;   Sanofi&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02703623</guid>
      <pubDate>Fri, 04 Mar 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02709889?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Malignant Melanoma;   Medullary Thyroid Cancer;   Glioblastoma;   Large Cell Neuroendocrine Carcinoma;   Neuroendocrine Prostate Cancer;   High Grade Gastroenteropancreatic Neuroendocrine Carcinoma;   Other Neuroendocrine Carcinoma;   Other Solid Tumors&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Rovalpituzumab tesirine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Stemcentrx&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02709889</guid>
      <pubDate>Wed, 02 Mar 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Phase 1 Clinical Study of AZD4635 and Durvalumab in Patients With Advanced Solid Malignancies</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02740985?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Advanced Solid Malignancies;   Non-Small Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: AZD4635 Monotherapy;   Drug: Durvalumab Combination&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    AstraZeneca&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02740985</guid>
      <pubDate>Mon, 29 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02698410?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Neuroendocrine Tumours&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Lanreotide (Autogel formulation) and Temozolomide&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Ipsen&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02698410</guid>
      <pubDate>Fri, 26 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Comparing Cervical Foley Catheter, Dinoprostone and a Combination of the Two for Labor Induction</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02815865?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Failed Medical or Unspecified Induction of Labor&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: Foley catheter and pitocin;   Device: Foley catheter and Dinoprostone;   Drug: Dinoprostone&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Kaplan Medical Center&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02815865</guid>
      <pubDate>Fri, 26 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Liberal Oxygenation Versus Conservative Oxygenation in ARDS</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02713451?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Acute Respiratory Distress Syndrome;   Intensive Care&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Modulation of Inspired Fraction of Oxygen (FiO2)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Centre Hospitalier Universitaire de Besancon&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02713451</guid>
      <pubDate>Thu, 25 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02702141?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Non-Hodgkin Lymphoma;   DLBCL;   Diffuse Large B-cell Lymphoma;   Grade 3 Follicular Lymphoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: SGN-CD19B&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Seattle Genetics, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02702141</guid>
      <pubDate>Thu, 25 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Alsertib (MLN8237) and Brentuximab Vedotin for Relapsed/Refractory CD30-Positive Lymphomas and Solid Malignancies</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02780011?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    CD30-positive Lymphoma;   CD30-positive Solid Tumor&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Brentuximab Vedotin;   Drug: Alsertib&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    The Methodist Hospital System;   Millenium Pharmaceuticals, Inc.&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02780011</guid>
      <pubDate>Wed, 24 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Preoperative Methylprednisolone to Patients Suspected of Appendicitis Undergoing Laparoscopy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02711449?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Suspected Appendicitis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Methylprednisolone;   Drug: 0.9% Saline&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Jakob Kleif;   Koege Sygehus&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02711449</guid>
      <pubDate>Tue, 23 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02706899?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Myelodysplastic Syndrome&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: vadastuximab talirine;   Drug: Azacitidine;   Drug: Placebo (for 33A)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Seattle Genetics, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02706899</guid>
      <pubDate>Fri, 19 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Evaluation of Cochlear Baha 5 SuperPower Sound Processor on the Baha Attract System</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02722330?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Single Sided Sensorineural Deafness;   Mixed Hearing Loss, Unilateral&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Baha 5 SuperPower on Baha Attract System&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Cochlear Bone Anchored Solutions&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02722330</guid>
      <pubDate>Wed, 17 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Long-term Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02698579?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Cerebral Adrenoleukodystrophy (CALD);   Adrenoleukodystrophy (ALD);   X-Linked Adrenoleukodystrophy (X-ALD)&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Safety and efficacy assessments&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    bluebird bio&lt;br/&gt;&lt;b&gt;Enrolling by invitation&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02698579</guid>
      <pubDate>Wed, 17 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02690207?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Herpes Zoster&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Herpes Zoster Vaccine GSK1437173A&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02690207</guid>
      <pubDate>Tue, 16 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Fish Oil Supplementation in Gastrointestinal Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02699047?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Gastrointestinal Cancer;   Colorectal Cancer;   Stomach Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Dietary Supplement: Encapsuled fish oil;   Dietary Supplement: Encapsulated Olive oil&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Universidade Federal de Santa Catarina;   Centro de Pesquisas Oncológicas&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02699047</guid>
      <pubDate>Fri, 12 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-204/KEYNOTE-204)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02684292?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hodgkin Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: pembrolizumab;   Biological: brentuximab vedotin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Merck Sharp &amp; Dohme Corp.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02684292</guid>
      <pubDate>Fri, 12 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02684071?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent Childhood Medulloblastoma;   Recurrent Childhood Ependymoma;   Childhood Atypical Teratoid/Rhabdoid Tumor;   Embryonal Tumor With Abundant Neuropil and True Rosettes;   Metastatic Malignant Neoplasm to the Leptomeninges&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Intra thecal methotrexate;   Drug: topotecan;   Drug: cyclophosphamide&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Nicklaus Children's Hospital f/k/a Miami Children's Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02684071</guid>
      <pubDate>Thu, 11 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02741076?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Opioid-Related Disorders;   Opiate Addiction;   Narcotic Abuse;   Drug Abuse&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Morphine Sulfate ER;   Drug: Oxycodone ER;   Drug: Oxymorphone ER&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Member Companies of the Opioid PMR Consortium&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02741076</guid>
      <pubDate>Wed, 10 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study to Evaluate Efficacy/Safety of 4 Doses of CHF5259 Via Dry Powder Inhaler (DPI) in Patients With COPD</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02680197?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Chronic Obstructive Pulmonary Disease (COPD)&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: CHF5259 or Placebo administration&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Chiesi Farmaceutici S.p.A.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02680197</guid>
      <pubDate>Thu, 04 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Software Treatment for Actively Reducing Severity of ADHD</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02674633?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Attention Deficit Disorder With Hyperactivity&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: EVO&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Akili Interactive Labs, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02674633</guid>
      <pubDate>Tue, 02 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Percutaneous Hepatic Perfusion vs Best Alternative Care in Patients With Hepatic-dominant Ocular Melanoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02678572?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Melanoma, Ocular&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Melphalan;   Procedure: TACE;   Drug: Dacarbazine;   Drug: Ipilimumab;   Drug: Pembrolizumab&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Delcath Systems Inc.;   United BioSource Corporation&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02678572</guid>
      <pubDate>Mon, 01 Feb 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer (TRINITY)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02674568?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Small Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Rovalpituzumab tesirine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Stemcentrx&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02674568</guid>
      <pubDate>Fri, 29 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Matched Targeted Therapy For High-Risk Leukemias</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02670525?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent, Refractory, or High Risk Leukemias;   Matched Targeted Therapy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Genetic: Leukemia Profiling&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Dana-Farber Cancer Institute&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02670525</guid>
      <pubDate>Thu, 28 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02685709?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acromegaly&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Octreotide capsules;   Drug: Injectable Somatostatin Analogs (octreotide or lanreotide);   Drug: Cabergoline&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Chiasma, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02685709</guid>
      <pubDate>Thu, 28 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02682381?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Short Bowel Syndrome&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Teduglutide 0.05mg/kg;   Drug: Teduglutide 0.025 mg/kg;   Drug: Standard of Care&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Shire&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02682381</guid>
      <pubDate>Wed, 27 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Intravenous Pentamidine for Pneumocystis Jirovecii Pneumonia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02669706?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hematologic Malignancy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Pentamidine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Illinois at Chicago&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02669706</guid>
      <pubDate>Mon, 25 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Optimal Treatment for Recurrent Clostridium Difficile</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02667418?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Clostridium;   Difficile;   Fidaxomicin;   Vancomycin&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Fidaxomicin;   Drug: Vancomycin with Taper/Pulse;   Drug: Vancomycin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    VA Office of Research and Development&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02667418</guid>
      <pubDate>Mon, 25 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02663908?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostate Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Degarelix;   Drug: Leuprolide&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Ferring Pharmaceuticals;   Memorial Sloan Kettering Cancer Center;   Duke Clinical Research Institute&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02663908</guid>
      <pubDate>Fri, 22 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02669017?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Non-Hodgkin Lymphoma;   Burkitt's Lymphoma;   Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma;   Lymphoma, Large B-Cell, Diffuse;   Lymphoma, Follicular;   Lymphoma, Mantle-Cell;   Lymphoma, Marginal Zone;   Waldenstrom Macroglobulinemia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: ADCT-402&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    ADC Therapeutics SARL&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02669017</guid>
      <pubDate>Thu, 21 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Endocrine and Emotional Effects of Lisdexamfetamine and d-Amphetamine.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02668926?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Lisdexamfetamine, d-amphetamine, Placebo;   Drug: d-amphetamine, Placebo, Lisdexamfetamine;   Drug: Placebo, Lisdexamfetamine, d-amphetamine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University Hospital, Basel, Switzerland&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02668926</guid>
      <pubDate>Thu, 21 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Study to Investigate the Efficacy and Safety of GSK3196165 in Inflammatory Hand Osteoarthritis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02683785?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Osteoarthritis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: GSK3196165;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02683785</guid>
      <pubDate>Thu, 21 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02669264?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Lymphoblastic Leukemia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: ADCT-402&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    ADC Therapeutics SARL&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02669264</guid>
      <pubDate>Thu, 21 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Double-blind, Randomized Study in Diabetic Subjects With Hyperlipidemia or Mixed Dyslipidemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02662569?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Diabetes, Hyperlipidemia, Mixed Dyslipidemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Evolocumab (AMG 145);   Drug: Atorvastatin;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Amgen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02662569</guid>
      <pubDate>Wed, 20 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Safety, Tolerability, and Efficacy Study of Intracerebroventricular BMN 190 in Patients With CLN2 Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02678689?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Jansky-Bielschowsky Disease;   Batten Disease;   Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2;   CLN2 Disease;   CLN2 Disorder&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: BMN190 recombinant human tripeptidyl peptidase-1 (rhTPP1)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    BioMarin Pharmaceutical&lt;br/&gt;&lt;b&gt;Enrolling by invitation&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02678689</guid>
      <pubDate>Fri, 15 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Early Fluconazole Treatment for Coccidiodomycosis Pneumonia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02663674?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Coccidioidomycosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Fluconazole;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified January 2016</description>
      <guid isPermaLink="false">NCT02663674</guid>
      <pubDate>Fri, 15 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>The Effect of a Low FODMAP Oral Nutrition Supplement On Breath Hydrogen Response In Healthy Human Subjects</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02667184?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Food Selection&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Dietary Supplement: Low FODMAP Oral Nutrition Supplement&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Minnesota - Clinical and Translational Science Institute&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02667184</guid>
      <pubDate>Fri, 15 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Nivolumab Plus Ipilimumab to Treat First Line Stage IV Non-Small Cell Lung Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02659059?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Non-Small-Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Nivolumab (Opdivo)+Ipilimumab (Yervoy)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Bristol-Myers Squibb&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02659059</guid>
      <pubDate>Fri, 15 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Comparison of Dexamethasone and Triamcinolone for Ultrasound-guided Occipital C2 Nerve Blocks</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02655523?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Headache&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Triamcinolone;   Drug: Dexamethasone;   Drug: Normal Saline;   Drug: Bupivacaine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Northwestern University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02655523</guid>
      <pubDate>Tue, 12 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02656849?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Solid Tumor&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: BAY 1000394&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Dana-Farber Cancer Institute;   Bayer&lt;br/&gt;&lt;b&gt;Withdrawn&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02656849</guid>
      <pubDate>Mon, 11 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02719769?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Bacteremia;   Fungemia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Accelerate Diagnostics, Inc.&lt;br/&gt;&lt;b&gt;Enrolling by invitation&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02719769</guid>
      <pubDate>Mon, 11 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02654145?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Asthma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Mepolizumab 100mg SC;   Drug: Albuterol/salbutamol MDIs;   Drug: Omalizumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02654145</guid>
      <pubDate>Mon, 11 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02658214?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Small Cell Lung Carcinoma;   Carcinoma, Squamous Cell of Head and Neck;   Stomach Neoplasms;   Triple Negative Breast Neoplasms;   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms;   Esophagogastric Junction Neoplasms&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: paclitaxel + carboplatin;   Drug: carboplatin + etoposide;   Drug: gemcitabine + carboplatin;   Drug: nab-paclitaxel (paclitaxel-albumin) + carboplatin;   Drug: oxaliplatin + 5-fluorouracil (5FU) + leucovorin (calcium folinate/folinic acid);   Biological: durvalumab;   Biological: tremelimumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    AstraZeneca&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02658214</guid>
      <pubDate>Mon, 11 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02821507?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Conventional Chondrosarcoma;   Myxoid Liposarcoma;   Mesenchymal Chondrosarcoma;   Dedifferentiated Chondrosarcoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: sirolimus and cyclophosphamide&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Leiden University Medical Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02821507</guid>
      <pubDate>Sat, 09 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>eHealth Partnered Evaluation Initiative (PEC 15-470)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02665468?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Non-secure Message Senders&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Supported adoption intervention;   Behavioral: Active comparator control&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    VA Office of Research and Development&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02665468</guid>
      <pubDate>Tue, 05 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Comparing the Efficiency of Cervical Ripening BALLoon (Cook) to the DINOprostone (Propess) for the Cervical Maturation in Case of Unfavorable Cervix (Bishop &lt;6) in the Population of Obese Pregnant Women (BMI &gt;= 30 kg/m²)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02649920?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Delivery&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: Cervical ripening balloon;   Drug: Dinoprostone&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Centre Hospitalier Departemental Vendee&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02649920</guid>
      <pubDate>Mon, 04 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>The Metabolite Identification and Material Balance Study of SP2086</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02815748?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Type 2 Diabetes&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: SP2086&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Jiangsu HengRui Medicine Co., Ltd.&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02815748</guid>
      <pubDate>Sun, 03 Jan 2016 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02653014?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Healthy;   Renal Insufficiency&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: KBP-5074&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    KBP Biosciences&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02653014</guid>
      <pubDate>Tue, 29 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>[Trial of device that is not approved or cleared by the U.S. FDA]</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02644343?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    [Redacted]&lt;br/&gt;&lt;b&gt;Withheld&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT02644343</guid>
      <pubDate>Mon, 28 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Natural History of Craniofacial Anomalies and Developmental Growth Variants</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02639312?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Prognathism;   Dentofacial Deformities;   Hemifacial Macrosomia;   Craniofacial Microsomia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Dental and Craniofacial Research (NIDCR)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02639312</guid>
      <pubDate>Wed, 23 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>AMG 176 First in Human Trial in Subjects With Relapsed or Refractory Multiple Myeloma.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02675452?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Relapsed or Refractory Multiple Myeloma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: AMG 176&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Amgen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02675452</guid>
      <pubDate>Tue, 22 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>MABp1 IN HIDRADENITIS SUPPURATIVA REFRACTORY TO ADALIMUMAB</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02643654?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hidradenitis Suppurativa&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: MABp1;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Evangelos J. Giamarellos-Bourboulis, M.D.;   Hellenic Institute for the Study of Sepsis&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02643654</guid>
      <pubDate>Sun, 20 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Exercise Training in Adults With Corrected Tetralogy of Fallot</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02643810?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Tetralogy of Fallot&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Exercise training&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University Medical Centre Ljubljana&lt;br/&gt;&lt;b&gt;Enrolling by invitation&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02643810</guid>
      <pubDate>Sun, 20 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Exercise Training in Individuals With Peripheral Arterial Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02642276?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Peripheral Arterial Disease;   Intermittent Claudication&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Exercise training&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University Medical Centre Ljubljana&lt;br/&gt;&lt;b&gt;Enrolling by invitation&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02642276</guid>
      <pubDate>Sun, 20 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02660424?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Osteoarthritis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: VX-150;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Vertex Pharmaceuticals Incorporated&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02660424</guid>
      <pubDate>Fri, 18 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02639702?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Schizophrenia;   Schizoaffective Disorder&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Clozapine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Centre for Addiction and Mental Health&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02639702</guid>
      <pubDate>Fri, 18 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Hemostasis Alterations in Neurosurgical Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02652897?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Glioma;   Coagulopathy;   Acquired Platelet Function Disorder;   Thromboelastometry;   Surgery&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Exposure to glioma resection surgery;   Procedure: Exposure to colon resection surgery&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Santiago R. Leal-Noval;   Instituto de Salud Carlos III&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02652897</guid>
      <pubDate>Fri, 18 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Stage Ib Trial of mSMART</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02635919?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Nicotine Dependence&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: mSMART&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Duke University;   Intelligent Automation, Inc.;   National Institute on Drug Abuse (NIDA)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02635919</guid>
      <pubDate>Thu, 17 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02634580?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hypercholesterolemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Evolocumab;   Drug: Ezetimibe;   Biological: Evolocumab;   Drug: Ezetimibe&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Amgen;   Data Monitoring Committee (DMC)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02634580</guid>
      <pubDate>Wed, 16 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02631590?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Biliary Carcinoma;   Gall Bladder Carcinoma;   Cholangiocarcinoma;   Gastrointestinal Tumor&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cisplatin;   Drug: Gemcitabine;   Drug: Copanlisib&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    H. Lee Moffitt Cancer Center and Research Institute;   Bayer&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02631590</guid>
      <pubDate>Mon, 14 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Interleukin-10 Promoter-1082A/G Polymorphism and Idiopathic Recurrent Miscarriage Risk</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02633475?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Abortion, Spontaneous&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Genetic: IL-10 polymorphism&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Fourth Affiliated Hospital of Guangxi Medical University;   Liuzhou Maternity and Child Healthcare Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02633475</guid>
      <pubDate>Fri, 11 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02630654?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Gastroenteropancreatic Neuroendocrine Tumors&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: This is a non-interventional study. Patients will be treated with any intervention deemed appropriate by the patient's physician.&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Ipsen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02630654</guid>
      <pubDate>Fri, 11 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Safety and Efficacy Study to Evaluate AMG 334 in Migraine Prevention</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02630459?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Migraine&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: AMG 334 Dose Level 1;   Drug: Placebo;   Drug: AMG 334 Dose Level 2;   Drug: AMG 334 Dose Level 3&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Amgen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02630459</guid>
      <pubDate>Fri, 11 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Exhaled Breath Condensate Biomarkers and Cough in IPF</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02630940?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Idiopathic Pulmonary Fibrosis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of East Anglia&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02630940</guid>
      <pubDate>Fri, 11 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Imaging Parameters and DME Treatment Response</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02637245?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Diabetic Macular Edema;   Diabetic Retinopathy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: No intervention&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Duke University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02637245</guid>
      <pubDate>Thu, 10 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Clindamycin-rifampin Drug Interaction in the Treatment of Bone and Joint Infections</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02629770?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Arthritis, Infectious;   Bone Diseases, Infectious&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: usual antibiotic treatment&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Fondation Ophtalmologique Adolphe de Rothschild;   Groupe Hospitalier Diaconesses Croix Saint-Simon&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02629770</guid>
      <pubDate>Thu, 10 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02632786?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    AL Amyloidosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: NEOD001;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Prothena Therapeutics Ltd.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02632786</guid>
      <pubDate>Wed, 09 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02632760?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Anaemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Ferric carboxymaltose;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Bayside Health;   National Health and Medical Research Council, Australia;   Monash University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02632760</guid>
      <pubDate>Mon, 07 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>[Trial of device that is not approved or cleared by the U.S. FDA]</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02698787?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    [Redacted]&lt;br/&gt;&lt;b&gt;Withheld&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT02698787</guid>
      <pubDate>Thu, 03 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>[Trial of device that is not approved or cleared by the U.S. FDA]</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02638883?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    [Redacted]&lt;br/&gt;&lt;b&gt;Withheld&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT02638883</guid>
      <pubDate>Thu, 03 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Rainbow Extension Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02640664?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Retinopathy of Prematurity&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Ranibizumab;   Drug: Ranibizumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novartis Pharmaceuticals&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02640664</guid>
      <pubDate>Tue, 01 Dec 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02624219?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Avian Influenza;   Influenza&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: AS03;   Drug: MF59;   Biological: Monovalent Influenza A/H5N8 vaccine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02624219</guid>
      <pubDate>Wed, 25 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>SAD and MAD Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of TD-1473 in Healthy Subjects</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02657122?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: TD-1473 for SAD;   Drug: Placebo for SAD;   Drug: TD-1473 for MAD;   Drug: Placebo for MAD&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Theravance Biopharma R &amp; D, Inc.&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02657122</guid>
      <pubDate>Wed, 25 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Cerebral Microembolism in the Critically Ill With Acute Kidney Injury</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02621749?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cerebral Embolism&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Renal replacement therapy&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University Hospital Inselspital, Berne&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02621749</guid>
      <pubDate>Fri, 20 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>[11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02621606?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Alzheimer's Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: [11C]MK-6884&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Merck Sharp &amp; Dohme Corp.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02621606</guid>
      <pubDate>Fri, 20 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study of INCB039110 in Combination With Corticosteroids for the Treatment of Acute GVHD</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02614612?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Graft Versus Host Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: INCB039110 (200 mg);   Drug: INCB039110 (300 mg);   Drug: prednisone or methylprednisolone (corticosteroids)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Incyte Corporation&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02614612</guid>
      <pubDate>Fri, 20 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02612844?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Diabetes;   Diabetes Mellitus, Type 1&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: NNC0143-0406;   Drug: insulin aspart&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novo Nordisk A/S&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified November 2015</description>
      <guid isPermaLink="false">NCT02612844</guid>
      <pubDate>Fri, 20 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Staging Procedures to Diagnose Malignant Pleural Mesothelioma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02648763?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Mesothelioma;   Solitary Fibrous Tumor of the Pleura&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Mayo Clinic&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02648763</guid>
      <pubDate>Fri, 20 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Study of Vadastuximab Talirine Given Prior to or After Allogeneic Hematopoietic Stem Cell Transplant in AML Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02614560?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Myeloid Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Fludarabine;   Drug: Melphalan;   Drug: vadastuximab talirine;   Drug: vadastuximab talirine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Seattle Genetics, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02614560</guid>
      <pubDate>Fri, 20 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Accu-Chek Connect at School (CATS) Pediatric Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02609633?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Diabetes&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: Accu-Chek(R) Connect DMS;   Device: DMS&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Hoffmann-La Roche;   Roche Diabetes Care GmbH&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02609633</guid>
      <pubDate>Wed, 18 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Improving Mental and Physical Health and Decreasing Hospital Readmission After Pancreatectomy Through Enhanced Patient and Caregiver Education and Engagement</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02617979?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pancreatectomy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: SAFECARE at Home customized lessons&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Washington University School of Medicine&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02617979</guid>
      <pubDate>Wed, 18 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>An Open Label Study of CM-AT for the Treatment of Children With Autism</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02649959?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Autism&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: CM-AT&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Curemark&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02649959</guid>
      <pubDate>Thu, 12 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Kinetics of Plasma Fibrinogen in Cardiac Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02605330?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Fibrinogens, Abnormal&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: Fibrinogen plasma level&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University Hospital Inselspital, Berne&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02605330</guid>
      <pubDate>Wed, 11 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>ObservationaL Study on the Qol of RAS Wild-type mCRC Patients Receiving Anti-EGFR MAbs + FOLFOX -1st Line</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02624895?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Metastatic Colorectal Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Amgen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02624895</guid>
      <pubDate>Mon, 09 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02603341?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Radiation: Photon;   Radiation: Proton&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Abramson Cancer Center of the University of Pennsylvania;   Patient-Centered Outcomes Research Institute&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02603341</guid>
      <pubDate>Mon, 09 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>ACCU-CHEK Connect Personal Diabetes Management Study (PDM CONNECT)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02600845?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Diabetes&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: ACCU-CHEK AVIVA CONNECT&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Hoffmann-La Roche;   Roche Diabetes Care GmbH&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02600845</guid>
      <pubDate>Fri, 06 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Impact of Resveratrol on Brain Function and Structure: A Randomised Double Blind Clinical Trial.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02621554?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Dietary Supplement: resveratrol supplementation;   Dietary Supplement: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Max Planck Institute for Human Cognitive and Brain Sciences;   University of Leipzig;   Evolva SA&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02621554</guid>
      <pubDate>Fri, 06 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02595866?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    AIDS-Related Non-Hodgkin Lymphoma;   Classical Hodgkin Lymphoma;   HIV Infection;   Locally Advanced Malignant Neoplasm;   Metastatic Malignant Neoplasm;   Recurrent Hepatocellular Carcinoma;   Recurrent Hodgkin Lymphoma;   Recurrent Kaposi Sarcoma;   Recurrent Malignant Neoplasm;   Recurrent Melanoma of the Skin;   Recurrent Non-Hodgkin Lymphoma;   Recurrent Non-Small Cell Lung Carcinoma;   Refractory Hodgkin Lymphoma;   Refractory Malignant Neoplasm;   Solid Neoplasm;   Stage IIIA Hepatocellular Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIA Skin Melanoma;   Stage IIIB Hepatocellular Carcinoma;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIB Skin Melanoma;   Stage IIIC Hepatocellular Carcinoma;   Stage IIIC Skin Melanoma;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Skin Melanoma;   Stage IVA Hepatocellular Carcinoma;   Stage IVB Hepatocellular Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02595866</guid>
      <pubDate>Tue, 03 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vulvar Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02595879?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB Vulvar Cancer;   Stage IB2 Cervical Cancer;   Stage II Vulvar Cancer;   Stage IIA1 Cervical Cancer;   Stage IIA2 Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Vulvar Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Vulvar Cancer;   Stage IIIC Vulvar Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vulvar Cancer;   Vulvar Adenocarcinoma;   Vulvar Squamous Cell Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: High-Dose Rate Brachytherapy;   Radiation: Intensity-Modulated Radiation Therapy;   Radiation: Internal Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Triapine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02595879</guid>
      <pubDate>Tue, 03 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02595944?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Stage IB Non-Small Cell Lung Carcinoma;   Stage IIA Non-Small Cell Lung Carcinoma;   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Laboratory Biomarker Analysis;   Biological: Nivolumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02595944</guid>
      <pubDate>Tue, 03 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>An Observational/Non-interventional, Study of NS3/4a Protease and NS5A Protein of Hepatitis C Virus in Brazilian Participants With Chronic HCV Infection</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02597270?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hepatitis C Virus&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Janssen-Cilag Ltd.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02597270</guid>
      <pubDate>Tue, 03 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02596035?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Renal Cell Carcinoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Nivolumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Bristol-Myers Squibb&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02596035</guid>
      <pubDate>Mon, 02 Nov 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02592876?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Lymphoma, B-cell;   Lymphoma, Large B-Cell, Diffuse;   Lymphoma, Follicular, Grade 3b;   Follicular Lymphoma, Grade 3b&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: denintuzumab mafodotin;   Drug: rituximab;   Drug: ifosfamide;   Drug: carboplatin;   Drug: etoposide&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Seattle Genetics, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02592876</guid>
      <pubDate>Thu, 29 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>H7N9 Boost in Healthy Adults</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02586792?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Influenza&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Monovalent influenza A/H7N9 virus vaccine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02586792</guid>
      <pubDate>Thu, 22 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02601950?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Malignant Rhabdoid Tumors (MRT);   Rhabdoid Tumors of the Kidney (RTK);   Atypical Teratoid Rhabdoid Tumors (ATRT);   Selected Tumors With Rhabdoid Features;   Synovial Sarcoma;   INI1-negative Tumors;   Malignant Rhabdoid Tumor of Ovary;   Renal Medullary Carcinoma;   Epithelioid Sarcoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Tazemetostat&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Epizyme, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02601950</guid>
      <pubDate>Wed, 21 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02584959?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hereditary Angioedema (HAE)&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: C1 esterase inhibitor [human] liquid&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Shire&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02584959</guid>
      <pubDate>Tue, 20 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02581410?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Herpes Zoster&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02581410</guid>
      <pubDate>Mon, 19 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Beauty From Within Community Screening Project</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02588690?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Heart Health Screening and Prevention&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Fingerstick cholesterol test;   Other: Atherosclerosis Cardiovascular Disease Risk assessment;   Procedure: Blood pressure measurement&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Cedars-Sinai Medical Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02588690</guid>
      <pubDate>Mon, 19 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>DS-3032b for Relapsed and/or Refractory (RR) Myeloma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02579824?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Myeloma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: DS-3032b&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Daiichi Sankyo UK Ltd.&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02579824</guid>
      <pubDate>Fri, 16 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02584855?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Psoriatic Arthritis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Ixekizumab;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Eli Lilly and Company&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02584855</guid>
      <pubDate>Fri, 16 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02576041?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Allergic Rhinitis;   Urticaria&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Bilastine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Menarini International Operations Luxembourg SA&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified January 2016</description>
      <guid isPermaLink="false">NCT02576041</guid>
      <pubDate>Tue, 13 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of Nivolumab Compared to Sorafenib as a Primary Treatment in Patients With Advanced Hepatocellular Carcinoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02576509?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hepatocellular Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Nivolumab;   Drug: Sorafenib&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Bristol-Myers Squibb;   Ono Pharmaceutical Co. Ltd&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02576509</guid>
      <pubDate>Tue, 13 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Effectiveness of the uPatient Platform in Prophylactic Treatment in Hemophilia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02581735?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Haemophilia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Patients with haemophilia&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Real Fundación Victoria Eugenia;   Universidad de Murcia;   Medtep Inc.&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02581735</guid>
      <pubDate>Tue, 13 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02573740?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Alzheimer's Disease;   Mild Cognitive Impairment&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: ABT-957;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    AbbVie&lt;br/&gt;&lt;b&gt;Terminated&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02573740</guid>
      <pubDate>Thu, 08 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02572167?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hodgkin Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: brentuximab vedotin;   Drug: nivolumab&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Seattle Genetics, Inc.;   Bristol-Myers Squibb&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02572167</guid>
      <pubDate>Wed, 07 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of Duvelisib in Combination With Rituximab and Bendamustine vs Placebo in Combination With Rituximab and Bendamustine in Subjects With Previously-Treated Indolent Non-Hodgkin Lymphoma (BRAVURA)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02576275?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Indolent Non-Hodgkin's Lymphoma;   Follicular Lymphoma;   Small Lymphocytic Lymphoma;   Marginal Zone Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Duvelisib;   Drug: Placebo;   Drug: Rituximab;   Drug: Bendamustine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Infinity Pharmaceuticals, Inc.&lt;br/&gt;&lt;b&gt;Withdrawn&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02576275</guid>
      <pubDate>Wed, 07 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Trial Assessing Evolocumab(AMG145) Compared to LDL-C Apheresis in Subjects Receiving LDL-C Apheresis Prior to Study Enrollment</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02585895?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hypercholesterolemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: evolocumab (AMG 145);   Other: Low Density Lipoprotein Cholesterol (LDL-C) Apheresis&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Amgen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02585895</guid>
      <pubDate>Wed, 07 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02570165?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pulmonary Disease, Chronic Obstructive&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Batefenterol;   Drug: Umeclidinium/ Vilanterol;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02570165</guid>
      <pubDate>Mon, 05 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>WISE CVD - Continuation (WISE HFpEF)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02582021?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Microvascular Coronary Dysfunction;   Cardiovascular Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Coronary Angiography;   Procedure: Coronary Reactivity Testing;   Procedure: Cardiac Magnetic Resonance Imaging;   Procedure: Cardiac Magnetic Resonance Angiography;   Procedure: Computed Coronary Tomographic Angiography;   Procedure: Rest-Stress Millar Testing;   Procedure: Aortic vasorelaxation tests&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Cedars-Sinai Medical Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02582021</guid>
      <pubDate>Mon, 05 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Trial of Self-managed Approaches for Patellofemoral Pain Syndrome in Active Duty</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02597673?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Patellofemoral Pain Syndrome&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Home Exercise Program (HEP);   Device: NMES;   Device: TENS&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Tennessee;   Blanchfield Army Community Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02597673</guid>
      <pubDate>Mon, 05 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>PregSource: Crowdsourcing to Understand Pregnancy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02577536?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Pregnancy;   Pregnancy Complications;   Morning Sickness;   Diabetes, Gestational;   Placenta Diseases;   Birth Weight&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: No Interventions&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02577536</guid>
      <pubDate>Mon, 05 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02568449?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent Pleural Malignant Mesothelioma;   Stage IV Pleural Mesothelioma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Nintedanib&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Barbara Ann Karmanos Cancer Institute;   National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02568449</guid>
      <pubDate>Fri, 02 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Combination Chemotherapy and Irinotecan Hydrochloride or Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02567435?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Alveolar Rhabdomyosarcoma;   Botryoid-Type Embryonal Rhabdomyosarcoma;   Embryonal Rhabdomyosarcoma;   Rhabdomyosarcoma;   Sclerosing Rhabdomyosarcoma;   Spindle Cell Rhabdomyosarcoma;   Untreated Childhood Rhabdomyosarcoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cyclophosphamide;   Biological: Dactinomycin;   Drug: Irinotecan Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration;   Radiation: Radiation Therapy;   Drug: Temsirolimus;   Drug: Vincristine Sulfate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02567435</guid>
      <pubDate>Fri, 02 Oct 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Efficacy Study of FUROSAP: A Testosterone Booster Supplement In Humans.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02702882?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hypogonadism&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Dietary Supplement: Fenugreek Seeds Extract&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Chemical Resources&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02702882</guid>
      <pubDate>Tue, 29 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Efficacy of Prunus Domestica Extract in BPH</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02702947?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    BPH&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Dietary Supplement: Prunus domestica extract&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Chemical Resources&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified September 2015</description>
      <guid isPermaLink="false">NCT02702947</guid>
      <pubDate>Tue, 29 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Mindfulness Meditation for Chronic Pelvic Pain Management</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02721108?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Chronic Pelvic Pain&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Mindfulness meditation;   Behavioral: Relaxation app&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Queen Mary University of London;   Headspace UK&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02721108</guid>
      <pubDate>Mon, 28 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog®</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02562313?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Type 1 Diabetes Mellitus&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: BioChaperone insulin lispro;   Drug: Humalog®&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Adocia;   Eli Lilly and Company&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02562313</guid>
      <pubDate>Mon, 28 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Ca</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02564549?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Prostate Cancer;   Prostate Adenocarcinoma;   Multiparametric MRI;   Gleason's Score 6&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: TRUS-guided biopsy;   Procedure: mpMRI with targeted biopsy&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Virginia Commonwealth University;   Massey Cancer Center;   Hunter Holmes Mcguire Veteran Affairs Medical Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02564549</guid>
      <pubDate>Mon, 28 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02565511?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Alzheimer's Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: CAD106 Immunotherapy;   Other: Placebo to CAD106;   Drug: CNP520;   Other: Placebo to CNP520&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Novartis Pharmaceuticals;   Banner Alzheimer's Institute;   National Institute on Aging (NIA);   Alzheimer's Association;   Amgen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02565511</guid>
      <pubDate>Mon, 28 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02562443?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Myelodysplastic Syndrome;   MDS;   Refractory Anemia With Excess Blasts;   RAEB&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: rigosertib;   Drug: Any approved or standard-of-care therapy&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Onconova Therapeutics, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02562443</guid>
      <pubDate>Fri, 25 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02560584?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Bladder Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Hexaminolevulinate hydrochloride;   Device: KARL STORZ D-Light C PDD Flexible Videoscope System&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Photocure;   KARL STORZ Endoscopy-America, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02560584</guid>
      <pubDate>Wed, 23 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02567253?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Ovarian Cancer;   Primary Peritoneal Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Cytoreductive surgery;   Drug: IPEC with Cisplatin (75mg/m²);   Drug: IPEC with Cisplatin (120mg/m²);   Drug: Hypertherm IntraPEritoneal Chemotherapy with Cisplatin (75mg/m²);   Drug: HIPEC with Cisplatin (120mg/m²)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University Hospital, Ghent&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02567253</guid>
      <pubDate>Wed, 23 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02561078?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Type 2 Diabetes Mellitus&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Human regular U-500 insulin (CSII);   Drug: Human regular U-500 insulin (MDI)&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Eli Lilly and Company;   Insulet Corporation&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02561078</guid>
      <pubDate>Wed, 23 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02683941?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Neuroendocrine Tumors&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Lanreotide (Autogel formulation);   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Ipsen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02683941</guid>
      <pubDate>Mon, 21 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02557672?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Bleeding;   Blood Loss, Surgical;   Cardiovascular Surgical Procedures;   Prothrombin Complex Concentrates;   Fresh Frozen Plasma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Prothrombin complex concentrate (Human);   Biological: Fresh frozen plasma (FFP)&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Mayo Clinic;   CSL Behring&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02557672</guid>
      <pubDate>Mon, 21 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Liver Test Study of Using JKB-122 in AIH Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02556372?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Autoimmune Hepatitis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: JKB-122&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    TaiwanJ Pharmaceuticals Co., Ltd&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02556372</guid>
      <pubDate>Sun, 20 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02555371?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Asthma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Mepolizumab 100mg;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02555371</guid>
      <pubDate>Thu, 17 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02549638?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Carcinoma, Squamous Cell;   Carcinoma, Squamous;   Squamous Cell Carcinoma;   Lung Neoplasms;   Cancer of Lung;   Cancer of the Lung;   Lung Cancer;   Neoplasms, Lung;   Neoplasms, Pulmonary;   Pulmonary Cancer;   Pulmonary Neoplasms&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Genetic: DNA Extraction&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Mayo Clinic&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02549638</guid>
      <pubDate>Thu, 10 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02546674?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Chronic Myeloid Leukemia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Nilotinib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novartis Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02546674</guid>
      <pubDate>Wed, 09 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Synergistic Effects of Aerobic Exercise and Cognitive Training on Cognition in Stroke Patients With Cognitive Decline</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02550990?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Stroke Patients With Cognitive Decline&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Cognitive training;   Behavioral: Aerobic exercise training;   Behavioral: Sequential combination of aerobic exercise and cognitive training&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Chang Gung Memorial Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02550990</guid>
      <pubDate>Sun, 06 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02557100?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Rheumatoid Arthritis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Abatacept;   Drug: Adalimumab;   Drug: Methotrexate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Bristol-Myers Squibb&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02557100</guid>
      <pubDate>Fri, 04 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Banded Versus Non-banded Roux-en-y Gastric Bypass</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02545647?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Morbid Obesity&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: BRYGB&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Rijnstate Hospital&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02545647</guid>
      <pubDate>Thu, 03 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02548962?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Multiple Myeloma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Ibrutinib;   Drug: Pomalidomide;   Drug: Dexamethasone;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Pharmacyclics;   Celgene Corporation&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02548962</guid>
      <pubDate>Thu, 03 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Dropless™ vs. Less Drops™ Pharmaceutical Regimens After Cataract Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819908?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Intraocular Lens Associated Postoperative Inflammation&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Imprimis Dropless;   Drug: Imprimis Less Drops&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Eye Center of North Florida&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819908</guid>
      <pubDate>Wed, 02 Sep 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Cisplatin and Pemetrexed</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02535312?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Advanced Peritoneal Malignant Mesothelioma;   Advanced Pleural Malignant Mesothelioma;   Recurrent Peritoneal Malignant Mesothelioma;   Recurrent Pleural Malignant Mesothelioma;   Solid Neoplasm;   Stage III Pleural Mesothelioma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIC Ovarian Cancer;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Ovarian Cancer;   Stage IV Pleural Mesothelioma;   Thymoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cisplatin;   Other: Laboratory Biomarker Analysis;   Drug: Methoxyamine;   Drug: Pemetrexed Disodium;   Other: Pharmacological Study&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02535312</guid>
      <pubDate>Thu, 27 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02537613?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Chronic Lymphocytic Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Obinutuzumab;   Drug: Ibrutinib&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Dana-Farber Cancer Institute;   Genentech, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02537613</guid>
      <pubDate>Thu, 27 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Erlotinib Hydrochloride and Hsp90 Inhibitor AT13387 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02535338?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent Non-Small Cell Lung Carcinoma;   Stage IV Non-Small Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Erlotinib Hydrochloride;   Drug: Hsp90 Inhibitor AT13387;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02535338</guid>
      <pubDate>Thu, 27 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02546323?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Atherosclerosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Rosuvastatin;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    AstraZeneca&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02546323</guid>
      <pubDate>Wed, 26 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02538965?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Leukemia, Myeloid&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Lenalidomide&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Celgene Corporation&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02538965</guid>
      <pubDate>Tue, 25 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>In Vivo Investigation of Initial Stages of Enamel Erosion</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02533466?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Tooth Erosion&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Sodium fluoride + potassium nitrate;   Other: Potassium nitrate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02533466</guid>
      <pubDate>Mon, 24 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02538874?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Liver Fibrosis/NASH&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: BMS-986171;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Bristol-Myers Squibb&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02538874</guid>
      <pubDate>Fri, 21 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Phase 1 Study of dmLT ID Vaccination in Healthy Adults</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02531685?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Gastroenteritis Escherichia Coli&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral entertoxigenic Escherichia coli (ETEC) Vaccine;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02531685</guid>
      <pubDate>Thu, 20 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Nivolumab and Ipilimumab With 5-azacitidine in Patients With Myelodysplastic Syndromes (MDS)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02530463?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Leukemia;   Myelodysplastic Syndrome&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Nivolumab;   Drug: Ipilimumab;   Drug: 5-azacitidine&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Bristol-Myers Squibb&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02530463</guid>
      <pubDate>Wed, 19 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Trial of Immune Reconstitution With Activated T-Cells Following Lymphodepleting Chemotherapy in Patients With Chronic Lymphocytic Leukemia (CLL)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02530515?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Leukemia;   Chronic Lymphocytic Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Fludarabine monophosphate;   Drug: Bendamustine;   Biological: Activated T-Cell Infusion;   Drug: Lenalidomide;   Behavioral: Phone Calls&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    M.D. Anderson Cancer Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02530515</guid>
      <pubDate>Wed, 19 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>GSK3174998 Alone or With Pembrolizumab in Subjects With Advanced Solid Tumors (ENGAGE-1)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02528357?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: GSK3174998;   Drug: Pembrolizumab&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    GlaxoSmithKline;   Merck Sharp &amp; Dohme Corp.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02528357</guid>
      <pubDate>Mon, 17 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02588092?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: ADCT-301&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    ADC Therapeutics SARL&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02588092</guid>
      <pubDate>Thu, 13 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>AdminiStration of Statin On Acute Ischemic stRoke patienT Trial</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02549846?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Ischemic Stroke&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Statin&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Hyogo College of Medicine;   Shionogi&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02549846</guid>
      <pubDate>Tue, 11 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02520778?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Laboratory Biomarker Analysis;   Drug: Navitoclax;   Drug: Osimertinib;   Other: Pharmacological Study&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02520778</guid>
      <pubDate>Mon, 10 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Magnetic Resonance Imaging Study in Obese Volunteers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02523352?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Obesity;   Pulmonary Atelectasis;   Obesity Hypoventilation Syndrome;   Magnetic Resonance Imaging;   Respiratory Mechanics&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Non-Invasive Mechanical ventilation - Recruitment maneuver;   Procedure: Non-Invasive Mechanical Ventilation - Decremental PEEP trial;   Procedure: Esophageal catheter positioning&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Massachusetts General Hospital&lt;br/&gt;&lt;b&gt;Enrolling by invitation&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02523352</guid>
      <pubDate>Mon, 10 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous Leukemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02520102?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Myeloid Leukemia NOS&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: sargramostim GZ402664&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Sanofi&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02520102</guid>
      <pubDate>Fri, 07 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Ramucirumab for Advanced Pre-treated Biliary Cancers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02520141?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Biliary Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Ramucirumab&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Eli Lilly and Company&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02520141</guid>
      <pubDate>Wed, 05 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Utility of a Smart Phone Application in Assessing Radial Artery Patency - the CAPITAL iRADIAL Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02519491?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Coronary Heart Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Modified Allen Test;   Other: Iphone artery assessment&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Ottawa Heart Institute Research Corporation&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02519491</guid>
      <pubDate>Tue, 04 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>ShapeUp Empower Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02518217?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Obesity;   Overweight&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Weight Loss Apps;   Behavioral: ShapeUp Empower;   Behavioral: Financial Incentives for Engagement&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    The Miriam Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02518217</guid>
      <pubDate>Mon, 03 Aug 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02517593?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Breast Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Genetic: Polygenic Risk Score&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Mayo Clinic;   CancerCare Manitoba&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02517593</guid>
      <pubDate>Fri, 31 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02511106?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Stage IB-IIIA Non-small Cell Lung Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: AZD9291 80 mg/40 mg;   Drug: Placebo AZD9291 80 mg/40 mg&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    AstraZeneca;   Parexel&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02511106</guid>
      <pubDate>Tue, 28 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Increased Salt Intake in Healthy Men</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02509962?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Dietary Supplement: Slow sodium tablets&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Charite University, Berlin, Germany&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02509962</guid>
      <pubDate>Fri, 24 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02504892?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Renal Cancer;   Chromophobe Renal Cell Carcinoma;   Birt-Hogg-Dube Syndrome&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Everolimus&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02504892</guid>
      <pubDate>Tue, 21 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Markers of T Cell Suppression: Associations With Malaria Infection and Antimalarial Treatment in Malian Children</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02504918?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Malaria&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified July 2015</description>
      <guid isPermaLink="false">NCT02504918</guid>
      <pubDate>Tue, 21 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Cediranib Maleate and Olaparib or Standard Chemotherapy in Treating Patients With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02502266?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Fallopian Tube Clear Cell Adenocarcinoma;   Fallopian Tube Endometrioid Adenocarcinoma;   Fallopian Tube Mucinous Adenocarcinoma;   Fallopian Tube Serous Adenocarcinoma;   Fallopian Tube Transitional Cell Carcinoma;   Ovarian Clear Cell Adenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mucinous Adenocarcinoma;   Ovarian Seromucinous Carcinoma;   Ovarian Serous Adenocarcinoma;   Ovarian Transitional Cell Carcinoma;   Primary Peritoneal Serous Adenocarcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Undifferentiated Fallopian Tube Carcinoma;   Undifferentiated Ovarian Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cediranib Maleate;   Other: Laboratory Biomarker Analysis;   Drug: Olaparib;   Drug: Paclitaxel;   Drug: Pegylated Liposomal Doxorubicin Hydrochloride;   Other: Questionnaire Administration;   Drug: Topotecan Hydrochloride&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02502266</guid>
      <pubDate>Fri, 17 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Open Lung Strategy in Critically Ill Morbid Obese Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02503241?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Obesity;   Respiratory Insufficiency;   Right-Sided Heart Failure;   Pulmonary Atelectasis;   Respiratory Mechanics&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Recruitment maneuver;   Procedure: PEEP titration&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Massachusetts General Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02503241</guid>
      <pubDate>Fri, 17 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02505542?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Axial Spondyloarthrithis;   Ankylosing Spondylitis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Certolizumab Pegol;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    UCB BIOSCIENCES GmbH;   Parexel&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02505542</guid>
      <pubDate>Thu, 16 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02500797?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent Adult Soft Tissue Sarcoma;   Stage III Bone Sarcoma;   Stage III Soft Tissue Sarcoma;   Stage IV Soft Tissue Sarcoma;   Stage IVA Bone Sarcoma;   Stage IVB Bone Sarcoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Other: Quality-of-Life Assessment&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Suspended&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02500797</guid>
      <pubDate>Wed, 15 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Vfend Special Investigation For Pediatric- Observational</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02554656?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pediatric Safety and Effectiveness&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Pfizer&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02554656</guid>
      <pubDate>Wed, 15 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02498600?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Suspended&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02498600</guid>
      <pubDate>Tue, 14 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02498613?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Estrogen Receptor Negative;   HER2/Neu Negative;   Metastatic Pancreatic Adenocarcinoma;   Pancreatic Adenocarcinoma;   Progesterone Receptor Negative;   Recurrent Breast Carcinoma;   Recurrent Non-Small Cell Lung Carcinoma;   Recurrent Pancreatic Carcinoma;   Recurrent Small Cell Lung Carcinoma;   Stage III Pancreatic Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIA Small Cell Lung Carcinoma;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIB Small Cell Lung Carcinoma;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Small Cell Lung Carcinoma;   Stage IVA Pancreatic Cancer;   Stage IVB Pancreatic Cancer;   Triple-Negative Breast Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: 18F-Fluoromisonidazole;   Drug: Cediranib Maleate;   Other: Laboratory Biomarker Analysis;   Drug: Olaparib;   Procedure: Positron Emission Tomography&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Cancer Institute (NCI);   AstraZeneca&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02498613</guid>
      <pubDate>Tue, 14 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02496767?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Amyotrophic Lateral Sclerosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: tirasemtiv;   Drug: Placebo tablets&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Cytokinetics&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02496767</guid>
      <pubDate>Fri, 10 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Training of Eccentric Knee Function After SCI</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02498548?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Spinal Cord Injury&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Trained SCI Knee&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Ohio State University;   University of Notre Dame&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02498548</guid>
      <pubDate>Thu, 09 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>EGFR Inhibitor AZD9291 and Necitumumab in Treating Patients With EGFR-Positive Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02496663?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent Non-Small Cell Lung Carcinoma;   Stage IV Non-Small Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Laboratory Biomarker Analysis;   Biological: Necitumumab;   Drug: Osimertinib;   Other: Pharmacological Study&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02496663</guid>
      <pubDate>Thu, 09 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Long-term Access Programme for Subjects With Severe Asthma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02543112?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Asthma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Mepolizumab 40mg or 100mg&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02543112</guid>
      <pubDate>Thu, 09 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02503436?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    &quot;Ovarian Cancer&quot;, &quot;Hereditary Ovarian Cancer Syndrome&quot;&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    AstraZeneca&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02503436</guid>
      <pubDate>Wed, 08 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02493517?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acromegaly&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Lanreotide Autogel®;   Drug: Lanreotide Acetate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Ipsen&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02493517</guid>
      <pubDate>Tue, 07 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02531633?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Giant Cell Arteritis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Sirukumab;   Drug: Placebo to match sirukumab;   Drug: Prednisone;   Drug: Placebo to match prednisone&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02531633</guid>
      <pubDate>Mon, 06 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02502708?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Glioblastoma Multiforme;   Glioma;   Gliosarcoma;   Malignant Brain Tumor;   Ependymoma;   Medulloblastoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Indoximod;   Drug: Temozolomide;   Radiation: Conformal Radiation&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    NewLink Genetics Corporation&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02502708</guid>
      <pubDate>Mon, 06 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Sentinel Lymph Node Biopsy in Patients With Early Stages Cervical Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02494063?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cervical Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: Sentinel lymph node biopsy&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Charles University, Czech Republic&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02494063</guid>
      <pubDate>Mon, 06 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02492763?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Type II Diabetes Mellitus&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: MK-8521;   Drug: Placebo;   Drug: Liraglutide;   Drug: Metformin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Merck Sharp &amp; Dohme Corp.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02492763</guid>
      <pubDate>Mon, 06 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>In Vivo Persistence of Adoptively-Transferred TIL Cultured With Akti in People With Metastatic Melanoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02489266?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Metastatic Melanoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: AKTi-treated TIL;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: Aldesleukin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Withdrawn&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02489266</guid>
      <pubDate>Thu, 02 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The LIPMAT Study: Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02495662?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Renal Dialysis;   Hemodynamics;   Vascular Remodeling;   Neointima&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: PEG-liposomal prednisolone sodium phosphate;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Leiden University Medical Center;   HagaZiekenhuis;   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   OLVG;   Medical Center Haaglanden;   Reinier de Graaf Groep;   Spaarne Gasthuis;   Erasmus Medical Center;   Alrijne Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02495662</guid>
      <pubDate>Thu, 02 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Population Pharmacokinetics of β-Lactams in Critically Ill Children</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02539407?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Pediatric Intensive Care Unit;   Pediatric Immuno-hematology Department&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Pharmacokinetics&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Assistance Publique - Hôpitaux de Paris&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02539407</guid>
      <pubDate>Thu, 02 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02489318?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostate Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Apalutamide;   Drug: Placebo;   Drug: Androgen Deprivation Therapy (ADT)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Janssen Research &amp; Development, LLC&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02489318</guid>
      <pubDate>Wed, 01 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02490098?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Type 1 Diabetes&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: 6-day intervention with sensor-augmented pump therapy;   Other: 6-day intervention with single-hormone closed-loop strategy;   Other: 6-day intervention with dual-hormone closed-loop strategy;   Drug: Insulin;   Drug: Glucagon;   Device: Continuous Glucose Monitoring System Enlite sensor®, Medtronic;   Device: Insulin pump MiniMed® Paradigm® Veo™, Medtronic&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Institut de Recherches Cliniques de Montreal;   Juvenile Diabetes Research Foundation&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02490098</guid>
      <pubDate>Wed, 01 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02487979?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Recurrent Osteosarcoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Glembatumumab Vedotin;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02487979</guid>
      <pubDate>Wed, 01 Jul 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02484443?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Metastatic Malignant Neoplasm in the Lung;   Metastatic Osteosarcoma;   Recurrent Osteosarcoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Dinutuximab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Biological: Sargramostim&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02484443</guid>
      <pubDate>Fri, 26 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02488616?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Type 1 Diabetes&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: 5-day intervention with single-hormone closed-loop strategy;   Other: 5-day intervention with sensor-augmented pump therapy;   Other: 5-day intervention with dual-hormone closed-loop strategy;   Device: Insulin pump;   Device: Continuous glucose monitoring system;   Drug: Insulin;   Drug: Glucagon&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Institut de Recherches Cliniques de Montreal&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02488616</guid>
      <pubDate>Fri, 26 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety, Tolerability, PK, and Activity of ATYR1940 in Patients With Muscular Dystrophy - Study Extension</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02531217?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Facioscapulohumeral Muscular Dystrophy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: ATYR1940&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    aTyr Pharma, Inc.&lt;br/&gt;&lt;b&gt;Enrolling by invitation&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02531217</guid>
      <pubDate>Thu, 25 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety and Feasibility Study of Rejuvenair™ for Treating Chronic Bronchitis Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02483637?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Bronchitis, Chronic;   Cryotherapy Effect&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: RejuvenAir&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    CSA Medical, Inc.&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02483637</guid>
      <pubDate>Thu, 25 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>BK Specific Cytotoxic T Lymphocytes (CTL) Lines for Stem Cell Transplant (SCT) Recipients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02479698?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    BK Virus&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Cytotoxic T lymphocytes (CTLs)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    M.D. Anderson Cancer Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02479698</guid>
      <pubDate>Fri, 19 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02478320?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Advanced Cancers&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Ilorasertib&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   AbbVie&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02478320</guid>
      <pubDate>Fri, 19 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed With Intraductal Papilloma Without Atypia or Flat Epithelial Atypia by Core Needle Biopsy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02489617?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Flat Epithelia Atypia;   Intraductal Papilloma Without Atypia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Pathologic evaluation of excised tissue&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Dana-Farber Cancer Institute&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02489617</guid>
      <pubDate>Thu, 18 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02497781?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Complicated Urinary Tract Infections (cUTIs)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Ceftazidime -avibactam;   Drug: Cefepime&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    AstraZeneca;   PRA Health Sciences&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02497781</guid>
      <pubDate>Tue, 16 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02475655?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    HIV Infections&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Ruxolitinib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02475655</guid>
      <pubDate>Tue, 16 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02471313?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Liver Cancer;   Liver Neoplasm;   Hepatocellular Carcinoma;   HCC&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: [18F] FMISO&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institutes of Health Clinical Center (CC)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02471313</guid>
      <pubDate>Fri, 12 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Effects of Different PEEP Levels on Work of Breathing in Morbidly Obese Patients Prior to and After Extubation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02492113?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Obesity&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Positive end-expiratory pressure (PEEP);   Procedure: ZEEP&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Massachusetts General Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02492113</guid>
      <pubDate>Fri, 12 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Analysis of Bone Marrow and Blood B Cell Immune Responses to Influenza Vaccination</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02485639?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Influenza&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Trivalent inactivated influenza vaccine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified January 2016</description>
      <guid isPermaLink="false">NCT02485639</guid>
      <pubDate>Thu, 11 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Verizon mHealth Solution for Patients With Peripheral Artery Disease (PAD)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02472561?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Peripheral Artery Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Fitbit Physical Activity Monitor;   Other: iHealth Glucometer;   Other: Withings Blood Pressure&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Duke University;   Verizon Wireless&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02472561</guid>
      <pubDate>Wed, 10 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>EXercise Influence on Taxane Side Effects (EXIT) Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02473861?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Breast Neoplasms&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Exercise&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of British Columbia&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02473861</guid>
      <pubDate>Tue, 09 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02469155?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Schizophrenia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: ITI-007;   Drug: Risperidone;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Intra-Cellular Therapies, Inc.&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02469155</guid>
      <pubDate>Tue, 09 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Radiation Therapy and Cisplatin With or Without Triapine in Treating Patients With Newly Diagnosed Stage IB2, II, or IIIB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02466971?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB2 Cervical Cancer;   Stage II Vaginal Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Vaginal Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Stage IVB Vaginal Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: Intensity-Modulated Radiation Therapy;   Radiation: Internal Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Radiation: Radiation Therapy;   Drug: Triapine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02466971</guid>
      <pubDate>Fri, 05 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02473224?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Gastroenteritis Norovirus&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Placebo;   Biological: Norovirus GII.2 Challenge&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02473224</guid>
      <pubDate>Thu, 04 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02465619?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cirrhosis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Institute of Liver and Biliary Sciences, India&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02465619</guid>
      <pubDate>Thu, 04 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Allied Health in Rheumatology Triage Project</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02465879?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Inflammatory Arthritis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Therapist Triage&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Sunnybrook Health Sciences Centre;   The Arthritis Society, Canada;   Ontario Rheumatology Association;   Ontario Best Practices Research Initiative&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2015</description>
      <guid isPermaLink="false">NCT02465879</guid>
      <pubDate>Thu, 04 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02467348?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute on Chronic Liver Failure&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Albumin;   Drug: Ascitic fluid&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Institute of Liver and Biliary Sciences, India&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02467348</guid>
      <pubDate>Thu, 04 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02465060?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Advanced Malignant Neoplasm;   Lymphoma;   Refractory Malignant Neoplasm;   Solid Neoplasm&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Afatinib;   Drug: Akt inhibitor AZD5363;   Drug: Binimetinib;   Drug: Crizotinib;   Other: Cytology Specimen Collection Procedure;   Drug: Dabrafenib;   Drug: Dasatinib;   Drug: Defactinib;   Drug: FGFR Inhibitor AZD4547;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Drug: Osimertinib;   Drug: Palbociclib;   Drug: PI3K-beta Inhibitor GSK2636771;   Drug: Sunitinib Malate;   Drug: Taselisib;   Drug: Trametinib;   Biological: Trastuzumab Emtansine;   Drug: Vismodegib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02465060</guid>
      <pubDate>Wed, 03 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Pillars4Life Trial</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02465892?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Breast Cancer;   Lung Cancer;   Esophageal Cancer;   Colon Cancer;   Pancreatic Cancer;   Liver Cancer;   Renal Cancer;   Bladder Cancer;   Prostate Cancer;   Ovarian Cancer;   Cervical Cancer;   Uterine Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Pillars4Life&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Duke University;   Pfizer&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02465892</guid>
      <pubDate>Wed, 03 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02462486?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Macular Degeneration&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: abicipar pegol;   Drug: ranibizumab;   Other: sham procedure&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Allergan&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02462486</guid>
      <pubDate>Tue, 02 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02462928?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Macular Degeneration&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: abicipar pegol;   Drug: ranibizumab;   Other: sham procedure&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Allergan&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02462928</guid>
      <pubDate>Tue, 02 Jun 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Phase 1, TAK-915-1001, Single Rising Dose, Multiple Rising Dose, Drug Interaction Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02461160?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy Volunteers&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: TAK-915;   Drug: Midazolam;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Takeda&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02461160</guid>
      <pubDate>Fri, 29 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Cost-effectiveness of Different Antiretroviral Treatment in Patients HIV Naive</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02470650?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Patient Compliance;   Antiretroviral Therapy Intolerance&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: elvitegravir/cobicistat/emtricitabine/tenofovir;   Drug: Darunavir;   Drug: abacavir/lamivudine;   Drug: Ritonavir;   Drug: Lamivudine;   Drug: rilpivirine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Juan A. Arnaiz&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02470650</guid>
      <pubDate>Fri, 29 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Childern Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02475733?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Complicated Intra-abdominal Infections (cIAIs)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Ceftazidime -avibactam;   Drug: Meropenem;   Drug: Metronidazole&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    AstraZeneca;   PRA Health Sciences&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02475733</guid>
      <pubDate>Mon, 25 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02468063?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cirrhosis With Septic Shock&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Low dose terlipressin;   Drug: Noradrenaline;   Drug: Noradrenaline&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Institute of Liver and Biliary Sciences, India&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02468063</guid>
      <pubDate>Fri, 22 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>To Compare the Efficacy of Carbepenem Versus Carbepenem Plus GM-CSF in Difficult To Treat Spontaneous Bacterial Peritonitis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02468089?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Spontaneous Bacterial Peritonitis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Carbepenem;   Drug: Albumin;   Drug: GMCSF (of Granulocyte-Monocyte Colony-Stimulating Factor) .&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Institute of Liver and Biliary Sciences, India&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02468089</guid>
      <pubDate>Fri, 22 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Study of Spectrum of Sleep Disorders in Cirrhotic Patients and the Efficacy of Zolpidem in Cirrhotic Patients With Insomnia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02484963?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cirrhosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Zolpidem;   Drug: placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Institute of Liver and Biliary Sciences, India&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02484963</guid>
      <pubDate>Fri, 22 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Photodynamic Therapy for PDA in NV AMD</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02452840?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Neovascular Age-related Macular Degeneration;   Macular Degeneration&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: No Intervention&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Duke University;   Bausch &amp; Lomb Incorporated&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02452840</guid>
      <pubDate>Thu, 21 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02463409?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Pseudohypoparathyroidism Type 1a;   Albright Hereditary Osteodystrophy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Theophylline&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Vanderbilt University;   Massachusetts General Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02463409</guid>
      <pubDate>Wed, 20 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>WATCHMAN Implantation During Hybrid Ablation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02471131?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Atrial Fibrillation;   Stroke&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: WATCHMAN Device implantation&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Maastricht University Medical Center;   Boston Scientific Corporation&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified February 2016</description>
      <guid isPermaLink="false">NCT02471131</guid>
      <pubDate>Wed, 20 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Dysport in the Treatment of Glabellar Lines in Chinese Subjects</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02450526?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Glabellar Lines&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Dysport;   Drug: Botox;   Other: AbobotulinumtoxinA Placebo;   Other: OnabotulinumtoxinA Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Ipsen&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02450526</guid>
      <pubDate>Tue, 19 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02446418?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Asthma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Fluticasone Furoate;   Drug: Vilanterol;   Drug: Fluticasone propionate;   Drug: Salmeterol;   Drug: Budesonide;   Drug: Formoterol Fumarate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02446418</guid>
      <pubDate>Thu, 14 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety and PK of MBX-400 (Cyclopropavir) in Normal Volunteers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02454699?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cytomegalovirus Infection&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Placebo;   Drug: MBX400&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02454699</guid>
      <pubDate>Thu, 14 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>2-arm Parallel Group Study of Fixed Combination of CHF 5993 vs Ultibro® in COPD Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02579850?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Chronic Obstructive Pulmonary Disease (COPD)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: CHF 5993 + Ultibro matched placebo;   Drug: Ultibro + CHF 5993 matched placebo;   Procedure: Central spirometry;   Other: COPD assessment test;   Procedure: Local laboratory Assessments;   Other: Saint George's Respiratory Questionnaire;   Other: EXACT-pro questionnaire&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Chiesi Farmaceutici S.p.A.&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02579850</guid>
      <pubDate>Tue, 12 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Observational Study of Outcomes in Cystic Fibrosis Patients With Selected Gating Mutations on a CFTR Allele (The VOCAL Study)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02445053?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cystic Fibrosis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: ivacaftor&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Vertex Pharmaceuticals Incorporated&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02445053</guid>
      <pubDate>Mon, 11 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Dose Escalation Study of JNJ-64052781 in Participants With Relapsed or Refractory B-cell Malignancies</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02454270?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    B-Cell Chronic Lymphocytic Leukemia;   Diffuse Large-Cell Lymphoma;   Follicular Lymphoma;   Mantle-Cell Lymphoma;   Acute Lymphoid Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Part 1 (Dose Escalation): JNJ-64052781;   Drug: Part 2 (Dose Expansion): JNJ-64052781&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Janssen Research &amp; Development, LLC&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02454270</guid>
      <pubDate>Wed, 06 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Dynamic CT Imaging After Nellix Endoprosthesis Implantation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02438605?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Aortic Aneurysm&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Nellix&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Rijnstate Hospital&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02438605</guid>
      <pubDate>Wed, 06 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Biomarkers of Liver Fibrosis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02438917?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hepatitis C&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Icahn School of Medicine at Mount Sinai;   KineMed&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02438917</guid>
      <pubDate>Wed, 06 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Pharmacokinetic Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02452931?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Precocious Puberty, Central&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Leuprolide Acetate 45 mg&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Tolmar Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02452931</guid>
      <pubDate>Tue, 05 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study for Treatment of Patients With EGFR Mutant, T790M-negative NSCLC</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02454842?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Non-small Cell Lung Cancer;   NSCLC;   Non-squamous NSCLC&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: TH-4000&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Threshold Pharmaceuticals&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02454842</guid>
      <pubDate>Mon, 04 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Hybrid Versus Catheter Ablation in Persistent AF</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02441738?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Atrial Fibrillation&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Hybrid Ablation;   Procedure: Catheter Ablation&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Maastricht University Medical Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified February 2016</description>
      <guid isPermaLink="false">NCT02441738</guid>
      <pubDate>Mon, 04 May 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacology of ONO-4474 in Healthy Volunteers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02454387?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Osteoarthritis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: ONO-4474 Part A1;   Drug: Placebo Part A1;   Drug: ONO-4474 Part A2;   Drug: Placebo Part A2;   Drug: ONO-4474 Part B;   Drug: Placebo Part B;   Drug: ONO-4474 Part C;   Drug: Placebo Part C;   Drug: ONO-4474 Part D;   Drug: Placebo Part D&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Ono Pharmaceutical Co. Ltd&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified January 2016</description>
      <guid isPermaLink="false">NCT02454387</guid>
      <pubDate>Wed, 29 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>VIDA Mobile Health Cardiovascular Prevention Program</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02431546?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Coronary Artery Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Mobile Health Application&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Duke University;   Vida Health, Inc.;   Duke Health (Duke Heart Center)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02431546</guid>
      <pubDate>Tue, 28 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02472028?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cerebrovascular Disorders&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: blood pressure lowering algorithm;   Other: usual strategy&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Assistance Publique - Hôpitaux de Paris&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02472028</guid>
      <pubDate>Mon, 27 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Bereaved Parent Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02425787?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Bereavement&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Interview&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    St. Jude Children's Research Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02425787</guid>
      <pubDate>Tue, 21 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Evaluation of the Relapse Rate One Month After Discharge From Emergency Department for Asthmatic Patients Given a Strict Formalized Follow up Protocol</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02424409?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Asthma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: 2: Intervention;   Behavioral: 1: Control&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Assistance Publique - Hôpitaux de Paris&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02424409</guid>
      <pubDate>Mon, 20 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Spatial Context and Fear Learning</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02423044?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Anxiety Disorders&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Mental Health (NIMH)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02423044</guid>
      <pubDate>Sat, 18 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Improving Embryogenesis by Adding Growth Factors to In Vitro Human Culture Media</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02426008?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    In Vitro Human Embryo Development&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Growth Factors and Cytokine adding to embryo culture media;   Other: No Intervention&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Ibn Sina Hospital;   Banon IVF Center Assiut, Egypt&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02426008</guid>
      <pubDate>Fri, 17 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>First-in-human: Single Ascending Dose, Food Effect, Drug-drug Interaction, Multiple Ascending Dose, Proof of Pharmacology</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02420782?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy Volunteers&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: ASP6282;   Drug: Itraconazole;   Drug: Pilocarpine;   Drug: Placebo;   Drug: Midazolam&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Astellas Pharma Europe B.V.&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02420782</guid>
      <pubDate>Wed, 15 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of a Self-Administered Memory Screening Test With Automated Reporting (SAMSTAR) in Participants With Mild Cognitive Impairment</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02419183?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Mild Cognitive Impairment&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: SAMSTAR;   Other: RAVLT&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Janssen Research &amp; Development, LLC&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02419183</guid>
      <pubDate>Tue, 14 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Phase IB of Selinexor in Combination With Standard Chemotherapy in Patients With Advanced Malignancies</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02419495?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Advanced Cancers&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Selinexor;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Eribulin;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Pemetrexed;   Drug: Topotecan;   Drug: Irinotecan;   Drug: 5-FU;   Drug: Capecitabine;   Drug: Oxaliplatin;   Drug: Olaparib;   Drug: Pembrolizumab&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Karyopharm Therapeutics, Inc&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02419495</guid>
      <pubDate>Tue, 14 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Evaluation of an Iris Dilatation Ring in Cataract Surgery (ADICC-ID)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02434588?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Small Pupil&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Bhattacharjee ring&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Fondation Ophtalmologique Adolphe de Rothschild&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02434588</guid>
      <pubDate>Tue, 14 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Pomalidomide in Treating Younger Patients With Recurrent, Progressive or Refractory Central Nervous System Tumors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02415153?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Neurofibromatosis Type 1;   Recurrent Central Nervous System Neoplasm;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Visual Pathway Glioma;   Refractory Central Nervous System Neoplasm&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Pomalidomide&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Suspended&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02415153</guid>
      <pubDate>Mon, 13 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02417935?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Diabetic Peripheral Neuropathic Pain&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Duloxetine;   Drug: Pregabalin;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Eli Lilly and Company;   Shionogi&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02417935</guid>
      <pubDate>Mon, 13 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Self-injection and Self-management</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02417493?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Food Allergy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Simulation of epinephrine self-injection&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Icahn School of Medicine at Mount Sinai;   Fordham University&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02417493</guid>
      <pubDate>Fri, 10 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02414841?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Chronic Kidney Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: vonapanitase;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Proteon Therapeutics&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02414841</guid>
      <pubDate>Wed, 08 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Bracing to Treat Knee Osteoarthritis in Elderly</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02443974?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Knee Osteoarthritis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: Brace (Fisiotensor®);   Device: Sleeve (Fisiotensor®)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Federal University of São Paulo&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02443974</guid>
      <pubDate>Wed, 08 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>CareSTEPS: A Supportive Care Program for the Caregivers of Advanced Lung Cancer Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02414672?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Lung Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: CareSTEPS&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Icahn School of Medicine at Mount Sinai;   National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02414672</guid>
      <pubDate>Tue, 07 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of SI-6603 in Patients With Lumbar Disc Herniation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02421601?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Intervertebral Disc Disease;   Lumbar Disc Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Condoliase&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Seikagaku Corporation&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02421601</guid>
      <pubDate>Mon, 06 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>P2/3 Randomized Study of Toca 511 &amp; Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02414165?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Glioblastoma Multiforme;   Anaplastic Astrocytoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Toca 511;   Drug: Toca FC;   Drug: Lomustine;   Drug: Temozolomide;   Biological: Bevacizumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Tocagen Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02414165</guid>
      <pubDate>Fri, 03 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Donor Human Milk in Young Children Receiving Bone Marrow Transplantation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02470104?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Bone Marrow Transplant - Autologous or Allogeneic&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Breastmilk&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Children's Hospital Medical Center, Cincinnati;   Prolacta Bioscience&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02470104</guid>
      <pubDate>Wed, 01 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Improving Self-Management in Head and Neck Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02409485?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Head and Neck Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Couples Skill-Training (CST)&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Icahn School of Medicine at Mount Sinai;   National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02409485</guid>
      <pubDate>Wed, 01 Apr 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02414399?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Pneumonia;   Diarrhea;   Malaria;   Co-infection;   Death;   Malnutrition&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Azithromycin;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Washington;   Kenya Medical Research Institute&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02414399</guid>
      <pubDate>Tue, 31 Mar 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02406742?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Leukemia, Lymphocytic, Chronic, B-Cell&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: CC-122;   Drug: CC-122;   Drug: Ibrutinib;   Drug: CC-122;   Drug: Obinutuzumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Celgene Corporation&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02406742</guid>
      <pubDate>Mon, 30 Mar 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02406729?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Dengue&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Dengue 1,2,3,4 (attenuated) vaccine;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Butantan Institute&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02406729</guid>
      <pubDate>Mon, 30 Mar 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Dried Blood Spot- Statin Pilot Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02402803?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Hyperlipidemias;   Cardiovascular Diseases&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Dried blood spot testing and phlebotomy&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Cedars-Sinai Medical Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02402803</guid>
      <pubDate>Wed, 25 Mar 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02405585?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Pancreatic Cancer;   Pancreatic Carcinoma Non-resectable&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: mFOLFIRINOX;   Biological: Algenpantucel-L Immunotherapy;   Radiation: SBRT;   Drug: Gemcitabine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    NewLink Genetics Corporation&lt;br/&gt;&lt;b&gt;Terminated&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02405585</guid>
      <pubDate>Wed, 25 Mar 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of Nivolumab (BMS-936558) in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia and Newly Diagnosed Older Acute Myeloid Leukemia (AML) (&gt;65 Years) Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02397720?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: 5-azacytidine;   Drug: Nivolumab;   Behavioral: Phone Call&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Bristol-Myers Squibb&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02397720</guid>
      <pubDate>Thu, 19 Mar 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Partially Hydrolyzed Whey Formula in Cow's Milk Allergic Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02397876?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Food Allergy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Partially Hydrolyzed Whey formula&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Icahn School of Medicine at Mount Sinai;   Nestlé&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02397876</guid>
      <pubDate>Thu, 19 Mar 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Trial of CM-AT in Children With Autism With All Levels of FCT</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02410902?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Autism&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: CM-AT;   Drug: PLACEBO&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Curemark&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02410902</guid>
      <pubDate>Thu, 19 Mar 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Effects of Bronchial Segmental Endotoxin Instillation in Humans</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02392442?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Lung Inflammation&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Saline;   Biological: Endotoxin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institutes of Health Clinical Center (CC)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02392442</guid>
      <pubDate>Wed, 18 Mar 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Placebo-Controlled Study to Investigate the Efficacy &amp; Safety of Injectafer in the Treatment of RLS</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02397057?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Restless Legs Syndrome (RLS)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Injectafer;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Luitpold Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02397057</guid>
      <pubDate>Wed, 18 Mar 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02392455?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Carcinoma, Non-Small-Cell Lung&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: treatment&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Boehringer Ingelheim&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02392455</guid>
      <pubDate>Tue, 17 Mar 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of Blinatumomab in Japanese Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02412306?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Blinatumomab&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Amgen;   Amgen Astellas Biopharma K.K.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02412306</guid>
      <pubDate>Thu, 12 Mar 2015 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>CINC424A2X01B Rollover Protocol</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02386800?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Splenomegaly&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Ruxolitinib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novartis Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02386800</guid>
      <pubDate>Fri, 06 Mar 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02379442?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Graft-Versus-Host Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: MSC&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Heart, Lung, and Blood Institute (NHLBI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02379442</guid>
      <pubDate>Wed, 04 Mar 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Pharmacokinetic Study of Melphalan in Children</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02390544?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hematopoietic Stem Cell Transplantation&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Melphalan&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Children's Hospital Medical Center, Cincinnati&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02390544</guid>
      <pubDate>Wed, 04 Mar 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Use of QTRAC Technique to Measure Axonal Excitability in Anti-MAG Neuropathy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02468596?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Peripheral Neuropathy Associated With Anti-myelin Associated Glycoprotein Antibodies (Anti-MAG Neuropathy)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: QTRAC assessment;   Other: Clinical assessment of peripheral nerve function&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Fondation Ophtalmologique Adolphe de Rothschild&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02468596</guid>
      <pubDate>Tue, 03 Mar 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02381886?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Advanced Malignancies That Harbor IDHR132 Mutations&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: IDH305&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novartis Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02381886</guid>
      <pubDate>Mon, 02 Mar 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background Methotrexate</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02387762?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Rheumatoid Arthritis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: ACP-196;   Drug: Placebo;   Drug: Methotrexate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Acerta Pharma BV&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified November 2015</description>
      <guid isPermaLink="false">NCT02387762</guid>
      <pubDate>Sun, 01 Mar 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02378922?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    AIDS-Related Hodgkin Lymphoma;   AIDS-Related Non-Hodgkin Lymphoma;   HIV Infection;   Recurrent Hodgkin Lymphoma;   Recurrent Non-Hodgkin Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Transplant Conditioning;   Biological: gene-modified HIV-protected hematopoietic stem cells;   Other: Laboratory Biomarker Analysis&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02378922</guid>
      <pubDate>Fri, 27 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02432235?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Hodgkin Lymphoma;   Non-Hodgkin Lymphoma;   Burkitt's Lymphoma;   Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma;   Lymphoma, Large B-Cell, Diffuse;   Lymphoma, Follicular;   Lymphoma, Mantle-Cell;   Lymphoma, Marginal Zone;   Waldenstrom's Macroglobulinaemia;   Lymphoma,T-cell Cutaneous;   Lymphoma, T-Cell, Peripheral&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: ADCT-301&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    ADC Therapeutics SARL&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02432235</guid>
      <pubDate>Thu, 26 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>PNT2258 for Treatment of Patients With Richter's Transformation (Brighton)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02378038?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Richter's Transformation&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: PNT2258&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    ProNAi Therapeutics, Inc&lt;br/&gt;&lt;b&gt;Terminated&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02378038</guid>
      <pubDate>Thu, 26 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02377427?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Asthma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Mepolizumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02377427</guid>
      <pubDate>Thu, 26 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Anxiety in Older Veterans</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02400723?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Anxiety Disorders&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Progressive Muscle Relaxation;   Behavioral: Diaphragmatic Breathing;   Other: Psychoeducation (Placebo)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    VA Office of Research and Development&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02400723</guid>
      <pubDate>Thu, 26 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Trial Assessing Efficacy, Safety and Tolerability of PCSK9 Inhibition in Paediatric Subjects With Genetic LDL Disorders</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02392559?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Heterozygous Familial Hypercholesterolemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Evolocumab;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Amgen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02392559</guid>
      <pubDate>Wed, 25 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02411461?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Pseudohypoparathyroidism;   Albright Hereditary Osteodystrophy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Vanderbilt University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02411461</guid>
      <pubDate>Wed, 25 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Bipolar Ventricular Tachycardia (VT) Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02374476?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Ventricular Tachycardia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Bipolar Ablation&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Srinivas Dukkipati;   Biosense Webster, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02374476</guid>
      <pubDate>Mon, 23 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Human Breastmilk in Young Children With Norovirus Infection of the Gut</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02371538?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Norovirus Infections&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Donor Breastmilk&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Children's Hospital Medical Center, Cincinnati;   Mothers' Milk Bank Northeast&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02371538</guid>
      <pubDate>Thu, 19 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02369874?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck (SCCHN).&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: MEDI4736;   Drug: MEDI4736 + Tremelimumab;   Drug: Standard of Care&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    AstraZeneca&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02369874</guid>
      <pubDate>Wed, 18 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Benefits of Exercise Training in Women With Ischemic Syndrome</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02374086?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Microvascular Coronary Dysfunction&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Exercise training&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Cedars-Sinai Medical Center&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02374086</guid>
      <pubDate>Wed, 18 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02371070?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Anticoagulation With Direct Oral Anticoagulants&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University Hospital Tuebingen;   Heart and Diabetes Center North Rhine-Westphalia&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified February 2015</description>
      <guid isPermaLink="false">NCT02371070</guid>
      <pubDate>Wed, 18 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02370303?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Lung Cancer;   Lung Neoplasms;   Cancer of Lung;   Cancer of the Lung;   Neoplasms, Lung;   Neoplasms, Pulmonary;   Pulmonary Cancer;   Pulmonary Neoplasms;   Carcinoma, Non-small-cell Lung;   Adenocarcinoma;   Squamous Cell Carcinoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Mayo Clinic;   Clearbridge Biomedics&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02370303</guid>
      <pubDate>Tue, 17 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02363322?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Ebola Virus Infection&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: ZMApp;   Other: Treatment A&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID);   The Ministry of Health and Social Welfare of the Republic of Liberia;   The Ministry of Health and Sanitation of the Republic of Sierra Leone;   INSERM (Institut national de la sante et de la recherche medicale [French National Institute of Health and Medical Research]);   The Ministry of Health and Public Hygiene of the Republic of Guinea&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02363322</guid>
      <pubDate>Fri, 13 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Minimally Invasive Surgery (MIS) for Spine Metastases</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02367378?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Spine Metastases&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Icahn School of Medicine at Mount Sinai&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02367378</guid>
      <pubDate>Fri, 13 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Neovascular Morphology and Persistent Disease Activity Among Patients With NV AMD</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02367365?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Neovascular Age-Related Macular Degeneration&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: No Intervention;   Other: No Intervention&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Duke University;   Bausch &amp; Lomb Incorporated&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02367365</guid>
      <pubDate>Fri, 13 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Patients With Renal or Hepatic Impairment</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02367872?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Participants With Renal or Hepatic Impairment&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: TAK-272&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Takeda&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02367872</guid>
      <pubDate>Fri, 13 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Weight Management Among Breast Cancer Survivors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02387671?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Body Weight&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Device: FitBit Flex wrist band;   Behavioral: Device: FitBit Aria weight scale;   Behavioral: Diet Intake Messages;   Behavioral: Behavioral Counseling&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Boston Medical Center;   Boston University&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified January 2015</description>
      <guid isPermaLink="false">NCT02387671</guid>
      <pubDate>Thu, 12 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Improving Goals of Care Discussion in Advanced Cancer Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02374255?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Primary Stage IV Hepatobiliary;   Esophageal;   Colorectal Cancer;   Glioblastoma;   Cancer of Stomach;   Cancer of Pancreas;   Melanoma;   Head or Neck Cancer;   Stage III;   Stage IV;   Lung Cancers;   Pancreatic Cancers&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: GoC intervention&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Icahn School of Medicine at Mount Sinai;   Patient-Centered Outcomes Research Institute&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02374255</guid>
      <pubDate>Mon, 09 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Can Text Reminders Improve Uptake of Cervical Screening?</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02363088?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Cervical Carcinoma;   Cervical Dysplasia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Neutral text message reminder;   Other: Messenger text message reminder;   Other: Social Norms A reminder;   Other: Social Norms B reminder;   Other: Framed Gain text reminder;   Other: Framed Loss text reminder&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Sarah Huf&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02363088</guid>
      <pubDate>Mon, 09 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Lactoferrin or Progesterone for Prevention of Preterm Delivery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02372942?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Preterm Delivery&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Lattoferrin;   Drug: Progesterone&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Padua&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02372942</guid>
      <pubDate>Sat, 07 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study Using Autologous Tumor Infiltrating Lymphocytes (LN-144) Followed by IL-2 Metastatic Melanoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02360579?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Metastatic Melanoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: LN-144&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Lion Biotechnologies&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02360579</guid>
      <pubDate>Tue, 03 Feb 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Genitourinary and Pharyngeal Pharmacokinetics of Solithromycin</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02348424?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Gonorrhoea&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Solithromycin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified January 2016</description>
      <guid isPermaLink="false">NCT02348424</guid>
      <pubDate>Thu, 22 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Primary Insufficiency of the Great Saphenous Vein (GSV) With a Diameter &gt;/= 12 mm, Antero-lateral Branches, or GSV Insufficiency Below the Knee</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02345018?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Varicose Veins;   Dilated Veins&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: Mechano-chemical ablation&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Rijnstate Hospital&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02345018</guid>
      <pubDate>Mon, 19 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan Registry 2</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02419794?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Ischemic Stroke&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: endovascular treatment&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Hyogo College of Medicine&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02419794</guid>
      <pubDate>Mon, 19 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>An Observational Study of the Functional Capacity of Heart Failure</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02350114?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Heart Failure&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: 6 Minute Walk Test&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Bristol-Myers Squibb;   Colorado Prevention Center;   This trial was conducted by the previous sponsor, Cardioxyl Pharmaceuticals, Inc.&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02350114</guid>
      <pubDate>Sun, 18 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>The Effect of Light on the Fetal Biophysical Profile</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02453230?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pregnancy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Lights on&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    St. Louis University&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02453230</guid>
      <pubDate>Fri, 16 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02342782?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma;   Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma;   Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma;   Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma;   Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Yttrium Y 90 Basiliximab;   Drug: Carmustine;   Drug: Etoposide;   Drug: Cytarabine;   Drug: Melphalan;   Procedure: Autologous Hematopoietic Stem Cell Transplantation;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    City of Hope Medical Center;   National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02342782</guid>
      <pubDate>Thu, 15 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02341560?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Nonarteritic Anterior Ischemic Optic Neuropathy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: QPI-1007 Injection - single low dose;   Drug: QPI-1007 Injection - single high dose;   Drug: QPI-1007 Injection - multiple low dose;   Drug: QPI-1007 Injection - multiple high dose;   Other: Sham Injection Procedure&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Quark Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02341560</guid>
      <pubDate>Tue, 13 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Effects of Bile Acids on GLP-1 Secretion After Roux-en-Y Gastric Bypass</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02340247?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Severe Obesity&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Water;   Drug: Ursodeoxycholic Acid;   Drug: Chenodeoxycholic Acid&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Hvidovre University Hospital;   University of Copenhagen&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02340247</guid>
      <pubDate>Tue, 13 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02339571?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent Melanoma of the Skin;   Stage IIIA Skin Melanoma;   Stage IIIB Skin Melanoma;   Stage IIIC Skin Melanoma;   Stage IV Skin Melanoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Biological: Sargramostim&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02339571</guid>
      <pubDate>Mon, 12 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02373813?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Rheumatoid Arthritis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: etanercept pre-filled syringe sq injection;   Drug: Oral methotrexate;   Drug: Placebo for etanercept sq injection;   Drug: Placebo for methotrexate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Amgen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02373813</guid>
      <pubDate>Mon, 12 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>PET-CT After Nellix Implantation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02349100?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Aortic Aneurysm;   Endovascular Repair&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Nellix Endoprosthesis&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Rijnstate Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02349100</guid>
      <pubDate>Mon, 12 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02339168?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostate Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Enzalutamide;   Drug: Metformin Hydrochloride&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of California, Davis;   National Cancer Institute (NCI);   Medivation, Inc.;   Astellas Pharma Inc&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02339168</guid>
      <pubDate>Mon, 12 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02337764?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Parkinson's Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: TVP-1012 1mg with levodopa&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Takeda&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02337764</guid>
      <pubDate>Fri, 09 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted Darunavir</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02337322?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acquired Immune Deficiency Syndrome Virus&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Dolutegravir;   Drug: Darunavir/r&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Juan A. Arnaiz&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02337322</guid>
      <pubDate>Fri, 09 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02337751?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Parkinson's Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: TVP-1012 1mg&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Takeda&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02337751</guid>
      <pubDate>Fri, 09 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02337738?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Parkinson's Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: TVP-1012 1mg;   Drug: TVP-1012 0.5mg;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Takeda&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02337738</guid>
      <pubDate>Fri, 09 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02337725?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Parkinson's Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: TVP-1012;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Takeda&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02337725</guid>
      <pubDate>Fri, 09 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Phase 1 Trial of Inactivated West Nile Virus Vaccine</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02337868?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    West Nile Viral Infection&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: HydroVax-001;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02337868</guid>
      <pubDate>Thu, 08 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Implementing Genomics in Practice (IGNITE) Proof of Concept Study: Genotyping in Family Medicine Clinics</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02335307?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pain&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Genetic: CYP2D6 genotyping;   Other: Pain assessment questionnaire;   Other: Physician assessment&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Florida;   National Human Genome Research Institute (NHGRI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02335307</guid>
      <pubDate>Wed, 07 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>PK of Efavirenz &amp; Lopinavir Nano-formulations in Healthy Volunteers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02631473?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    HIV&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: 50mg NANO-efavirenz;   Drug: 400mg NANO-Lopinavir;   Drug: 200mg NANO-Lopinavir;   Drug: 100mg Ritonavir;   Drug: 300mg NANO-Efavirenz;   Drug: 600mg Sustiva;   Drug: 200mg NANO-Efavirenz;   Drug: Kaletra® (lopinavir 400mg/ritonavir 100mg);   Drug: +/- 200mg NANO-Lopinavir;   Drug: +/- 200mg ritonavir NORVIR;   Drug: 400mg Sustiva&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    St Stephens Aids Trust;   University of Liverpool&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02631473</guid>
      <pubDate>Tue, 06 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Risk Factors of Neonatal Respiratory Distress for Newborns With Prenatally Diagnosed Congenital Lung Malformations</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02352207?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Foetus With Congenital Pulmonary Malformation&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: identification of a pulmonary malformation in the fetus&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Assistance Publique - Hôpitaux de Paris&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02352207</guid>
      <pubDate>Mon, 05 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Impact of Hyperoxia During Cardiopulmonary</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819739?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cardiac Complications&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: medical oxygen&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Centre Hospitalier Universitaire, Amiens&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819739</guid>
      <pubDate>Mon, 05 Jan 2015 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active Surveillance</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02326805?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Stage I Prostate Adenocarcinoma;   Stage II Prostate Adenocarcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Laboratory Biomarker Analysis;   Other: Placebo;   Biological: Rilimogene-galvacirepvec&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified February 2016</description>
      <guid isPermaLink="false">NCT02326805</guid>
      <pubDate>Wed, 24 Dec 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02322190?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Chronic Graft vs. Host Disease;   Graft vs Host Disease;   Graft-Versus-Host Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Extracorporeal Photopheresis (ECP);   Drug: Methoxsalenused in conjuction with photopheresis procedure&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02322190</guid>
      <pubDate>Sat, 20 Dec 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AML</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02326584?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Acute Myeloid Leukemia;   Acute Myelogenous Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Standard dose cytarabine for induction;   Drug: SGN-CD33A;   Drug: Daunorubicin;   Drug: High dose cytarabine for consolidation&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Seattle Genetics, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02326584</guid>
      <pubDate>Thu, 18 Dec 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Clinical Study Comparing Basic Performance and Hemocompatibility of 3 Different Dialyzers in Hemodialysis Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02433210?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    End Stage Renal Disease (ESRD)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: ELISIO-H;   Device: Revaclear;   Device: Optiflux&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Missouri-Columbia;   Nipro Medical Corporation;   Dialysis Clinic, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02433210</guid>
      <pubDate>Tue, 16 Dec 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Magnesium Sulfate in Pregnancy and Postpartum</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02317146?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Severe Pre-eclampsia With Postnatal Complication&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Magnesium Sulfate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Complejo Hospitalario Dr. Arnulfo Arias Madrid&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified February 2016</description>
      <guid isPermaLink="false">NCT02317146</guid>
      <pubDate>Thu, 11 Dec 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Nivolumab in Treating Patients With Refractory Metastatic Anal Canal Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02314169?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Anal Canal Squamous Cell Carcinoma;   Metastatic Anal Canal Carcinoma;   Recurrent Anal Canal Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Laboratory Biomarker Analysis;   Biological: Nivolumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02314169</guid>
      <pubDate>Wed, 10 Dec 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02311933?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Estrogen Receptor Positive;   HER2/Neu Negative;   Recurrent Breast Carcinoma;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Tamoxifen Citrate;   Drug: Z-Endoxifen Hydrochloride&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02311933</guid>
      <pubDate>Mon, 08 Dec 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02314923?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Ebola Virus&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: BPSC-1001 Vaccine;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Merck Sharp &amp; Dohme Corp.;   BioProtection Systems Corporation;   Department of Health and Human Services&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02314923</guid>
      <pubDate>Mon, 08 Dec 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02325349?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Advanced Head and Neck Carcinoma;   Advanced Non-small Cell Lung Carcinoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: radiopharmaceutical (Flotegatide (18F) or RGD (68Ga)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Assistance Publique - Hôpitaux de Paris&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02325349</guid>
      <pubDate>Sun, 07 Dec 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Clindamycin Once a Day in Septic Abortion</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02309346?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Septic Abortion&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Clindamycin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Hospital de Clinicas de Porto Alegre&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02309346</guid>
      <pubDate>Wed, 03 Dec 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02307916?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Tympanic Membrane Perforation&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: FGF-2;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Dr. Bradley Welling;   United States Department of Defense&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02307916</guid>
      <pubDate>Tue, 02 Dec 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Cerebral Embolic Load in Patients Undergoing Surgical Aortic Valve Replacement: A Comparison of the Conventional With the Minimized Extracorporeal Circulation Technique Using Transcranial Doppler Ultrasound</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02308566?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Aortic Valve Stenosis;   Extracorporeal Circulation&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Minimized Extracorporeal Circulation (MECC);   Procedure: Conventional Extracorporeal Circulation (CECC)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University Hospital Inselspital, Berne&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02308566</guid>
      <pubDate>Tue, 02 Dec 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02306161?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Metastatic Ewing Sarcoma;   Metastatic Malignant Neoplasm in the Bone;   Metastatic Malignant Neoplasm in the Bone Marrow;   Metastatic Malignant Neoplasm in the Lung;   Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone;   Peripheral Primitive Neuroectodermal Tumor of Soft Tissues&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Drug: Etoposide;   Radiation: External Beam Radiation Therapy;   Biological: Ganitumab;   Drug: Ifosfamide;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Radiation: Stereotactic Radiosurgery;   Procedure: Therapeutic Surgical Procedure;   Drug: Vincristine Sulfate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02306161</guid>
      <pubDate>Mon, 01 Dec 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02327078?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Melanoma;   Carcinoma, Non-Small-Cell Lung;   Colorectal Neoplasms;   Carcinoma, Squamous Cell of Head and Neck;   Ovarian Neoplasms;   B Cell NHL Including DLBCL;   HL;   Glioblastoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Nivolumab + Epacadostat&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Incyte Corporation;   Bristol-Myers Squibb&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02327078</guid>
      <pubDate>Mon, 01 Dec 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>The Effect of an Evidence-based Physiotherapy Regimen for Patients With Rotator Cuff Tendinopathy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02304003?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Tendinopathy;   Shoulder Impingement Syndrome;   Shoulder Pain;   Subacromial Impingement&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Structured Physiotherapy Regimen;   Other: Standard Care&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Bergen University College;   University of Bergen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02304003</guid>
      <pubDate>Wed, 26 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02304315?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hepatitis B Infection&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: GC1102 50,000 IU;   Biological: GC1102 80,000 IU&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Green Cross Corporation&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified December 2015</description>
      <guid isPermaLink="false">NCT02304315</guid>
      <pubDate>Wed, 26 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02301962?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Panitumumab&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    GlaxoSmithKline;   Amgen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02301962</guid>
      <pubDate>Mon, 24 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02301975?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Asthma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Fluticasone Furoate/Vilanterol 100/25 mcg via ELLIPTA inhaler;   Drug: Placebo inhalation powders via ELLIPTA inhaler;   Drug: Fluticasone Propionate/Salmeterol 250/50 mcg via ACCUHALER/DISKUS inhaler;   Drug: Placebo inhalation powder via ACCUHALER/DISKUS inhaler;   Drug: Fluticasone Propionate 250 mcg via ACCUHALER/DISKUS inhaler&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02301975</guid>
      <pubDate>Mon, 24 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02302092?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Urinary Tract Infection&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Flomoxef;   Drug: Cefepime&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Takeda&lt;br/&gt;&lt;b&gt;Terminated&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02302092</guid>
      <pubDate>Mon, 24 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Cabozantinib for Malignant Pheochromocytoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02302833?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Neuroendocrine Tumors&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cabozantinib;   Behavioral: Questionnaire&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Exelixis&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02302833</guid>
      <pubDate>Fri, 21 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02295748?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Duchenne Muscular Dystrophy&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Deflazacort&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Marathon Pharmaceuticals, LLC&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02295748</guid>
      <pubDate>Tue, 18 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Phase IIb Study to Evaluate Efficacy and Tolerability of ODX (Osteodex) in Metastatic CRPC</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02378870?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostate Cancer Metastatic&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Osteodex;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    DexTech Medical AB&lt;br/&gt;&lt;b&gt;Terminated&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02378870</guid>
      <pubDate>Mon, 17 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Telerehabilitation for Attention and Memory in Stroke</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02405351?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Stroke&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Adaptive Working Memory Training&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Nova Scotia Health Authority;   Heart and Stroke Foundation of Canada&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02405351</guid>
      <pubDate>Mon, 17 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Phase IIB TL + YCWP + DC in Melanoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02301611?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Melanoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: TLPLDC;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Cancer Insight, LLC;   Elios Therapeutics, LLC&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02301611</guid>
      <pubDate>Wed, 12 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02291432?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Urinary Incontinence;   Stress;   Urination Disorders;   Urologic Diseases;   Lower Urinary Tract Symptoms;   Urological Manifestations&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: autologous muscle-derived cells (AMDC)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Cook&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02291432</guid>
      <pubDate>Tue, 11 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Wear of Enamel Against Polished Zirconia Crowns</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02289781?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Tooth Wear&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: posterior crowns&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Florida;   3M Pharmaceuticals Pty Limited&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02289781</guid>
      <pubDate>Fri, 07 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Telavancin Observational Use Registry (TOUR)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02288234?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Hospital Acquired Bacterial Pneumonia;   Complicated Skin and Skin Structure Infections;   Ventilator Associated Bacterial Pneumonia;   Gram Positive Infection&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Theravance Biopharma Antibiotics, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02288234</guid>
      <pubDate>Wed, 05 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Esophageal Motility Disease Screening in Patient With Suspicion or Diagnosis of IBD</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02478944?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Inflammatory Bowel Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Manometry&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University Hospital Erlangen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02478944</guid>
      <pubDate>Wed, 05 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02285166?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hyperlipidemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Omega-3-acid ethyl esters;   Drug: Standard antihyperlipidemic therapy other than administration of omega-3 fatty acid ethyl esters (Lotriga).&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Takeda&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02285166</guid>
      <pubDate>Tue, 04 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Effects of Cognitive Training on Speech Perception</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02294812?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Hearing Loss;   Deafness and Auditory Perception&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Cognitive training&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Aaron Newman&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02294812</guid>
      <pubDate>Mon, 03 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Comparative Effectiveness of Rehabilitation Services for Survivors of Acute Ischemic Stroke</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02284165?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Ischemic Stroke&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: retrospective analysis&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Duke University;   Patient-Centered Outcomes Research Institute&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified September 2015</description>
      <guid isPermaLink="false">NCT02284165</guid>
      <pubDate>Mon, 03 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02283762?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Scleroderma, Systemic&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Riociguat (Adempas, BAY63-2521);   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Bayer&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02283762</guid>
      <pubDate>Mon, 03 Nov 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02282215?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Myeloid Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: CLT-008;   Biological: G-CSF&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Cellerant Therapeutics;   Department of Health and Human Services&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02282215</guid>
      <pubDate>Fri, 31 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02280811?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Vaginal Cancer;   Cervical Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: E6 TCR;   Drug: Aldesleukin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02280811</guid>
      <pubDate>Thu, 30 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02281318?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Asthma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Mepolizumab;   Drug: Placebo;   Drug: SOC&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02281318</guid>
      <pubDate>Thu, 30 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety &amp; Efficacy of Dual Therapy With Raltegravir/Lamivudine</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02284035?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    AIDS&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Raltegravir/3TC;   Drug: EFV/TDF/FTC;   Drug: ATV/r + TDF/FTC or DRV/r + TDF/FTC;   Drug: DTG+ABC/3TC DTG+TDF/FTC EVG/cobi/TDF/FTC RAL+TDF/FTC;   Drug: EFV plus ABC/3TC or RPV/TDF/FTC;   Drug: ATV/r plus ABC/3TC;   Drug: DRV/r + ABC/3TC or LPV/r + ABC/3TC or LPV/r + TDF/FTC;   Drug: RAL plus ABC/3TC;   Drug: Other ART regimens&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Juan A. Arnaiz&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02284035</guid>
      <pubDate>Tue, 28 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Pharmacokinetics and Safety of Roledumab, in RhD-negative Pregnant Women Carrying an RhD-positive Foetus</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02287896?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Rh Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: ROLEDUMAB&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Laboratoire français de Fractionnement et de Biotechnologies&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02287896</guid>
      <pubDate>Tue, 28 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Nivolumab in Eliminating Minimal Residual Disease and Preventing Relapse in Patients With Acute Myeloid Leukemia in Remission After Chemotherapy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02275533?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Adult Acute Myeloid Leukemia in Remission&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Clinical Observation;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02275533</guid>
      <pubDate>Fri, 24 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>ETREAT Study on Effectiveness of Botulinum Toxin Type A Injections to Treat Post-stroke Upper and/or Lower Limb Spasticity</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02275312?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Spasticity&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Ipsen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02275312</guid>
      <pubDate>Thu, 23 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Anatomical and Functional Results of Surgery of the Tympanic Membrane Perforation of the Child</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02296944?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Tympanic Membrane Perforation;   Tempanoplasty&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Collection of anatomical and functional results in the appearance of the tympanic membrane after surgery&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Assistance Publique - Hôpitaux de Paris&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02296944</guid>
      <pubDate>Wed, 22 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Undergoing Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02273362?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hepatocellular Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Erlotinib Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02273362</guid>
      <pubDate>Wed, 22 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Glycemic Index in Mitochondrial Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02284334?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Mitochondrial Diseases&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: test meal&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Pennsylvania;   Children's Hospital of Philadelphia&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02284334</guid>
      <pubDate>Tue, 21 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety and Efficacy Study of CC-486 and Durvalumab in Subjects With Myelodysplastic Syndromes</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02281084?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Myelodysplastic Syndromes&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: CC-486 (ORAL AZACITIDINE);   Drug: Durvalumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Celgene Corporation&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02281084</guid>
      <pubDate>Tue, 21 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02271997?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Iron Deficiency&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Ferrous fumarate;   Drug: Ferrous gluconate;   Drug: Iron(III)carboxymaltose&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Rijnstate Hospital&lt;br/&gt;&lt;b&gt;Enrolling by invitation&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02271997</guid>
      <pubDate>Mon, 20 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Type 1 Diabètes Adults With Hypoglycemia Unawareness and Documented Nocturnal Hypoglycemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02282254?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Type 1 Diabetes&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Overnight intervention&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Institut de Recherches Cliniques de Montreal&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02282254</guid>
      <pubDate>Sun, 19 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A German Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Type 2 Diabetes Patients.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02268929?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Diabetes&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: Accu-Chek Smart Pix Software;   Device: Accu-Chek Smart Pix readout Device&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Hoffmann-La Roche;   Roche Diabetes Care Deutschland GmbH&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02268929</guid>
      <pubDate>Thu, 16 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Phase 3, Multinational, Multicenter, Open-Label Study of ProMetic BioTherapeutics IVIG</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02269163?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Primary Immunodeficiency&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Immune Globulin (Human) Intravenous;   Biological: Commercial Immune Globulin Intravenous&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    ProMetic BioTherapeutics, Inc&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02269163</guid>
      <pubDate>Thu, 16 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>NIRS Ticagrelor Evaluation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02282332?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Coronary Artery Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Ticagrelor&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Medstar Research Institute;   AstraZeneca&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02282332</guid>
      <pubDate>Wed, 15 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Belgian Cross-sectional Allogeneic Transplant Survivor Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02312830?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Hematopoietic Stem Cell Transplantation;   Hematopoietic Stem Cell Transplantation, Allogeneic&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Universitaire Ziekenhuizen Leuven&lt;br/&gt;&lt;b&gt;Enrolling by invitation&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02312830</guid>
      <pubDate>Wed, 15 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>ATAPAC Study (TauroLock Activity in Adult Cancer Patients)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02279121?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Catheter-Related Infections&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: Taurolock;   Drug: saline solution&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Centre Hospitalier Régional Metz-Thionville;   centre régional de pharmacovigilance de Nancy;   Theradial&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02279121</guid>
      <pubDate>Thu, 09 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02262221?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Head and Neck Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Scheduled radiologic evaluations&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Fondazione IRCCS Istituto Nazionale dei Tumori, Milano;   Bocconi University;   University of Pavia&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02262221</guid>
      <pubDate>Mon, 06 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02257528?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Recurrent Cervical Carcinoma;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Laboratory Biomarker Analysis;   Biological: Nivolumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02257528</guid>
      <pubDate>Thu, 02 Oct 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Metformin Extended Release Versus Metformin Immediate Release in Subjects With Type 2 Diabetes (CONSENT)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02252965?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Diabetes Mellitus, Type 2&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Metformin XR;   Drug: Metformin IR&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Merck KGaA&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02252965</guid>
      <pubDate>Fri, 26 Sep 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>McGrath MAC ISR-McGRATH MAC Video Laryngoscope Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02250521?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Intubation; Difficult&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: McGrath MAC enhanced direct laryngoscope&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    The University of Texas Health Science Center, Houston&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02250521</guid>
      <pubDate>Tue, 23 Sep 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02271945?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Relapsed/Refractory Aggressive B-cell Lymphomas&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: MEDI-551 and MEDI0680 (AMP-514)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    MedImmune LLC&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02271945</guid>
      <pubDate>Tue, 23 Sep 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Telemedicine Intervention to Improve Cognitive Function</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02248649?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Parkinson's Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Structured exercise;   Behavioral: Health education&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    VA Office of Research and Development&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02248649</guid>
      <pubDate>Mon, 22 Sep 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Alcon Ex-PRESS™ Glaucoma Filtration Device in Japanese Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02246777?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Glaucoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Ex-PRESS™ Glaucoma Filtration Device, Model P50PL&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Alcon Research&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02246777</guid>
      <pubDate>Thu, 18 Sep 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Adult Accuracy Study of the Enlite 3 Glucose Sensor</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02246582?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Type 1 Diabetes;   Type 2 Diabetes&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: Enlite 3;   Device: Guardian Mobile App;   Device: 640G Insulin Pump&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Medtronic Diabetes&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02246582</guid>
      <pubDate>Thu, 11 Sep 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Evaluation of Fetoplacental Oxygenation With Functional MRI in Pregnant Women</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02238301?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Intrauterine Growth Restriction&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Bold sequence patients test;   Other: Bold sequence&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Assistance Publique - Hôpitaux de Paris&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02238301</guid>
      <pubDate>Tue, 09 Sep 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>People Presenting With Neurocysticercosis in North America</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02233855?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Neurocysticercosis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified January 2016</description>
      <guid isPermaLink="false">NCT02233855</guid>
      <pubDate>Sat, 06 Sep 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02236936?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Squamous Cell Carcinoma of the Hypopharynx Stage III;   Squamous Cell Carcinoma of the Hypopharynx Stage IV;   Laryngeal Squamous Cell Carcinoma Stage III;   Laryngeal Squamous Cell Carcinoma Stage IV;   Oropharyngeal Squamous Cell Carcinoma Stage III;   Oropharyngeal Squamous Cell Carcinoma Stage IV;   Squamous Cell Carcinoma of the Oral Cavity Stage III;   Squamous Cell Carcinoma of the Oral Cavity Stage IV;   Locally Advanced Malignant Neoplasm&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Dietary Supplement: Standard care of parenteral nutrition;   Dietary Supplement: Parenteral over night nutrition;   Biological: Cetuximab;   Drug: Cisplatin;   Radiation: Radiotherapy&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Arbeitsgemeinschaft medikamentoese Tumortherapie;   Medical University of Graz&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02236936</guid>
      <pubDate>Fri, 05 Sep 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Genetic Testing to Understand and Address Renal Disease Disparities</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02234063?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Hypertension;   Chronic Kidney Disease;   Genomics&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Immediate Genetic Testing&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Icahn School of Medicine at Mount Sinai&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02234063</guid>
      <pubDate>Thu, 04 Sep 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Cost Effective Treatment for Headache in Pregnancy When Acetaminophen Alone is Ineffective.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02295280?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Headache&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Metoclopramide;   Drug: Diphenhydramine;   Drug: Codeine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    St. Louis University&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02295280</guid>
      <pubDate>Fri, 29 Aug 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>My Stroke Team (MYST): Stroke App Pilot Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02230280?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Stroke;   Comorbidity;   Chronic Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: A community navigation and rehabilitation intervention that includes a mobile health solution&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    McMaster University&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02230280</guid>
      <pubDate>Thu, 28 Aug 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02229227?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Diabetes Mellitus, Type 2&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Albiglutide;   Drug: Insulin Glargine and Insulin Lispro&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    GlaxoSmithKline;   PPD&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02229227</guid>
      <pubDate>Thu, 28 Aug 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Reducing Proviral HIV DNA With Interferon-a</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02227277?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    HIV;   HIV/AIDS&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Peg-IFN-α2b&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    The Wistar Institute;   National Institutes of Health (NIH);   National Institute of Allergy and Infectious Diseases (NIAID);   Merck Sharp &amp; Dohme Corp.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02227277</guid>
      <pubDate>Mon, 25 Aug 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02224781?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent Melanoma;   Stage IIIA Skin Melanoma;   Stage IIIB Skin Melanoma;   Stage IIIC Skin Melanoma;   Stage IV Skin Melanoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Dabrafenib;   Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Other: Quality-of-Life Assessment;   Drug: Trametinib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02224781</guid>
      <pubDate>Fri, 22 Aug 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Induction Study of Cisplatin, Docetaxel, and Nintedanib Stage IB-IIIA Non-Small Cell Lung Cancer (NCLC)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02225405?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Lung Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Nintedanib;   Drug: Cisplatin;   Drug: Docetaxel&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Boehringer Ingelheim&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02225405</guid>
      <pubDate>Fri, 22 Aug 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>BioEnergetics and Metabolomics in Cystic Fibrosis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02225899?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cystic Fibrosis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Emory University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02225899</guid>
      <pubDate>Thu, 21 Aug 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Characterization of Aortic Tissue at Reoperation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02375542?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Aortic Aneurysm;   Aortic Dissection&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    CryoLife Europa&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02375542</guid>
      <pubDate>Tue, 19 Aug 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Antiplatelet Therapy After Cardiac Arrest</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02224274?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Cardiac Arrest;   Postresuscitation Syndrome;   Myocardial Infarction (STEMI and NSTEMI)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Clopidogrel;   Drug: Ticagrelor&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University Medical Centre Ljubljana&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02224274</guid>
      <pubDate>Tue, 19 Aug 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02222480?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hypertension&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Fimasartan;   Drug: Hydrochlorothiazide;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Boryung Pharmaceutical Co., Ltd;   Seoul National University Hospital&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02222480</guid>
      <pubDate>Mon, 18 Aug 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety Study of SGN-CD70A in Cancer Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02216890?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Renal Cell Carcinoma;   Mantle-Cell Lymphoma;   Diffuse, Large B-Cell, Lymphoma;   Follicular Lymphoma, Grade 3&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: SGN-CD70A&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Seattle Genetics, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02216890</guid>
      <pubDate>Tue, 12 Aug 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02213744?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Breast Cancer;   HER2 Positive Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: MM-302;   Drug: Gemcitabine;   Drug: Capecitabine;   Drug: Vinorelbine;   Drug: Trastuzumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Merrimack Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02213744</guid>
      <pubDate>Wed, 06 Aug 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02211261?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Type 2 Diabetes Mellitus&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: PF-06293620;   Biological: Placebo;   Biological: PF-06293620;   Biological: Placebo;   Biological: PF-06293620;   Biological: Placebo;   Biological: PF-06293620;   Biological: Placebo;   Biological: PF-06293620;   Biological: Placebo;   Biological: PF-06293620;   Biological: Placebo;   Biological: PF-06293620;   Biological: Placebo;   Biological: PF-06293620;   Biological: Placebo;   Biological: PF-06293620;   Biological: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Pfizer&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02211261</guid>
      <pubDate>Wed, 06 Aug 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Melanoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02211131?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Talimogene Laherparepvec;   Procedure: Immediate surgical resection of melanoma lesion(s)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Amgen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02211131</guid>
      <pubDate>Tue, 05 Aug 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02207244?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Psoriasis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Guselkumab 100 mg;   Drug: Placebo for guselkumab;   Drug: Adalimumab;   Drug: Placebo for adalimumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Janssen Research &amp; Development, LLC&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02207244</guid>
      <pubDate>Thu, 31 Jul 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Assessing Human-to-Mosquito Transmission in Volunteers Participating in Malaria Vaccine Candidate Trials in Mali</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02206451?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Malaria&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02206451</guid>
      <pubDate>Thu, 31 Jul 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>GnRHa Trigger in Asian Oocyte Donors- a Dose Finding Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02208986?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Normal Oocyte Donors&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Triptorelin&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Vietnam National University;   Merck Sharp &amp; Dohme Corp.;   The Fertility Clinic, Skive Regional Hospital, Denmark;   Faculty of Health, Aarhus University Denmark;   University of Southern Denmark&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02208986</guid>
      <pubDate>Tue, 29 Jul 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Compare the Efficacy of Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02201771?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Coronary Artery Bypass;   Antiplatelet Agents&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Aspirin;   Drug: Ticagrelor&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Ruijin Hospital&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02201771</guid>
      <pubDate>Thu, 24 Jul 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Defining Remission With Etanercept in AS in Real Life Clinical Practice</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02202850?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Ankylosing Spondylitis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: etanercept;   Drug: etanercept&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Pfizer&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02202850</guid>
      <pubDate>Wed, 23 Jul 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Validation of Questionnaires HAL and HEP</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02512211?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Haemophilia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Universidad Católica San Antonio de Murcia&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02512211</guid>
      <pubDate>Tue, 22 Jul 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02196181?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    BRAF V600E Mutation Present;   BRAF V600K Mutation Present;   Recurrent Melanoma;   Stage IIIA Skin Melanoma;   Stage IIIB Skin Melanoma;   Stage IIIC Skin Melanoma;   Stage IV Skin Melanoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Dabrafenib;   Other: Laboratory Biomarker Analysis;   Drug: Trametinib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02196181</guid>
      <pubDate>Fri, 18 Jul 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02200770?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders (NMO/NMOSD)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: MEDI-551;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    MedImmune LLC&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02200770</guid>
      <pubDate>Wed, 16 Jul 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Phase 2 Open Label Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02193776?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Tuberculosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Pa-824;   Drug: bedaquiline;   Drug: moxifloxacin;   Drug: pyrazinamide;   Drug: isoniazid, rifampicin, pyrazinamide and ethambutol combination tablet&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Global Alliance for TB Drug Development&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02193776</guid>
      <pubDate>Wed, 16 Jul 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02193282?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Stage IB Non-Small Cell Lung Carcinoma;   Stage IIA Non-Small Cell Lung Carcinoma;   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Erlotinib Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02193282</guid>
      <pubDate>Tue, 15 Jul 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pre-eclampsia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02218931?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Pre-eclampsia;   Obesity;   Raised Lipids;   High Blood Pressure;   Insulin Resistance&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Targeted ESTEEM diet;   Other: Non-randomised cohort&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Queen Mary University of London&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02218931</guid>
      <pubDate>Fri, 11 Jul 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02188121?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Serious Mental Illness;   Schizophrenia;   Schizoaffective Disorder;   Bipolar Disorder;   Cardiovascular Disease;   Major Depressive Disorder;   Psychosis NOS&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Simvastatin;   Drug: Losartan&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Mclean Hospital;   Michael J. Gill Mental Health Clinic;   The Massachusetts Mental Health Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02188121</guid>
      <pubDate>Tue, 08 Jul 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Community Vascular and Multiple Chronic Conditions Intervention Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02209285?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Multiple Chronic Conditions&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: ACHRU - Community Partnership Program&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    McMaster University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02209285</guid>
      <pubDate>Mon, 07 Jul 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Ceritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02186821?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Tumors With Aberrations in ALK or ROS1&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Ceritinib (LDK378)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novartis Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02186821</guid>
      <pubDate>Thu, 03 Jul 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Azilsartan/Amlodipine Combination Tablets LD &amp; HD Specified Drug-use Survey &quot;Long-term Use Survey&quot;</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02181816?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hypertension&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Azilsartan/amlodipine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Takeda&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02181816</guid>
      <pubDate>Wed, 02 Jul 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02180867?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Adult Fibrosarcoma;   Alveolar Soft Part Sarcoma;   Angiomatoid Fibrous Histiocytoma;   Atypical Fibroxanthoma;   Clear Cell Sarcoma of Soft Tissue;   Epithelioid Malignant Peripheral Nerve Sheath Tumor;   Epithelioid Sarcoma;   Extraskeletal Myxoid Chondrosarcoma;   Extraskeletal Osteosarcoma;   Fibrohistiocytic Neoplasm;   Glomus Tumor of the Skin;   Inflammatory Myofibroblastic Tumor;   Intimal Sarcoma;   Leiomyosarcoma;   Liposarcoma;   Low Grade Fibromyxoid Sarcoma;   Low Grade Myofibroblastic Sarcoma;   Malignant Cutaneous Granular Cell Tumor;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Triton Tumor;   Mesenchymal Chondrosarcoma;   Myxofibrosarcoma;   Myxoid Chondrosarcoma;   Myxoinflammatory Fibroblastic Sarcoma;   Nerve Sheath Neoplasm;   PEComa;   Pericytic Neoplasm;   Plexiform Fibrohistiocytic Tumor;   Sclerosing Epithelioid Fibrosarcoma;   Stage IB Soft Tissue Sarcoma;   Stage IIB Soft Tissue Sarcoma;   Stage III Soft Tissue Sarcoma;   Stage IV Soft Tissue Sarcoma;   Synovial Sarcoma;   Undifferentiated (Embryonal) Sarcoma;   Undifferentiated High Grade Pleomorphic Sarcoma of Bone&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Doxorubicin Hydrochloride;   Drug: Ifosfamide;   Other: Laboratory Biomarker Analysis;   Drug: Pazopanib Hydrochloride;   Other: Pharmacological Study;   Radiation: Radiation Therapy;   Procedure: Therapeutic Conventional Surgery&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02180867</guid>
      <pubDate>Tue, 01 Jul 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02178241?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Metastatic Ureteral Neoplasm;   Metastatic Urethral Neoplasm;   Stage III Bladder Urothelial Carcinoma;   Stage III Ureter Cancer;   Stage III Urethral Cancer;   Stage IV Bladder Urothelial Carcinoma;   Stage IV Ureter Cancer;   Stage IV Urethral Cancer;   Ureter Urothelial Carcinoma;   Urethral Urothelial Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Eribulin Mesylate;   Drug: Gemcitabine Hydrochloride&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02178241</guid>
      <pubDate>Thu, 26 Jun 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02174731?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Anemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Roxadustat;   Drug: Epoetin alfa&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    AstraZeneca;   FibroGen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02174731</guid>
      <pubDate>Tue, 24 Jun 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02174627?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Anemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Roxadustat;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    AstraZeneca;   FibroGen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02174627</guid>
      <pubDate>Tue, 24 Jun 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Safety Study to Investigate the Skin Irritancy Potential of Diclofenac-Menthol Gel</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02169154?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pain&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: 1% Diclofenac Sodium;   Drug: 3% Menthol;   Drug: 0.09% Menthol;   Drug: 0.2% Sodium Lauryl Sulfate;   Drug: 0.9% Saline&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02169154</guid>
      <pubDate>Thu, 19 Jun 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02166814?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Essential Hypertension, Dyslipidemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Fimasartan and Rosuvastatin;   Drug: Fimasartan;   Drug: Rosuvastatin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Boryung Pharmaceutical Co., Ltd&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02166814</guid>
      <pubDate>Mon, 16 Jun 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Hodgkin Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02166463?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Classical Hodgkin Lymphoma;   Stage IIB Hodgkin Lymphoma;   Stage IIIB Hodgkin Lymphoma;   Stage IVA Hodgkin Lymphoma;   Stage IVB Hodgkin Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Bleomycin Sulfate;   Drug: Brentuximab Vedotin;   Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Drug: Prednisone;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Drug: Vincristine Sulfate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified February 2016</description>
      <guid isPermaLink="false">NCT02166463</guid>
      <pubDate>Mon, 16 Jun 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02164513?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pulmonary Disease, Chronic Obstructive&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: fluticasone furoate (FF);   Drug: vilanterol (VI);   Drug: umeclidinium bromide (UMEC)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02164513</guid>
      <pubDate>Thu, 12 Jun 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02169505?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Lymphoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Brentuximab Vedotin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    M.D. Anderson Cancer Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02169505</guid>
      <pubDate>Wed, 11 Jun 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02158091?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Chronic Lymphocytic Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: IPI-145;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Rituximab&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Dana-Farber Cancer Institute;   Infinity Pharmaceuticals, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02158091</guid>
      <pubDate>Wed, 04 Jun 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02156349?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Diabetes&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: Accu-Chek Smart Pix Software;   Device: Accu-Chek Smart Pix readout Device&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Hoffmann-La Roche;   Roche Diabetes Care Deutschland GmbH&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02156349</guid>
      <pubDate>Tue, 03 Jun 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>An Open-Label, First-in-Human Study of the Safety, Tolerability, and Pharmacokinetics of VX-970 in Combination With Cytotoxic Chemotherapy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02157792?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Advanced Solid Tumor&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: VX-970;   Drug: Gemcitabine;   Drug: Cisplatin;   Drug: Etoposide;   Drug: Carboplatin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Vertex Pharmaceuticals Incorporated&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02157792</guid>
      <pubDate>Sun, 01 Jun 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Cognitive vs. Emotional Psychopharmacological Manipulations of Fear vs. Anxiety</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02153944?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Anxiety Disorder&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Propanolol;   Drug: Methylphenidate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Mental Health (NIMH)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02153944</guid>
      <pubDate>Sat, 31 May 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02152995?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Poorly Differentiated Thyroid Gland Carcinoma;   Recurrent Thyroid Gland Carcinoma;   Stage IVA Thyroid Gland Follicular Carcinoma;   Stage IVA Thyroid Gland Papillary Carcinoma;   Stage IVB Thyroid Gland Follicular Carcinoma;   Stage IVB Thyroid Gland Papillary Carcinoma;   Stage IVC Thyroid Gland Follicular Carcinoma;   Stage IVC Thyroid Gland Papillary Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Computed Tomography;   Radiation: Iodine I 124;   Radiation: Iodine I-131;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Procedure: Positron Emission Tomography;   Drug: Trametinib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02152995</guid>
      <pubDate>Thu, 29 May 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02154711?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Mitochondrial Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Pennsylvania&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02154711</guid>
      <pubDate>Thu, 29 May 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02152943?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Breast Cancer;   Solid Tumors&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Everolimus;   Drug: Trastuzumab;   Drug: Letrozole&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Novartis&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02152943</guid>
      <pubDate>Thu, 29 May 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Breathing Exercises for Asthma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02151422?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Asthma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Breathing exercise&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Michigan&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02151422</guid>
      <pubDate>Wed, 28 May 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02152982?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Glioblastoma;   Gliosarcoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Drug: Temozolomide;   Drug: Veliparib&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Cancer Institute (NCI);   AbbVie&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02152982</guid>
      <pubDate>Tue, 27 May 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Morphine Titration by Patient Self-controlled by a Mechanical Device Versus Administration by the Nurse for Patients With Severe Acute Pain in the Emergency Department</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02152176?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Pain&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Titration of morphine by Patient Controlled Analgesy&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University Hospital, Angers&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02152176</guid>
      <pubDate>Thu, 22 May 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Effect of High- and Low-sodium Intake on the Pharmacokinetics and Pharmacodynamic Effects of Fimasartan</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02147704?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hypertension&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Dietary Supplement: High-sodium diet;   Dietary Supplement: low-sodium diet&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    DongGuk University;   Boryung Pharmaceutical Co., Ltd&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02147704</guid>
      <pubDate>Wed, 21 May 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02141477?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Omacetaxine;   Drug: Decitabine&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Teva Pharmaceuticals USA&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02141477</guid>
      <pubDate>Thu, 15 May 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Risk Management Plan (RMP) Survey for Purchasers of Alli® (60 mg Orlistat) in the European Union.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02141230?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Weight Loss&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Alli® 60 mg&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    GlaxoSmithKline;   Hamell&lt;br/&gt;&lt;b&gt;Withdrawn&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02141230</guid>
      <pubDate>Thu, 15 May 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02140411?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Efficacy and Safety of Ranibizumab (Lucentis)&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Lucentis Intravitreal injections&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novartis Pharmaceuticals&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02140411</guid>
      <pubDate>Wed, 14 May 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02135692?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Asthma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Mepolizumab;   Drug: SOC&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02135692</guid>
      <pubDate>Thu, 08 May 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02135614?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Respiratory Syncytial Virus (RSV) Infections&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Presatovir;   Drug: Presatovir placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Gilead Sciences&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02135614</guid>
      <pubDate>Thu, 08 May 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02132312?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Unilateral Cataract Extraction;   Congenital Cataract&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: OMS302;   Drug: Phenylephrine HCl&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Omeros Corporation&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified October 2015</description>
      <guid isPermaLink="false">NCT02132312</guid>
      <pubDate>Thu, 01 May 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Folic Acid Supplementation in Pregnant Women: Dose Response</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02124642?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pregnancy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Dietary Supplement: Folic acid, 400 mcg/day;   Dietary Supplement: Folic acid 800 mcg/day&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Georgia;   University of Florida;   Emory University;   Cornell University&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02124642</guid>
      <pubDate>Thu, 24 Apr 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02123823?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Neoplasms&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Everolimus;   Drug: Everolimus;   Drug: Everolimus;   Drug: Exemestane;   Drug: BI 836845;   Drug: BI 836845;   Drug: Exemestane;   Drug: Exemestane&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Boehringer Ingelheim&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02123823</guid>
      <pubDate>Tue, 22 Apr 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Phase II Trial of Myeloablative Conditioning &amp; Transplantation of Partially HLA-mismatched Marrow With Post-transplant Cyclophosphamide for Peds Pts w/ Hematologic Malignancies</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02120157?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Myeloablative Conditioning;   HLA-mismatched Bone Marrow Transplantation;   Graft Survival;   Transplantion, Bone Marrow&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cyclophosphamide;   Radiation: TBI;   Drug: Busulfan;   Other: Unmanipulated Bone Marrow;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Sidney Kimmel Comprehensive Cancer Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02120157</guid>
      <pubDate>Wed, 16 Apr 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02116777?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Adult Solid Neoplasm;   Childhood Solid Neoplasm;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Central Nervous System Neoplasm;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Refractory Central Nervous System Neoplasm&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Talazoparib;   Drug: Temozolomide&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT02116777</guid>
      <pubDate>Tue, 15 Apr 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02115282?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Estrogen Receptor Positive;   HER2/Neu Negative;   Male Breast Carcinoma;   Progesterone Receptor Positive;   Recurrent Breast Carcinoma;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Entinostat;   Drug: Exemestane;   Drug: Goserelin Acetate;   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02115282</guid>
      <pubDate>Mon, 14 Apr 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02112916?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Adult T Acute Lymphoblastic Leukemia;   Childhood T Acute Lymphoblastic Leukemia;   Stage II Childhood Lymphoblastic Lymphoma;   Stage II Contiguous Adult Lymphoblastic Lymphoma;   Stage II Non-Contiguous Adult Lymphoblastic Lymphoma;   Stage III Adult Lymphoblastic Lymphoma;   Stage III Childhood Lymphoblastic Lymphoma;   Stage IV Adult Lymphoblastic Lymphoma;   Stage IV Childhood Lymphoblastic Lymphoma;   Untreated Adult Acute Lymphoblastic Leukemia;   Untreated Childhood Acute Lymphoblastic Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Bortezomib;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Dexamethasone;   Drug: Doxorubicin Hydrochloride;   Drug: Etoposide;   Drug: Hydrocortisone Sodium Succinate;   Drug: Ifosfamide;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Pegaspargase;   Radiation: Radiation Therapy;   Drug: Thioguanine;   Drug: Vincristine Sulfate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02112916</guid>
      <pubDate>Wed, 09 Apr 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02105961?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pulmonary Disease, Chronic Obstructive&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Mepolizumab;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02105961</guid>
      <pubDate>Thu, 03 Apr 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02105948?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pulmonary Disease, Chronic Obstructive&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Mepolizumab;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02105948</guid>
      <pubDate>Thu, 03 Apr 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Comparative Study of Microwave Radiometry and Ultrasonography for the Diagnosis of Acute Appendicitis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02108340?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Appendicitis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: Microwave radiometry&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Hippocration General Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02108340</guid>
      <pubDate>Wed, 02 Apr 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Mindfulness Meditation for Spine Surgery Pain</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02104349?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Meditation;   Spine Surgery;   Pain, Postoperative&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Mindfulness meditation&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Icahn School of Medicine at Mount Sinai&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02104349</guid>
      <pubDate>Tue, 01 Apr 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02101853?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    B Acute Lymphoblastic Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Asparaginase;   Biological: Blinatumomab;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Dexamethasone;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Mitoxantrone Hydrochloride;   Drug: Pegaspargase;   Other: Pharmacological Study;   Drug: Therapeutic Hydrocortisone;   Drug: Thioguanine;   Drug: Vincristine Sulfate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02101853</guid>
      <pubDate>Fri, 28 Mar 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02101788?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Micropapillary Serous Carcinoma;   Ovarian Serous Adenocarcinoma;   Primary Peritoneal Serous Adenocarcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Drug: Paclitaxel;   Drug: Pegylated Liposomal Doxorubicin Hydrochloride;   Other: Pharmacological Study;   Other: Quality-of-Life Assessment;   Drug: Tamoxifen Citrate;   Drug: Topotecan Hydrochloride;   Drug: Trametinib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT02101788</guid>
      <pubDate>Fri, 28 Mar 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02113436?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Asthma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: FP/ SLM HFA MDI 50/25 mcg;   Drug: FP HFA MDI 50 mcg&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02113436</guid>
      <pubDate>Thu, 27 Mar 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Comparison of Midazolam and Zolpidem as Oral Premedication in Children</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02096900?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Parental/Caregiver Anxiety;   Child's Anxiety&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: zolpidem;   Drug: Midazolam&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Loma Linda University&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02096900</guid>
      <pubDate>Mon, 24 Mar 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02095925?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Cancer;   Deep Venous Thrombosis;   Pulmonary Embolism&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Harry R. Buller;   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   VU University Medical Center;   University Medical Center Groningen;   Slotervaart Hospital;   Hôpital Louis Mourier;   Università degli Studi 'G. d'Annunzio' Chieti e Pescara;   Instituto Nacional de Cancerologia de Mexico&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02095925</guid>
      <pubDate>Fri, 21 Mar 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02102165?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Metastatic Breast Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: metastatic lesion biopsy&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Breast International Group;   Breast European Adjuvant Studies Team;   Frontier Science &amp; Technology Research Foundation, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02102165</guid>
      <pubDate>Wed, 19 Mar 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02089217?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Carotid Stenosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Carotid endarterectomy;   Device: Carotid stenting&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Thomas G. Brott, M.D.;   National Institute of Neurological Disorders and Stroke (NINDS)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02089217</guid>
      <pubDate>Thu, 13 Mar 2014 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>PERIGON Pivotal Trial</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02088554?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Aortic Stenosis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Model 400 aortic valve bioprosthesis&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Medtronic Cardiovascular;   Medtronic&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02088554</guid>
      <pubDate>Tue, 04 Mar 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02079636?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Carcinoma, Non-small Cell Lung&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Abemaciclib;   Drug: Pemetrexed;   Drug: Gemcitabine;   Drug: Ramucirumab;   Drug: LY3023414;   Drug: Pembrolizumab&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Eli Lilly and Company;   Merck Sharp &amp; Dohme Corp.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02079636</guid>
      <pubDate>Tue, 04 Mar 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Cervical Spondylotic Myelopathy Surgical Trial</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02076113?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cervical Spondylosis With Myelopathy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Ventral (Front) decompression with Fusion;   Procedure: Dorsal (Back) Decompression with Fusion;   Procedure: Dorsal (back) Laminoplasty&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Lahey Clinic;   Patient-Centered Outcomes Research Institute&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02076113</guid>
      <pubDate>Wed, 26 Feb 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>The Effect of NSAID Use in the Acute Phase of Skeletally Immature Bone Healing: A Prospective Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02076321?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Fractures&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Acetaminophen;   Drug: Ibuprofen&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Missouri-Columbia&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02076321</guid>
      <pubDate>Wed, 19 Feb 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>TDM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02073916?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Metastatic Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: TDM1;   Drug: Lapatinib;   Drug: Abraxane&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    The Methodist Hospital System&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02073916</guid>
      <pubDate>Tue, 18 Feb 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With Paclitaxel</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02073487?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Trastuzumab Emtansine;   Drug: Trastuzumab;   Drug: Lapatinib;   Drug: Abraxane;   Drug: Paclitaxel;   Drug: Pertuzumab&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    The Methodist Hospital System;   Celgene Corporation;   Novartis&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02073487</guid>
      <pubDate>Tue, 18 Feb 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Olive Oil for Breast Cancer Prevention in Women at High Risk for Breast Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02068092?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Breast Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Hydroxytyrosol&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    The Methodist Hospital System&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02068092</guid>
      <pubDate>Tue, 18 Feb 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Immediate Mobilization After Cardiac Catheterisation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02069275?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Vascular Access Complication;   Comfort&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Immediate mobilization;   Other: Two hours bedrest&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Rigshospitalet, Denmark&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02069275</guid>
      <pubDate>Thu, 13 Feb 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02059265?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Endometrial Clear Cell Adenocarcinoma;   Estrogen Receptor Negative;   Ovarian Clear Cell Cystadenocarcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Recurrent Uterine Corpus Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Dasatinib;   Other: Laboratory Biomarker Analysis&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified February 2016</description>
      <guid isPermaLink="false">NCT02059265</guid>
      <pubDate>Fri, 07 Feb 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Evaluating an Internet-based Program for Anxious Youth: a Pilot RCT</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02059226?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Anxiety&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: cognitive behavioural therapy;   Other: Internet-based resource page&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Mandi Newton;   IWK Health Centre&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02059226</guid>
      <pubDate>Thu, 06 Feb 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Safety of Sublingual dmLT for ETEC</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02052934?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Gastroenteritis Escherichia Coli&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral entertoxigenic Escherichia coli (ETEC) Vaccine;   Biological: Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral entertoxigenic Escherichia coli (ETEC) Vaccine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified January 2016</description>
      <guid isPermaLink="false">NCT02052934</guid>
      <pubDate>Thu, 30 Jan 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Accuracy Evaluation of Shoulder Replacement Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02052206?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Osteoarthritis of the Shoulder;   Complexe Proximal Humeral Fractures&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: Shoulder replacement surgery&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Balgrist University Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02052206</guid>
      <pubDate>Thu, 30 Jan 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02054533?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Crohn's Disease;   Ulcerative Colitis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Icahn School of Medicine at Mount Sinai&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02054533</guid>
      <pubDate>Mon, 27 Jan 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02048813?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Anemia;   Fever, Sweat, and Hot Flashes;   Stage I Chronic Lymphocytic Leukemia;   Stage I Small Lymphocytic Lymphoma;   Stage II Chronic Lymphocytic Leukemia;   Stage II Small Lymphocytic Lymphoma;   Stage III Chronic Lymphocytic Leukemia;   Stage III Small Lymphocytic Lymphoma;   Stage IV Chronic Lymphocytic Leukemia;   Stage IV Small Lymphocytic Lymphoma;   Weight Change&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cyclophosphamide;   Drug: Fludarabine Phosphate;   Drug: Ibrutinib;   Other: Laboratory Biomarker Analysis;   Other: Pharmacogenomic Study;   Other: Quality-of-Life Assessment;   Biological: Rituximab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02048813</guid>
      <pubDate>Mon, 27 Jan 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02042443?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Adult Cholangiocarcinoma;   Advanced Adult Hepatocellular Carcinoma;   BCLC Stage C Adult Hepatocellular Carcinoma;   BCLC Stage D Adult Hepatocellular Carcinoma;   Hilar Cholangiocarcinoma;   Localized Non-Resectable Adult Liver Carcinoma;   Recurrent Adult Liver Carcinoma;   Recurrent Childhood Liver Cancer;   Recurrent Extrahepatic Bile Duct Carcinoma;   Recurrent Gallbladder Carcinoma;   Stage II Gallbladder Cancer;   Stage III Childhood Hepatocellular Carcinoma;   Stage IIIA Gallbladder Cancer;   Stage IIIB Gallbladder Cancer;   Stage IV Childhood Hepatocellular Carcinoma;   Stage IV Distal Bile Duct Cancer;   Stage IVA Gallbladder Cancer;   Stage IVB Gallbladder Cancer;   Unresectable Extrahepatic Bile Duct Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Capecitabine;   Drug: Fluorouracil;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Trametinib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT02042443</guid>
      <pubDate>Mon, 20 Jan 2014 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Monitoring With Ultrasound Imaging of Intrauterine Device (IUD) Position Placed Immediately After Giving Birth</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02024672?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Contraception;   Postpartum&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Immediate postpartum placement of IUD&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Icahn School of Medicine at Mount Sinai&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02024672</guid>
      <pubDate>Fri, 27 Dec 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>PALBOCICLIB + PD-0325901 for NSCLC &amp; Solid Tumors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02022982?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    KRAS Mutant Non-Small Cell Lung Cancer;   Solid Tumors&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Palbociclib;   Drug: PD-0325901&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Dana-Farber Cancer Institute&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02022982</guid>
      <pubDate>Mon, 23 Dec 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>[Trial of device that is not approved or cleared by the U.S. FDA]</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02018198?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    [Redacted]&lt;br/&gt;&lt;b&gt;Withheld&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT02018198</guid>
      <pubDate>Tue, 17 Dec 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02034552?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostatic Neoplasms&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Radium-223 dichloride (Xofigo,BAY88-8223);   Drug: Abiraterone acetate;   Drug: Prednisone;   Drug: Enzalutamide&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Bayer&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02034552</guid>
      <pubDate>Mon, 16 Dec 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02014584?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Alopecia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Dutasteride;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Stiefel, a GSK Company;   GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02014584</guid>
      <pubDate>Thu, 12 Dec 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02008357?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cognition Disorders&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Solanezumab;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Eli Lilly and Company;   Alzheimer's Therapeutic Research Institute&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02008357</guid>
      <pubDate>Fri, 06 Dec 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Ibrutinib Versus Ibrutinib + Rituximab (i vs iR) in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02007044?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Ibrutinib;   Drug: Rituximab&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Pharmacyclics&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02007044</guid>
      <pubDate>Thu, 05 Dec 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02003209?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Estrogen Receptor Positive;   HER2/Neu Positive;   Progesterone Receptor Positive;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Aromatase Inhibition Therapy;   Drug: Carboplatin;   Other: Cytology Specimen Collection Procedure;   Drug: Docetaxel;   Drug: Goserelin Acetate;   Other: Laboratory Biomarker Analysis;   Biological: Pertuzumab;   Other: Quality-of-Life Assessment;   Procedure: Therapeutic Conventional Surgery;   Biological: Trastuzumab;   Radiation: Whole Breast Irradiation&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified February 2016</description>
      <guid isPermaLink="false">NCT02003209</guid>
      <pubDate>Mon, 02 Dec 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02003222?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Adult B Acute Lymphoblastic Leukemia;   Untreated Adult Acute Lymphoblastic Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Biological: Blinatumomab;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Dexamethasone;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Pegaspargase;   Drug: Prednisone;   Drug: Vincristine Sulfate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02003222</guid>
      <pubDate>Mon, 02 Dec 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01989585?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Metastatic Melanoma;   Recurrent Melanoma;   Solid Neoplasm;   Stage IIIA Skin Melanoma;   Stage IIIB Skin Melanoma;   Stage IIIC Skin Melanoma;   Stage IV Skin Melanoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Dabrafenib;   Other: Laboratory Biomarker Analysis;   Biological: Navitoclax;   Other: Pharmacological Study;   Drug: Trametinib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT01989585</guid>
      <pubDate>Mon, 18 Nov 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01989546?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Advanced Ovarian Cancer;   Primary Peritoneal Cancer;   Advanced Breast Cancer;   Advanced Solid Tumors&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: BMN 673&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT01989546</guid>
      <pubDate>Sat, 16 Nov 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01986010?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cytomegalovirus Infections&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: V160 Low Dose IM;   Biological: V160 Medium Dose IM;   Biological: V160 High Dose IM;   Biological: V160 Medium Dose plus Merck Aluminum Phosphate Adjuvant (MAPA) 225 µg /dose IM;   Biological: V160 High Dose plus MAPA 225 µg /dose IM;   Biological: V160 Maximum Dose IM;   Other: Placebo IM;   Biological: V160 Medium Dose ID;   Other: Placebo ID&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Merck Sharp &amp; Dohme Corp.&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01986010</guid>
      <pubDate>Mon, 11 Nov 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>The CCP Study: Coordinated Programme to Prevent Arthritis - Can We Identify Arthritis at a Pre-clinical Stage ?</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02012764?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Inflammatory Arthritis;   Rheumatoid Arthritis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Leeds;   AbbVie&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02012764</guid>
      <pubDate>Fri, 08 Nov 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Endogenous Opioid Activity and Affective State in Insulin Resistant Women</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02069379?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Depression;   Insulin Resistance;   Metabolic Syndrome&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Metformin;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Michigan;   National Institute of Mental Health (NIMH)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02069379</guid>
      <pubDate>Wed, 06 Nov 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01979536?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Stage II Childhood Anaplastic Large Cell Lymphoma;   Stage III Childhood Anaplastic Large Cell Lymphoma;   Stage IV Childhood Anaplastic Large Cell Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Brentuximab Vedotin;   Drug: Crizotinib;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Dexamethasone;   Drug: Doxorubicin Hydrochloride;   Drug: Etoposide;   Drug: Ifosfamide;   Other: Laboratory Biomarker Analysis;   Drug: Methotrexate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01979536</guid>
      <pubDate>Mon, 04 Nov 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01981551?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Desmoid Tumors;   Aggressive Fibromatosis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: PF-03084014&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT01981551</guid>
      <pubDate>Thu, 31 Oct 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01976312?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Central Retinal Vein Occlusion&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Sham injection;   Drug: Ranibizumab 0.5 mg&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novartis Pharmaceuticals&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01976312</guid>
      <pubDate>Fri, 18 Oct 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01976338?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Branch Retinal Vein Occlusion&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Ranibizumab 0.5 mg;   Other: Sham injection&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novartis Pharmaceuticals&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01976338</guid>
      <pubDate>Fri, 18 Oct 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01960855?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Rheumatoid Arthritis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: ABT-494;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    AbbVie&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01960855</guid>
      <pubDate>Wed, 09 Oct 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Improving Medication-taking After Liver Transplant</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01960322?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Nonadherence;   Tacrolimus;   Pediatric Liver Transplant Recipients&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Telemetric&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Icahn School of Medicine at Mount Sinai;   University of California, Los Angeles;   Children's Hospital Medical Center, Cincinnati;   Children's Hospital of Pittsburgh;   The EMMES Corporation&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01960322</guid>
      <pubDate>Tue, 08 Oct 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMML</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01957644?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Myelodysplastic Syndromes;   Leukemia, Myelomonocytic, Chronic&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Azacitidine;   Drug: Volasertib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Boehringer Ingelheim&lt;br/&gt;&lt;b&gt;Suspended&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01957644</guid>
      <pubDate>Tue, 01 Oct 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Genetic Basis of Congenital Heart Disease in Africa</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01952171?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Congenital Heart Disease;   Heart Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Human Genome Research Institute (NHGRI);   University of Lagos, Nigeria;   Uganda Heart Institute, Kampala, Uganda&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01952171</guid>
      <pubDate>Tue, 24 Sep 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Phase III of ADT +/- Docetaxel +/- Local RT +/- Abiraterone Acetate in Metastatic Hormone-naïve Prostate Cancer.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01957436?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostate Cancer Adenocarcinoma Metastatic&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: abiraterone acetate;   Radiation: radiotherapy;   Other: Androgen Deprivation Therapy;   Drug: Docetaxel&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    UNICANCER;   Janssen-Cilag Ltd.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01957436</guid>
      <pubDate>Tue, 24 Sep 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01948791?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Alzheimer's Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Rivastigmine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novartis Pharmaceuticals&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01948791</guid>
      <pubDate>Thu, 19 Sep 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Effectiveness of DECIDE in Patient-Provider Communication, Therapeutic Alliance &amp; Care Continuation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01947283?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Mental Disorders&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: DECIDE-PA;   Behavioral: DECIDE-PC&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Massachusetts General Hospital;   Patient-Centered Outcomes Research Institute&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01947283</guid>
      <pubDate>Wed, 18 Sep 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Effects of Ranolazine and Exercise on Daily Physical Activity Trial</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01948310?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Chronic Stable Angina&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Ranolazine;   Behavioral: Aerobic Exercise;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Duke University;   Gilead Sciences&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT01948310</guid>
      <pubDate>Tue, 17 Sep 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Treatment of Multifocal Lung Adenocarcinoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01946100?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Lung Neoplasms;   Carcinoma Non-small-cell Lung;   Adenocarcinoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Genetic: Multifocal Lung Adenocarcinoma&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Mayo Clinic&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01946100</guid>
      <pubDate>Mon, 16 Sep 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01938625?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hepatitis C, Chronic&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Simeprevir;   Drug: Daclatasvir;   Drug: Ribavirin;   Drug: Cyclosporine;   Drug: Tacrolimus&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Janssen R&amp;D Ireland&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01938625</guid>
      <pubDate>Thu, 05 Sep 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01935973?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Endometrial Adenocarcinoma;   Endometrial Clear Cell Adenocarcinoma;   Endometrial Mixed Adenocarcinoma;   Endometrial Serous Adenocarcinoma;   Endometrial Undifferentiated Carcinoma;   Recurrent Uterine Corpus Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Akt Inhibitor GSK2141795;   Other: Laboratory Biomarker Analysis;   Drug: Trametinib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT01935973</guid>
      <pubDate>Tue, 03 Sep 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01935089?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    HIV-1 Infection&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Pegylated Interferon alpha 2b&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    The Wistar Institute;   University of Pennsylvania;   Merck Sharp &amp; Dohme Corp.&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01935089</guid>
      <pubDate>Tue, 27 Aug 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01927744?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Head and Neck Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Docetaxel;   Drug: Erlotinib;   Other: Placebo;   Behavioral: Questionnaires;   Behavioral: Phone Call;   Drug: Chemotherapy&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Astellas Pharma Inc;   OSI Pharmaceuticals;   Kadoorie Foundation&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01927744</guid>
      <pubDate>Tue, 20 Aug 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Treatment of Multiple Gingival Recessions</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02818855?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Gingival Recession&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Coronally advanced flap (CAF);   Drug: Collagen Matrix;   Procedure: Subepithelial connective tissue graft&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Sao Paulo&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02818855</guid>
      <pubDate>Tue, 20 Aug 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01926665?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Carfilzomib;   Drug: Dexamethasone&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Onyx Pharmaceuticals&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01926665</guid>
      <pubDate>Mon, 19 Aug 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01925612?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Lymphoma, B-cell;   Lymphoma, Large B-cell, Diffuse&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: brentuximab vedotin;   Drug: brentuximab vedotin;   Drug: rituximab;   Drug: vincristine;   Drug: cyclophosphamide;   Drug: prednisone;   Drug: doxorubicin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Seattle Genetics, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01925612</guid>
      <pubDate>Thu, 15 Aug 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Effective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02030613?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Juvenile Idiopathic Arthritis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Genetic: Blood test&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Assistance Publique - Hôpitaux de Paris&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02030613</guid>
      <pubDate>Tue, 13 Aug 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Morphological Markers of Gastroesophageal Reflux Disease (GERD)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01921686?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Eosinophilic Esophagitis;   Gastroesophageal Reflux Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Sample collection and Questionnaire&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Baylor College of Medicine&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01921686</guid>
      <pubDate>Fri, 09 Aug 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Rapid Diagnosis of Heparin-Induced Thrombocytopenia in Surgical Critically Ill Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02790567?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Heparin-induced Thrombocytopenia (HIT)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: HEP score;   Other: 4Ts score;   Other: ID-PaGIA test;   Other: HIT-Ab(PF4-H) test&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Centre Hospitalier Universitaire de Besancon&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified May 2013</description>
      <guid isPermaLink="false">NCT02790567</guid>
      <pubDate>Thu, 01 Aug 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Technology Assisted Programs That Promote Mental Health for Teenagers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01912729?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Depression&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Networked Peer Support with Peer Guide;   Behavioral: Networked Peer Support with Clinician Coach&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Northwestern University&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01912729</guid>
      <pubDate>Mon, 29 Jul 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Controlling and Lowering Blood Pressure With The MOBIUSHD™ (CALM-FIM_EUR)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01911897?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hypertension&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: MobiusHD&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Vascular Dynamics, Inc.&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01911897</guid>
      <pubDate>Thu, 25 Jul 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01913106?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostatic Neoplasms&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: HSV-tk +Valacyclovir in Combination with Brachytherapy&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    The Methodist Hospital System&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01913106</guid>
      <pubDate>Thu, 25 Jul 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Fixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH-2)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01908751?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Femoral Neck Fractures&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Sliding Hip Screw;   Procedure: Cancellous Screws;   Drug: Vitamin D;   Drug: Vitamin D Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    McMaster University;   Canadian Institutes of Health Research (CIHR);   McMaster Surgical Associates;   Hamilton Health Sciences Corporation&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01908751</guid>
      <pubDate>Thu, 18 Jul 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01905137?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Myofascial Pelvic Pain&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Intervention-Botulinum Toxin Type A;   Drug: placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Boston Urogynecology Associates;   Allergan&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01905137</guid>
      <pubDate>Thu, 18 Jul 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>BPPV Treatment in Biaxial Rotational Chair</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01905800?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Benign Paroxysmal Positional Vertigo&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Biaxial rotational chair&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Haukeland University Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01905800</guid>
      <pubDate>Mon, 15 Jul 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>CPT and Smoking Cessation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01901848?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Stress Disorders, Post-Traumatic;   Smoking&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Cognitive Processing Therapy (CPT);   Drug: Bupropion;   Drug: nicotine replacement therapy (NRT);   Behavioral: Integrated Care for Smoking Cessation (ICSC);   Behavioral: smokefreeVET&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    VA Office of Research and Development&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01901848</guid>
      <pubDate>Fri, 12 Jul 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Ipilimumab, Nivolumab, and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01896999?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent Hodgkin Lymphoma;   Refractory Hodgkin Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Brentuximab Vedotin;   Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01896999</guid>
      <pubDate>Mon, 08 Jul 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Fatigue Reduction Diet</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01902745?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Chronic Fatigue&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Social Cognitive Theory&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Michigan;   University of Michigan Cancer Center&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01902745</guid>
      <pubDate>Tue, 02 Jul 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01891981?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Leukemia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Moxetumomab Pasudotox&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   MedImmune LLC&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01891981</guid>
      <pubDate>Fri, 28 Jun 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01886872?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Stage I Chronic Lymphocytic Leukemia;   Stage II Chronic Lymphocytic Leukemia;   Stage III Chronic Lymphocytic Leukemia;   Stage IV Chronic Lymphocytic Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Bendamustine Hydrochloride;   Drug: Ibrutinib;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Biological: Rituximab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified December 2015</description>
      <guid isPermaLink="false">NCT01886872</guid>
      <pubDate>Mon, 24 Jun 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Kidney Cancer Undergoing Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01892930?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent Renal Cell Cancer;   Stage IV Renal Cell Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Radiation: stereotactic body radiation therapy;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Roswell Park Cancer Institute;   National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01892930</guid>
      <pubDate>Thu, 20 Jun 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in Austria</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01877239?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Rheumatoid Arthritis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: non-intervention&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Pfizer&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01877239</guid>
      <pubDate>Tue, 11 Jun 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01875237?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Leukemia;   Myeloma;   Myeloproliferative Diseases&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Fludarabine;   Drug: Melphalan;   Drug: Alemtuzumab;   Procedure: Stem Cell infusion;   Drug: Tacrolimus;   Drug: Mini Methotrexate;   Drug: G-CSF;   Procedure: Donor Lymphocyte Infusion (DLI);   Drug: AP1903;   Drug: Methylprednisolone;   Behavioral: Questionnaire&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Bellicum Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01875237</guid>
      <pubDate>Fri, 07 Jun 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Decision Support for Parents Receiving Information About Child's Rare Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01875640?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Disorder of Sex Development;   Intersex Conditions;   Congenital Adrenal Hyperplasia;   Hypospadias&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Decision Support Tool&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Michigan;   Patient-Centered Outcomes Research Institute;   Virginia Commonwealth University;   Temple University;   University of California, Los Angeles;   Seattle Children's Hospital&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01875640</guid>
      <pubDate>Thu, 30 May 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01868477?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Adult Patients With Low- and Int-1-risk Myelodysplastic Syndrome.&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Erythropoietin alpha;   Drug: Erythropoietin alpha;   Drug: Deferasirox&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novartis Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01868477</guid>
      <pubDate>Thu, 30 May 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Brentuximab Vedotin Combined With AVD Chemotherapy and Involved-Site Radiotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01868451?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hodgkin Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Brentuximab vedotin (SGN-35);   Drug: Doxorubicin HCL;   Drug: Vinblastine Sulfate;   Device: Dacarbazine;   Radiation: Involved-Site Radiation Therapy (ISRT);   Procedure: Interim PET;   Drug: Neupogen&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Memorial Sloan Kettering Cancer Center;   Seattle Genetics, Inc.;   University of Rochester;   Beckman Research Institute;   Stanford University&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01868451</guid>
      <pubDate>Thu, 30 May 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Predicting Adherence to a Heart-Healthy Diet in Lean and Obese Individuals</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01862796?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Obesity;   Overweight&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Weight Loss;   Behavioral: Weight Loss;   Behavioral: Food Intake&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified February 2016</description>
      <guid isPermaLink="false">NCT01862796</guid>
      <pubDate>Thu, 23 May 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Phase I Study of iPS Cell Generation From Patients With COPD</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01860898?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Thoracic Diseases;   Respiratory Tract Diseases;   Cancer of Lung;   Cancer of the Lung;   Lung Cancer;   Lung Diseases, Obstructive;   COPD;   Pulmonary Emphysema;   Neoplasms, Lung;   Neoplasms, Pulmonary;   Pulmonary Cancer;   Pulmonary Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Skin Biopsy&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Mayo Clinic&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01860898</guid>
      <pubDate>Tue, 21 May 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01856192?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Stage II Diffuse Large B-Cell Lymphoma;   Stage III Diffuse Large B-Cell Lymphoma;   Stage IV Diffuse Large B-Cell Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Lenalidomide;   Drug: Prednisone;   Biological: Rituximab;   Drug: Vincristine Sulfate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT01856192</guid>
      <pubDate>Tue, 14 May 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Blood Cell Response to Exercise</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01872273?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Metabolic Syndrome&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Moderate Physical Exercise&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    USDA Grand Forks Human Nutrition Research Center&lt;br/&gt;&lt;b&gt;Withdrawn&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01872273</guid>
      <pubDate>Wed, 01 May 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01841736?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Atypical Carcinoid Tumor;   Foregut Carcinoid Tumor;   Hindgut Carcinoid Tumor;   Lung Carcinoid Tumor;   Metastatic Carcinoid Tumor;   Metastatic Digestive System Neuroendocrine Tumor G1;   Midgut Carcinoid Tumor;   Recurrent Digestive System Neuroendocrine Tumor G1;   Regional Digestive System Neuroendocrine Tumor G1&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Laboratory Biomarker Analysis;   Drug: Pazopanib Hydrochloride;   Other: Placebo;   Other: Quality-of-Life Assessment&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Suspended&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01841736</guid>
      <pubDate>Wed, 24 Apr 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Arm Spasticity - Non-Interventional Study Early BIRD (BoNT Treatment: Initial and Repeated Documentation) [AS-NIS Early BIRD]</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01840475?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Post-stroke Arm Spasticity&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Ipsen&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01840475</guid>
      <pubDate>Tue, 23 Apr 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01835158?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Clear Cell Renal Cell Carcinoma;   Stage III Renal Cell Cancer;   Stage IV Renal Cell Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cabozantinib S-malate;   Other: Laboratory Biomarker Analysis;   Drug: Sunitinib Malate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT01835158</guid>
      <pubDate>Tue, 16 Apr 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01835145?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent Uveal Melanoma;   Stage IIIA Uveal Melanoma;   Stage IIIB Uveal Melanoma;   Stage IIIC Uveal Melanoma;   Stage IV Uveal Melanoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cabozantinib S-malate;   Drug: Dacarbazine;   Other: Laboratory Biomarker Analysis;   Drug: Temozolomide&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Cancer Institute (NCI);   Exelisis&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT01835145</guid>
      <pubDate>Tue, 16 Apr 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01837381?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hepatocellular Carcinoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: TEA&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Chinese University of Hong Kong;   Prince of Wales Hospital, Shatin, Hong Kong&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT01837381</guid>
      <pubDate>Mon, 15 Apr 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01827358?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Staphylococcal Infection&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Mupirocin calcium;   Drug: Mupirocin calcium&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT01827358</guid>
      <pubDate>Thu, 04 Apr 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Uterine Artery Embolization(UAE) Versus High-Intensity-Focused-Ultrasound(HIFU) for Treatment of Uterine Fibroids</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01834703?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Uterine Fibroids&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: UAE;   Procedure: HIFU&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Chinese University of Hong Kong;   Prince of Wales Hospital, Shatin, Hong Kong&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified February 2016</description>
      <guid isPermaLink="false">NCT01834703</guid>
      <pubDate>Thu, 04 Apr 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01822496?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Radiation: 3-Dimensional Conformal Radiation Therapy;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Crizotinib;   Drug: Erlotinib Hydrochloride;   Drug: Etoposide;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01822496</guid>
      <pubDate>Mon, 01 Apr 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Open Versus Endovascular Repair of Popliteal Artery Aneurysm Trial</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01817660?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Popliteal Artery Aneurysm.&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Open repair of popliteal artery;   Procedure: Endovascular repair of popliteal artery&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Boston Medical Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01817660</guid>
      <pubDate>Thu, 21 Mar 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Combined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular Carcinoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01817205?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hepatocellular Carcinoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: TACE with Hyperthermia Treatment&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Chinese University of Hong Kong;   Prince of Wales Hospital, Shatin, Hong Kong&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT01817205</guid>
      <pubDate>Thu, 21 Mar 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Trial to Reduce Adhesions Following a Primary Cesarean Section</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01819467?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Tissue Adhesions&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Seprafilm&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    South East Area Health Education Center, Wilmington, NC;   New Hanover Regional Medical Center&lt;br/&gt;&lt;b&gt;Terminated&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01819467</guid>
      <pubDate>Mon, 18 Mar 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01811368?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Refractory Non Hodgkin Lymphoma;   Relapsed Non Hodgkin Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: rituximab;   Biological: ibritumomab tiuxetan;   Biological: anti-thymocyte globulin;   Radiation: total nodal irradiation;   Procedure: peripheral blood stem cell transplantation;   Procedure: allogeneic hematopoietic stem cell transplantation;   Drug: cyclosporine;   Drug: mycophenolate mofetil&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of California, Davis;   Spectrum Pharmaceuticals, Inc&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01811368</guid>
      <pubDate>Mon, 11 Mar 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Minocycline for Schizophrenia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01809158?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Schizophrenia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: minocycline;   Drug: placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Addis Ababa University;   Stanley Medical Research Institute&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01809158</guid>
      <pubDate>Mon, 11 Mar 2013 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Identifying Risk for Diabetes and Heart Disease in Women</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01809288?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Obesity;   Insulin Resistance;   Triglycerides;   Diabetes&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01809288</guid>
      <pubDate>Sat, 09 Mar 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Tooth and Tissue Sample Collection During Wisdom Teeth Removal</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01805869?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Tooth;   Tooth Impaction&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Third Molar Removal&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Dental and Craniofacial Research (NIDCR)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01805869</guid>
      <pubDate>Tue, 05 Mar 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01802333?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Untreated Adult Acute Myeloid Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Idarubicin;   Other: Laboratory Biomarker Analysis;   Drug: Vorinostat&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01802333</guid>
      <pubDate>Wed, 27 Feb 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Evaluation of Ruxolitinib And Azacytidine Combination as a Therapy For Patients With Myelofibrosis And Myelodysplastic Syndrome/ Myeloproliferative Neoplasm</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01787487?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Ruxolitinib (RUX);   Drug: Azacitidine (AZA);   Behavioral: Questionnaires&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Incyte Corporation&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01787487</guid>
      <pubDate>Wed, 06 Feb 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01780662?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent Adult Hodgkin Lymphoma;   Recurrent Childhood Hodgkin Lymphoma;   Refractory Childhood Hodgkin Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Brentuximab Vedotin;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT01780662</guid>
      <pubDate>Tue, 29 Jan 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01777152?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Anaplastic Large-Cell Lymphoma;   Non-Hodgkin Lymphoma;   T-Cell Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: brentuximab vedotin;   Drug: doxorubicin;   Drug: prednisone;   Drug: vincristine;   Drug: cyclophosphamide&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Seattle Genetics, Inc.;   Millennium Pharmaceuticals, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01777152</guid>
      <pubDate>Wed, 23 Jan 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>[Trial of device that is not approved or cleared by the U.S. FDA]</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01777880?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    [Redacted]&lt;br/&gt;&lt;b&gt;Withheld&lt;/b&gt;</description>
      <guid isPermaLink="false">NCT01777880</guid>
      <pubDate>Wed, 16 Jan 2013 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Tivantinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01749384?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Solid Neoplasm&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Bevacizumab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Tivantinib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01749384</guid>
      <pubDate>Tue, 11 Dec 2012 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Chronic Kidney Disease in Teenagers With Congenital Cardiac Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01845402?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Chronic Kidney Failure;   Congenital Heart Defects&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: blood and urine samples&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Assistance Publique - Hôpitaux de Paris&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01845402</guid>
      <pubDate>Tue, 11 Dec 2012 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Testing the AVI-7100 Flu Drug in Healthy Volunteers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01747148?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Influenza&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: AVI-7100 versus placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified September 2015</description>
      <guid isPermaLink="false">NCT01747148</guid>
      <pubDate>Sat, 08 Dec 2012 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01743001?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pulmonary Arterial Hypertension&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Macitentan 10 mg;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Actelion&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01743001</guid>
      <pubDate>Thu, 29 Nov 2012 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Complete Remission</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01757535?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Leukemia, Myeloid, Acute&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: 300 mg Oral Azacitidine;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Celgene Corporation&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01757535</guid>
      <pubDate>Wed, 21 Nov 2012 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01729455?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Systemic Lupus Erythematosus&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: BENLYSTA;   Other: SLE treatment&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Human Genome Sciences Inc., a GSK Company;   GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01729455</guid>
      <pubDate>Wed, 14 Nov 2012 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Sorafenib in Elderly mRCC</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01728948?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Carcinoma, Renal Cell&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Sorafenib( Nexavar, BAY43-9006)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Bayer&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01728948</guid>
      <pubDate>Wed, 14 Nov 2012 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01729104?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Carfilzomib;   Drug: Lenalidomide;   Drug: Rituximab&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Celgene;   Onyx Therapeutics, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01729104</guid>
      <pubDate>Fri, 09 Nov 2012 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>MLN 9708 With Lenalidomide as Maintenance Post Autologous Stem Cell Transplant for Multiple Myeloma Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01718743?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Myeloma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Lenalidomide;   Drug: MLN9708;   Radiation: Questionnaires&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Millennium Pharmaceuticals, Inc.&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01718743</guid>
      <pubDate>Mon, 29 Oct 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01717482?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Lung Neoplasms;   Carcinoma, Non-Small-Cell Lung&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Metformin;   Other: Placebo Comparator&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Mayo Clinic;   Alliance for Clinical Trials in Oncology&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01717482</guid>
      <pubDate>Thu, 25 Oct 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Chemoradiation Therapy and Ipilimumab in Treating Patients With Locally Advanced Cervical Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01711515?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cisplatin;   Other: Cytology Specimen Collection Procedure;   Radiation: External Beam Radiation Therapy;   Radiation: Internal Radiation Therapy;   Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT01711515</guid>
      <pubDate>Thu, 18 Oct 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of Sotatercept (ACE-011) in Subjects With Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF) and Anemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01712308?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Leukemia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Sotatercept&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Celgene&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01712308</guid>
      <pubDate>Thu, 18 Oct 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01716806?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hodgkin Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: brentuximab vedotin;   Drug: bendamustine;   Drug: dacarbazine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Seattle Genetics, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01716806</guid>
      <pubDate>Tue, 16 Oct 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Belimumab Assessment of Safety in SLE</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01705977?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Systemic Lupus Erythematosus&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Other: Standard therapy&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Human Genome Sciences Inc., a GSK Company;   GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01705977</guid>
      <pubDate>Wed, 10 Oct 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Treatment Protocol for the Compassionate Use of Domperidone</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01696734?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Gastrointestinal Diseases&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Domperidone;   Behavioral: Questionnaires;   Other: Phone Calls&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    M.D. Anderson Cancer Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01696734</guid>
      <pubDate>Thu, 27 Sep 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Evaluation of the Phased Radio Frequency Ablation System</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01693120?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Persistent Atrial Fibrillation&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: Medtronic Phased RF Ablation System&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Medtronic Atrial Fibrillation Solutions&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01693120</guid>
      <pubDate>Wed, 19 Sep 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01691859?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Asthma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Mepolizumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01691859</guid>
      <pubDate>Thu, 13 Sep 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Trial to Compare the Laser Treatment (SLT vs. ALT) in Glaucoma Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01687465?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Glaucoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Argon laser trabeculoplasty;   Procedure: Selective laser trabeculoplasty&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Lawson Health Research Institute&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01687465</guid>
      <pubDate>Tue, 11 Sep 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Tobacco-Focused Patient Navigation to Address Barriers to Utilization of Community-Based Smoking Cessation Services in Primary Care</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01678118?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Minority Smokers&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Patient Navigator&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Memorial Sloan Kettering Cancer Center;   Sophie Davis School of Biomedical Education at The City College of New York;   New York University School of Medicine;   Ralph Lauren Center for Cancer Care and Prevention;   Heritage Health Center, New York&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01678118</guid>
      <pubDate>Thu, 30 Aug 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01672476?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hypertension&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Placebo;   Drug: Valsartan;   Drug: Fimasartan&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Boryung Pharmaceutical Co., Ltd;   Bucheon St. Mary's Hospital;   Konyang University Hospital;   Korea University Anam Hospital;   National Health Insurance Service Ilsan Hospital;   Daegu Fatima Hospital;   Dong-A University;   Soon Chun Hyang University;   Asan Medical Center;   Gangnam Severance Hospital;   Severance Hospital;   Ulsan University Hospital;   Kangbuk Samsung Hospital;   Sejong General Hospital;   Ewha Womans University Mokdong Hospital;   Jeju National University Hospital;   Hallym University Medical Center;   Hanyang University&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01672476</guid>
      <pubDate>Mon, 20 Aug 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Clinical Trials for Single Oral Dose of 60mg Fimasartan and Single IV Infusion of 30mg Fimasartan to Evaluate the Absolute Bioavailability of Kanarb® Tablet (Fimasartan) in Healthy Subjects</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01671020?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Fimasartan;   Drug: Fimasartan&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Boryung Pharmaceutical Co., Ltd&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01671020</guid>
      <pubDate>Mon, 20 Aug 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Point-of-Care Focused Cardiac Ultrasound in Assessing the Thoracic Aorta</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01671618?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Aortic Aneurysm, Thoracic;   Aortic Dissection&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Yale University&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01671618</guid>
      <pubDate>Mon, 20 Aug 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01663402?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Coronary Syndrome&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: alirocumab;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Sanofi;   Regeneron Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01663402</guid>
      <pubDate>Wed, 08 Aug 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01648348?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Adult Anaplastic Astrocytoma;   Adult Anaplastic Oligodendroglioma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Mixed Glioma;   Recurrent Adult Brain Neoplasm&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Anti-Endoglin Chimeric Monoclonal Antibody TRC105;   Biological: Bevacizumab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Other: Quality-of-Life Assessment&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01648348</guid>
      <pubDate>Fri, 20 Jul 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Point-of-Care Ultrasound in the Emergency Department Evaluation of Syncope</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01671371?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Syncope&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Point-of-Care Ultrasound&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Yale University&lt;br/&gt;&lt;b&gt;Terminated&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01671371</guid>
      <pubDate>Tue, 17 Jul 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Pilot Study to Determine if Working Memory Training Aids Cognitive Functioning in Patients With Parkinson's Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01647698?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Parkinson Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Adaptive working memory training task;   Behavioral: Non-adaptive working memory training task (i.e. an active control task);   Behavioral: No training&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Gail Eskes;   Nova Scotia Health Authority&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01647698</guid>
      <pubDate>Fri, 13 Jul 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-small Cell Lung Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01642251?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Extensive Stage Small Cell Lung Carcinoma;   Large Cell Lung Carcinoma;   Neuroendocrine Carcinoma;   Small Cell Carcinoma;   Stage IV Non-Small Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cisplatin;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Drug: Veliparib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01642251</guid>
      <pubDate>Fri, 13 Jul 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>CoSeal for Hemostasis of Aortic Anastamoses</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01653769?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Surgical Bleeding;   Aneurysms;   Aortic Dissection&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    The Methodist Hospital System&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01653769</guid>
      <pubDate>Mon, 02 Jul 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Estimation of the VQ11 Auto-questionnaire, to Follow Patients With Chronic Obstructive Pulmonary Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01651676?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    COPD&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: VQ11 validation&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Centre Hospitalier Universitaire, Amiens&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01651676</guid>
      <pubDate>Fri, 29 Jun 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01630733?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Non-Small Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Custirsen;   Drug: Docetaxel&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    OncoGenex Technologies&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01630733</guid>
      <pubDate>Tue, 26 Jun 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01629082?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Myeldysplastic Syndrome (MDS);   Chronic Myelomonocytic Leukemia;   Bone Marrow Diseases;   Neutropenia;   Acute Myeloid Leukemia (AML)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Clofarabine;   Drug: Lenalidomide&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Heart, Lung, and Blood Institute (NHLBI);   Celgene Corporation&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01629082</guid>
      <pubDate>Fri, 22 Jun 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01624220?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Spinal Tumor&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Radiation: Spinal SBRT (Standard Dose);   Radiation: Spinal SBRT (Higher Dose);   Procedure: Gold Seed Implantation;   Behavioral: Questionnaires&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    M.D. Anderson Cancer Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01624220</guid>
      <pubDate>Mon, 18 Jun 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Prospective Evaluation of the Radiographic Efficacy of Enbrel</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01623752?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Rheumatoid Arthritis;   Psoriasis Arthritis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Etanercept;   Drug: Etanercept&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Pfizer&lt;br/&gt;&lt;b&gt;Enrolling by invitation&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01623752</guid>
      <pubDate>Mon, 18 Jun 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01625923?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Idiopathic Gastroparesis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Olanzapine&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Michigan;   Massachusetts General Hospital&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01625923</guid>
      <pubDate>Mon, 18 Jun 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients Non-Small Lung Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01622621?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Lung Neoplasms&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Sublobar Resection;   Radiation: Stereotactic Body Radiotherapy (SBRT)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Mayo Clinic&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01622621</guid>
      <pubDate>Fri, 15 Jun 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01622868?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    HER2 Positive Breast Carcinoma;   Invasive Breast Carcinoma;   Metastatic Malignant Neoplasm in the Brain;   Recurrent Breast Carcinoma;   Stage IV Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Laboratory Biomarker Analysis;   Drug: Lapatinib Ditosylate;   Radiation: Stereotactic Radiosurgery;   Radiation: Whole-Brain Radiotherapy&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT01622868</guid>
      <pubDate>Fri, 15 Jun 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01652872?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Management of Anemia in Chronic Kidney Disease Patients Not on Dialysis.&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: Darbepoetin alfa&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Amgen&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01652872</guid>
      <pubDate>Thu, 07 Jun 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>MITRAFIT- Cardinal Adjustable Mitral Repair Follow-up International Postmarketing Surveillance (PMS)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01617720?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Mitral Regurgitation&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Valtech Cardio Ltd&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01617720</guid>
      <pubDate>Thu, 07 Jun 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Acute Effect of Animal and Vegetable Protein Rich Meals With Comparable Dietary Fibers Content on Appetite Sensation and Energy Intake</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01616251?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Obesity&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Acute effect of animal and vegetable protein rich meals with comparable dietary fibers content on appetite sensation and energy intake&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Copenhagen&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01616251</guid>
      <pubDate>Thu, 07 Jun 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Impact of Integrating an Internet Weight Control Program Into Primary Care</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01606813?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Overweight;   Obese&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Usual Care;   Behavioral: Brief Physician Counseling;   Behavioral: Referral and access to an internet weight control program;   Behavioral: Brief follow up email notes from PCPs&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Milton S. Hershey Medical Center;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   University of North Carolina, Chapel Hill;   The University of Texas Health Science Center, Houston&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01606813</guid>
      <pubDate>Thu, 24 May 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01602315?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (RM HNSCC) Patients Who Are Resistant or Ineligible/Intolerant to Platinum-based Chemotherapy.;   Recurrent Head and Neck Squamous Cell Carcinoma;   Metastatic Head and Neck Squamous Cell Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: BYL719 as film-coated (FC) whole tablets;   Drug: BYL719 as dispersible tablets (DT);   Biological: cetuximab;   Drug: BYL719 as film-coated (FC) drink suspension&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novartis Pharmaceuticals&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01602315</guid>
      <pubDate>Wed, 16 May 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01599832?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Clear Cell Renal Cell Carcinoma;   Recurrent Renal Cell Cancer;   Stage IV Renal Cell Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: pazopanib hydrochloride;   Other: laboratory biomarker analysis;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Other: pharmacogenomic studies&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Chicago;   National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01599832</guid>
      <pubDate>Mon, 14 May 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01594398?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Lung Cancer;   Non Small Cell Lung Cancer (NSCLC);   Breast Cancer;   Estrogen Receptor Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: entinostat;   Drug: entinostat;   Drug: Erlotinib;   Drug: Erlotinib;   Drug: Exemestane;   Drug: Exemestane&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Syndax Pharmaceuticals&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01594398</guid>
      <pubDate>Fri, 04 May 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01592214?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Staphylococcal Infection&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Placebo;   Drug: XF-73 in 4% Klucel gel;   Drug: XF-73 in 2% Klucel gel&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified September 2014</description>
      <guid isPermaLink="false">NCT01592214</guid>
      <pubDate>Thu, 03 May 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With Benign Prostatic Hyperplasia and Lower Urinary Track Symptoms (BPH)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01589263?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Benign Prostatic Hyperplasia;   Lower Urinary Track Symptoms&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: onaBoNT-A + placebo;   Drug: Tamsulosin + placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    VA Office of Research and Development&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01589263</guid>
      <pubDate>Fri, 27 Apr 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01585805?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    BRCA1 Mutation Carrier;   BRCA2 Mutation Carrier;   Metastatic Pancreatic Adenocarcinoma;   PALB2 Gene Mutation;   Pancreatic Adenocarcinoma;   Recurrent Pancreatic Carcinoma;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Veliparib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified January 2016</description>
      <guid isPermaLink="false">NCT01585805</guid>
      <pubDate>Wed, 25 Apr 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Validating a New Writer s Cramp Scale</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01579266?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Dystonia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Neurological Disorders and Stroke (NINDS)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01579266</guid>
      <pubDate>Sat, 14 Apr 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01575548?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Clear Cell Renal Cell Carcinoma;   Recurrent Renal Cell Carcinoma;   Stage IV Renal Cell Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Pazopanib Hydrochloride;   Other: Pharmacological Study;   Other: Placebo;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT01575548</guid>
      <pubDate>Tue, 10 Apr 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01578655?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostate Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: cabazitaxel;   Drug: prednisone;   Drug: custirsen sodium&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    OncoGenex Technologies&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01578655</guid>
      <pubDate>Mon, 09 Apr 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01587703?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Carcinoma, Midline&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: GSK525762&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01587703</guid>
      <pubDate>Tue, 03 Apr 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01571284?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Colorectal Cancer Metastatic&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: AFLIBERCEPT AVE0005;   Drug: FOLFIRI&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Sanofi;   Regeneron Pharmaceuticals&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01571284</guid>
      <pubDate>Tue, 03 Apr 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>CT Antigen TCR-redirected T Cells for Ovarian Cancer.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01567891?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Ovarian Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: NYESO-1c259 T cells&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Adaptimmune&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01567891</guid>
      <pubDate>Fri, 16 Mar 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Stem Cell Injection to Treat Heart Damage During Open Heart Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01557543?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Heart Disease;   Ischemic Heart Disease;   Coronary Artery Disease;   Coronary Artery Disease (CAD)&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Cell Therapy&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Heart, Lung, and Blood Institute (NHLBI);   NIH Heart Center at Suburban Hospital&lt;br/&gt;&lt;b&gt;Suspended&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01557543</guid>
      <pubDate>Fri, 16 Mar 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01555853?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Lymphoma, Non-Hodgkin;   Hodgkin Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Abraxane&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Washington University School of Medicine&lt;br/&gt;&lt;b&gt;Terminated&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01555853</guid>
      <pubDate>Tue, 13 Mar 2012 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01553149?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Neurofibromatosis Type 1;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Visual Pathway Glioma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Lenalidomide;   Other: Pharmacological Study&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01553149</guid>
      <pubDate>Sat, 10 Mar 2012 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01538680?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Colorectal Neoplasms&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Regorafenib (BAY73-4506)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Bayer&lt;br/&gt;&lt;b&gt;No longer available&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01538680</guid>
      <pubDate>Tue, 21 Feb 2012 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01525069?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Cholangiocarcinoma;   Liver Neoplasms&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Floxuridine;   Drug: Dexamethasone;   Drug: Gemcitabine;   Drug: Oxaliplatin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Washington University School of Medicine&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01525069</guid>
      <pubDate>Wed, 25 Jan 2012 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01518998?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hypertension&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Fimasartan , Amlodipine, Placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Boryung Pharmaceutical Co., Ltd;   Gachon University Gil Medical Center;   The Catholic University of Korea;   Kyungpook National University;   Daegu Catholic University Medical Center;   Wonkwang University Hospital;   Wonju Severance Christian Hospital;   Korea University Guro Hospital;   DongGuk University;   Yeungnam University;   Chonnam National University Hospital;   Cheil General Hospital and Women’s Healthcare Center;   Chungnam National University;   Asan Medical Center;   Seoul National University Bundang Hospital;   Inha University Hospital;   Seoul National University Hospital;   Inje University;   Samsung Medical Center;   Busan National University Yangsan Hospital;   Soon Chun Hyang University;   Catholic University of Korea Saint Paul's Hospital;   Hallym University Kangnam Sacred Heart Hospital;   Jeju National University Hospital;   Hanyang University Seoul Hospital;   Kangbuk Samsung Hospital&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01518998</guid>
      <pubDate>Tue, 24 Jan 2012 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Reducing Radioisotope Dose: the Half-Dose CZT Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01518777?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Coronary Artery Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Half-dose isotope for NuclearStressTest&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    The Methodist Hospital System&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01518777</guid>
      <pubDate>Mon, 23 Jan 2012 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01543204?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Psoriasis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Etanercept&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Amgen&lt;br/&gt;&lt;b&gt;Terminated&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01543204</guid>
      <pubDate>Tue, 17 Jan 2012 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Endoscopic Mucosal Resection for the Diagnosis of a-Ganglionosis, a Controlled Prospective Trial (EDGE Trial)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01515501?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Constipation;   Hirschsprung Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: Endoscopic mucosal resection (EMR)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Massachusetts General Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01515501</guid>
      <pubDate>Wed, 11 Jan 2012 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01507428?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: 18F-Fluoromisonidazole;   Drug: Carboplatin;   Procedure: Computed Tomography;   Procedure: Computed Tomography;   Radiation: External Beam Radiation Therapy;   Drug: Fludeoxyglucose F-18;   Radiation: Image-Guided Adaptive Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Procedure: Positron Emission Tomography;   Procedure: Positron Emission Tomography&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT01507428</guid>
      <pubDate>Thu, 05 Jan 2012 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01498770?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Bipolar Disorder&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Asenapine;   Drug: Aripiprazole;   Drug: Quetiapine;   Drug: Risperidone;   Drug: Olanzapine;   Drug: Ziprasidone;   Drug: Iloperidone;   Drug: Paliperidone;   Drug: Lurasidone;   Drug: Clozapine;   Drug: Amisulpride;   Drug: Sertindole;   Drug: Zotepine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Merck Sharp &amp; Dohme Corp.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01498770</guid>
      <pubDate>Wed, 21 Dec 2011 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01519804?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Non-Squamous Non-Small Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Placebo;   Drug: cisplatin/carboplatin;   Drug: onartuzumab;   Drug: paclitaxel&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Genentech, Inc.&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01519804</guid>
      <pubDate>Mon, 19 Dec 2011 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01571583?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Chronic Hepatitis C Virus (HCV) Infection&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Telaprevir;   Drug: Pegylated interferon alfa-2a;   Drug: Ribavirin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Janssen-Cilag International NV&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01571583</guid>
      <pubDate>Fri, 16 Dec 2011 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Nicotine Reinforcement and Aversion in Young Adult Light Smokers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01495819?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Nicotine Addiction&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Saline;   Drug: Nicotine&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Yale University&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01495819</guid>
      <pubDate>Wed, 07 Dec 2011 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01493310?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Male Breast Cancer;   Recurrent Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: mifepristone;   Drug: placebo;   Drug: nab-paclitaxel&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Chicago&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01493310</guid>
      <pubDate>Fri, 02 Dec 2011 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02818725?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Infiltrating Urothelial Carcinoma;   KRAS Gene Mutation&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Chemotherapy;   Drug: panitumumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    UNICANCER&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02818725</guid>
      <pubDate>Tue, 29 Nov 2011 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or Metastatic</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01540253?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Unspecified Adult Solid Tumor, Protocol Specific&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: PI3K inhibitor BKM120;   Drug: docetaxel;   Other: pharmacological study;   Other: questionnaire administration;   Other: laboratory biomarker analysis&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Roswell Park Cancer Institute;   National Cancer Institute (NCI);   Novartis&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01540253</guid>
      <pubDate>Tue, 29 Nov 2011 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>An Efficacy and Safety Trial of Intranasal Ketorolac in Emergency Department Patients for the Treatment of Acute Pain</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01471639?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Other Acute Pain&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: intranasal ketorolac&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    The Cleveland Clinic;   Luitpold Pharmaceuticals&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01471639</guid>
      <pubDate>Fri, 04 Nov 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Acceptance Based Behavioral Intervention for Weight Loss: A Randomized Trial</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01461421?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Obesity&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Nutrition Education;   Behavioral: Behavioral Weight Loss Strategies;   Behavioral: Standard Cognitive Techniques;   Behavioral: Acceptance Based Techniques&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    The Miriam Hospital&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01461421</guid>
      <pubDate>Tue, 25 Oct 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01459380?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Seromucinous Carcinoma;   Ovarian Serous Cystadenocarcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Undifferentiated Ovarian Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Bevacizumab;   Drug: Carboplatin;   Other: Laboratory Biomarker Analysis;   Drug: Pegylated Liposomal Doxorubicin Hydrochloride;   Drug: Veliparib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01459380</guid>
      <pubDate>Thu, 06 Oct 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01454596?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Malignant Glioma;   Glioblastoma;   Brain Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Anti-EGFRvIII CAR transduced PBL;   Drug: Aldesleukin;   Drug: Fludarabine;   Drug: Cyclophosphamide&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Suspended&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT01454596</guid>
      <pubDate>Thu, 06 Oct 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer Patients Who Have Failed an Anthracycline (CAT)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01446016?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Breast Neoplasms;   Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Taxane;   Drug: Taxotere;   Drug: Abraxane;   Drug: Ixabepilone&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    The Methodist Hospital System&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01446016</guid>
      <pubDate>Thu, 29 Sep 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Imaging Whole Coronary Artery With Intravascular Ultrasound (Ivus) And Imap For Plaque Tissue Composition In Patients With Acute Myocardial Infarction</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01437553?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Acute Coronary Syndrome&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: iMAP&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Federal University of São Paulo;   Boston Scientific Corporation&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01437553</guid>
      <pubDate>Sun, 18 Sep 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Staged Phase I/II Hepatitis C Prophylactic Vaccine</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01436357?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hepatitis C&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Placebo;   Biological: AdCh3NSmut1;   Biological: MVA-NSmut&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified January 2016</description>
      <guid isPermaLink="false">NCT01436357</guid>
      <pubDate>Thu, 15 Sep 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Cell Collection to Study Eye Diseases</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01432847?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Retinal Disease;   AMD;   Retinal Degeneration&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Eye Institute (NEI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT01432847</guid>
      <pubDate>Sat, 10 Sep 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01421069?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Juvenile Idiopahtic Arthritis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: etanercept&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Pfizer&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01421069</guid>
      <pubDate>Thu, 18 Aug 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Early Outcome of Mechanochemical Endovenous Ablation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01459263?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Varicosis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Device: ClariVein&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Rijnstate Hospital;   St. Antonius Hospital&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01459263</guid>
      <pubDate>Mon, 08 Aug 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Difference in Pain Perception by Patients With Prostate Biopsy Using Instillagel Compared With Guided Ultrasound Gel</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT02819713?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostate Biopsy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: ultrasound gel;   Other: Instillagel&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Rijnstate Hospital&lt;br/&gt;&lt;b&gt;Withdrawn&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT02819713</guid>
      <pubDate>Mon, 08 Aug 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Non-Invasive Imaging of Atherosclerosis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01418313?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Atherosclerosis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Icahn School of Medicine at Mount Sinai;   National Heart, Lung, and Blood Institute (NHLBI);   National Institutes of Health (NIH);   New York University School of Medicine&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01418313</guid>
      <pubDate>Fri, 05 Aug 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01400516?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Rheumatoid Arthritis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Teriparatide&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Brigham and Women's Hospital;   Eli Lilly and Company&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01400516</guid>
      <pubDate>Thu, 21 Jul 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Motivational Intervention for Asthma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01381159?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Asthma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Motivational Interviewing;   Behavioral: Control&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Hopital du Sacre-Coeur de Montreal;   Jewish General Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01381159</guid>
      <pubDate>Tue, 21 Jun 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01376570?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    HIV;   Opiate Dependence&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Abstinence-reinforcing contingency management intervention;   Behavioral: Performance Feedback intervention&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Albert Einstein College of Medicine of Yeshiva University;   National Institute on Drug Abuse (NIDA)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01376570</guid>
      <pubDate>Thu, 16 Jun 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01371981?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Leukemia Cutis;   Myeloid Sarcoma;   Untreated Adult Acute Myeloid Leukemia;   Untreated Childhood Myeloid Neoplasm&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Asparaginase;   Drug: Bortezomib;   Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Drug: Mitoxantrone Hydrochloride;   Other: Pharmacological Study;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Drug: Sorafenib Tosylate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT01371981</guid>
      <pubDate>Fri, 10 Jun 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01372579?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Estrogen Receptor-negative Breast Cancer;   HER2-negative Breast Cancer;   Male Breast Cancer;   Progesterone Receptor-negative Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Triple-negative Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: eribulin mesylate;   Drug: carboplatin;   Procedure: biopsy&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Northwestern University;   Eisai Inc.&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01372579</guid>
      <pubDate>Wed, 01 Jun 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01385826?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Uveitis;   Juvenile Arthritis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Anti-tumor necrosis factor alpha monoclonal antibody;   Drug: placebo&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Assistance Publique - Hôpitaux de Paris;   Abbott&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01385826</guid>
      <pubDate>Tue, 24 May 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01357668?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Juvenile Idiopathic Arthritis&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Bristol-Myers Squibb&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified December 2015</description>
      <guid isPermaLink="false">NCT01357668</guid>
      <pubDate>Thu, 19 May 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01354951?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostate Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Prostate Biopsy, Focal Brachytherapy , Assessment of QOL&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Memorial Sloan Kettering Cancer Center;   University of Colorado, Denver;   M.D. Anderson Cancer Center;   Northwell Health&lt;br/&gt;&lt;b&gt;Terminated&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01354951</guid>
      <pubDate>Mon, 16 May 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01351909?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    HER2/Neu Negative;   Recurrent Breast Carcinoma;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cyclophosphamide;   Other: Laboratory Biomarker Analysis;   Drug: Veliparib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01351909</guid>
      <pubDate>Tue, 10 May 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Closure Techniques and Scar Appearance</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01352533?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Wound Closure Techniques&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Running polypropylene closure;   Procedure: Tissue Adhesive (Derma-Bond);   Procedure: Subcuticular polyglactin-910 combined with tissue adhesive&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Northwestern University&lt;br/&gt;&lt;b&gt;Not yet recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01352533</guid>
      <pubDate>Fri, 29 Apr 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01343043?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Synovial Sarcoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Biological: NY-ESO-1(c259)T Cells&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Adaptimmune&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01343043</guid>
      <pubDate>Tue, 26 Apr 2011 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01313377?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Liver Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: gemcitabine hydrochloride;   Drug: oxaliplatin;   Other: clinical observation;   Procedure: adjuvant therapy;   Procedure: quality-of-life assessment&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    UNICANCER&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01313377</guid>
      <pubDate>Thu, 10 Mar 2011 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Pharmacokinetic, Safety and Tolerability Study of SPARC1028</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01305512?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Solid Tumor in Advanced Stage&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: SPARC1028&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Sun Pharma Advanced Research Company Limited&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01305512</guid>
      <pubDate>Thu, 24 Feb 2011 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Carfilzomib Plus Panobinostat in Relapsed/Refractory Multiple Myeloma (MM)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01301807?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Myeloma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Carfilzomib;   Drug: Panobinostat&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Novartis;   Onyx Therapeutics, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01301807</guid>
      <pubDate>Mon, 21 Feb 2011 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01297543?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Chronic Myeloid Leukemia;   Myelodysplasia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: human myeloid progenitor cells;   Drug: G-CSF&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Cellerant Therapeutics;   Department of Health and Human Services&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01297543</guid>
      <pubDate>Fri, 11 Feb 2011 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01281852?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Recurrent Cervical Carcinoma;   Stage IVB Cervical Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cisplatin;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Drug: Veliparib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01281852</guid>
      <pubDate>Fri, 21 Jan 2011 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01276613?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pancreatic Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Gemcitabine;   Drug: Losartan&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    M.D. Anderson Cancer Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01276613</guid>
      <pubDate>Wed, 12 Jan 2011 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01275677?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Estrogen Receptor Negative;   Estrogen Receptor Positive;   HER2/Neu Positive;   Progesterone Receptor Negative;   Progesterone Receptor Positive;   Recurrent Breast Carcinoma;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIC Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cyclophosphamide;   Drug: Docetaxel;   Drug: Doxorubicin Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Other: Quality-of-Life Assessment;   Biological: Trastuzumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified February 2016</description>
      <guid isPermaLink="false">NCT01275677</guid>
      <pubDate>Tue, 11 Jan 2011 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Optimizing Protein Intake in Older Americans With Mobility Limitations</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01275365?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Mobility Limitation&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Testosterone enanthate;   Drug: Testosterone enanthate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Brigham and Women's Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01275365</guid>
      <pubDate>Tue, 11 Jan 2011 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01274338?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent Melanoma;   Stage IIIB Skin Melanoma;   Stage IIIC Skin Melanoma;   Stage IV Skin Melanoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Ipilimumab;   Other: Quality-of-Life Assessment;   Biological: Recombinant Interferon Alfa-2b&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT01274338</guid>
      <pubDate>Sat, 08 Jan 2011 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01272037?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Ductal Breast Carcinoma In Situ;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Invasive Breast Carcinoma;   Multicentric Breast Carcinoma;   Multifocal Breast Carcinoma;   Synchronous Bilateral Breast Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Anastrozole;   Drug: Exemestane;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Quality-of-Life Assessment;   Drug: Systemic Chemotherapy;   Drug: Tamoxifen Citrate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT01272037</guid>
      <pubDate>Thu, 06 Jan 2011 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Proflavine: A Feasibility Study for In Vivo Imaging of Oral Neoplasia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01269190?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Head and Neck Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Proflavine;   Procedure: Imaging;   Device: Widefield Multispectral Imaging Devices;   Device: High-Resolution Microendoscope (HRME)&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   National Institutes of Health (NIH)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01269190</guid>
      <pubDate>Thu, 30 Dec 2010 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Evaluate the Efficacy and Safety of Pasireotide LAR on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01283542?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Non-functioning Pituitary Adenoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Pasireotide LAR&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novartis Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01283542</guid>
      <pubDate>Fri, 17 Dec 2010 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01259089?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Adenocarcinoma of the Lung;   Non-small Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: erlotinib hydrochloride;   Drug: Hsp90 inhibitor AUY922;   Other: laboratory biomarker analysis;   Procedure: needle biopsy;   Genetic: mutation analysis;   Other: pharmacological study&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Northwestern University;   Robert H. Lurie Cancer Center&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01259089</guid>
      <pubDate>Fri, 10 Dec 2010 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01254630?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Herpes Zoster&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: V212;   Biological: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Merck Sharp &amp; Dohme Corp.&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01254630</guid>
      <pubDate>Fri, 03 Dec 2010 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>The Effect of 1 Year of Multiprofessional Therapy on Obesity</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01358773?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Obesity&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: multidisciplinary intervention&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Ana R. Damaso;   Raquel Munhoz da Silveira Campos;   Sofia Emanuelle Castro;   Ana Claudia Pelissari Kravchychyn&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01358773</guid>
      <pubDate>Fri, 03 Dec 2010 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Study of AMG 337 in Subjects With Advanced Solid Tumors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01253707?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Advanced Malignancy;   Advanced Solid Tumors;   Cancer;   Oncology;   Oncology Patients;   Tumors&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: AMG 337&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Amgen&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01253707</guid>
      <pubDate>Wed, 24 Nov 2010 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Impact of Systemic Manifestations/Comorbidities on Clinical State, Prognosis, Utilisation of Health Care Resources in Patients With COPD</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01245933?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Chronic Obstructive Pulmonary Disease (COPD)&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: Analysis of sleep disturbances&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Philipps University Marburg Medical Center;   Hannover Medical School;   Ludwig-Maximilians - University of Munich&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified January 2016</description>
      <guid isPermaLink="false">NCT01245933</guid>
      <pubDate>Thu, 18 Nov 2010 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01237587?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Fibromyalgia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Duloxetine;   Drug: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Eli Lilly and Company&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01237587</guid>
      <pubDate>Mon, 08 Nov 2010 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01206764?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Renal Cell Carcinoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: RAD001&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Novartis Pharmaceuticals&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01206764</guid>
      <pubDate>Tue, 21 Sep 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01198158?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Clear Cell Renal Cell Carcinoma;   Recurrent Renal Cell Carcinoma;   Stage III Renal Cell Cancer;   Stage IV Renal Cell Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Bevacizumab;   Drug: Everolimus;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01198158</guid>
      <pubDate>Wed, 08 Sep 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01196390?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Adenocarcinoma of the Gastroesophageal Junction;   Esophageal Adenocarcinoma;   Stage IB Esophageal Cancer;   Stage IIA Esophageal Cancer;   Stage IIB Esophageal Cancer;   Stage IIIA Esophageal Cancer;   Stage IIIB Esophageal Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Carboplatin;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Other: Quality-of-Life Assessment;   Radiation: Radiation Therapy;   Procedure: Therapeutic Conventional Surgery;   Biological: Trastuzumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01196390</guid>
      <pubDate>Sat, 04 Sep 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01191853?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Healthy Volunteers&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Heart, Lung, and Blood Institute (NHLBI)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01191853</guid>
      <pubDate>Sat, 28 Aug 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01189643?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Sarcoma;   Desmoplastic Small Round Cell Tumor (DSRCT)&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: irinotecan, temozolomide, and bevacizumab incorporated into an existing schedule of high dose alkylator&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Memorial Sloan Kettering Cancer Center;   Genentech, Inc.&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01189643</guid>
      <pubDate>Wed, 25 Aug 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head &amp; Neck Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01185171?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Head and Neck Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: ZD 1839 500mg&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Chicago&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01185171</guid>
      <pubDate>Wed, 18 Aug 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01182155?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Lung Cancer;   Non-Small Cell Lung Cancer;   Small Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: Exhaled Breath Sampling&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Stanford University&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01182155</guid>
      <pubDate>Thu, 12 Aug 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01174121?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Metastatic Colorectal Cancer;   Metastatic Gastric Cancer;   Metastatic Pancreatic Cancer;   Metastatic Hepatocellular Carcinoma;   Metastatic Cholangiocarcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Young TIL;   Drug: Aldesleukin;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: Pembrolizumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01174121</guid>
      <pubDate>Sat, 31 Jul 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>The Role of Audiovisual Biofeedback on Image Quality During 4D Anatomic and Functional Imaging</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01172041?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Lung Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: Real time position management system;   Device: LS PET/CT;   Drug: 18-FDG&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Stanford University&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01172041</guid>
      <pubDate>Mon, 26 Jul 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01169337?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Light Chain Deposition Disease;   Smoldering Plasma Cell Myeloma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Clinical Observation;   Other: Laboratory Biomarker Analysis;   Drug: Lenalidomide;   Other: Quality-of-Life Assessment&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified January 2016</description>
      <guid isPermaLink="false">NCT01169337</guid>
      <pubDate>Fri, 23 Jul 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01165229?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Herpes Zoster&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Herpes Zoster Vaccine GSK1437173A;   Biological: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01165229</guid>
      <pubDate>Thu, 15 Jul 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01165177?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Herpes Zoster&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Herpes Zoster Vaccine GSK1437173A;   Biological: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01165177</guid>
      <pubDate>Thu, 15 Jul 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Cyberknife Radiosurgery and Quality of Life</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01163539?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Bone Cancer;   Central Nervous System Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Stanford University&lt;br/&gt;&lt;b&gt;Terminated&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01163539</guid>
      <pubDate>Wed, 14 Jul 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01326390?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Kidney (Renal Cell) Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: dTA/dBA C-arm fluoroscopy system with Dyna CT;   Procedure: DSA arteriogram- hepatic arteries;   Procedure: CO2 aortogram&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Stanford University&lt;br/&gt;&lt;b&gt;Terminated&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01326390</guid>
      <pubDate>Tue, 06 Jul 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Phase II Study of Ofatumumab-Based Induction Chemoimmunotheraphy Followed by Consolidation Ofatumumab Immunotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01145209?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Small Lymphocytic Lymphoma;   CLL (Chronic Lymphocytic Leukemia)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Fludarabine Phosphate;   Biological: Ofatumumab;   Drug: Cyclophosphamide&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Heart, Lung, and Blood Institute (NHLBI);   University of Virginia;   GlasoSmithKline&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01145209</guid>
      <pubDate>Tue, 15 Jun 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01144780?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Myeloproliferative Disorders;   Myeloproliferative Disorders (MPD)&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Stanford University&lt;br/&gt;&lt;b&gt;Terminated&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01144780</guid>
      <pubDate>Mon, 14 Jun 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01144754?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Lymphoma;   Non-Hodgkin's Lymphoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Rituximab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Stanford University&lt;br/&gt;&lt;b&gt;Terminated&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01144754</guid>
      <pubDate>Mon, 14 Jun 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01109004?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Multiple Myeloma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Lenalidomide;   Drug: lenalidomide, bortezomib and dexamethasone;   Drug: Lenalidomide&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Heart, Lung, and Blood Institute (NHLBI);   Blood and Marrow Transplant Clinical Trials Network;   National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01109004</guid>
      <pubDate>Wed, 21 Apr 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01108094?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Skin Cancers;   Carcinoma, Basal Cell;   Skin Cancer;   Basal Cell Carcinoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Itraconazole&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Stanford University&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01108094</guid>
      <pubDate>Mon, 19 Apr 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Prognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01326364?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Pancreatic Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Stereotactic body radiotherapy;   Drug: Iodixanol;   Drug: Iohexol&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Stanford University&lt;br/&gt;&lt;b&gt;Terminated&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01326364</guid>
      <pubDate>Wed, 14 Apr 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Safety and Hemodynamic Effects and Pharmacokinetics of CXL-1020 in Patients With Stable Heart Failure</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01092325?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Heart Failure&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: CXL-1020;   Drug: CXL-1020;   Drug: Placebo for CXL-1020 Cohort 1;   Drug: Placebo for CXL-1020 Cohort 2;   Drug: CXL-1020 Dose for Echo Cohort A;   Drug: CXL-1020 Doses for Echo Cohort B&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Bristol-Myers Squibb;   This trial was conducted by the previous sponsor, Cardioxyl&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01092325</guid>
      <pubDate>Tue, 23 Mar 2010 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01081262?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Borderline Ovarian Mucinous Tumor;   Ovarian Mucinous Cystadenocarcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Stage IA Fallopian Tube Cancer;   Stage IA Ovarian Cancer;   Stage IB Fallopian Tube Cancer;   Stage IB Ovarian Cancer;   Stage IC Fallopian Tube Cancer;   Stage IC Ovarian Cancer;   Stage IIA Fallopian Tube Cancer;   Stage IIA Ovarian Cancer;   Stage IIB Fallopian Tube Cancer;   Stage IIB Ovarian Cancer;   Stage IIC Fallopian Tube Cancer;   Stage IIC Ovarian Cancer;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Bevacizumab;   Drug: Capecitabine;   Drug: Carboplatin;   Other: Laboratory Biomarker Analysis;   Drug: Oxaliplatin;   Drug: Paclitaxel;   Other: Quality-of-Life Assessment&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01081262</guid>
      <pubDate>Thu, 04 Mar 2010 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01075672?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Obsessive Compulsive Disorder;   Body Dysmorphic Disorder;   Tourette Syndrome;   Trichotillomania;   Panic Disorder;   Social Phobia;   Generalized Anxiety Disorder;   Depression;   Post-Traumatic Stress Disorder;   Attention Deficit Hyperactivity Disorder;   Eating Disorder;   Specific Phobia;   General Medical Condition&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Cognitive behavioral therapy (CBT)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Massachusetts General Hospital&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01075672</guid>
      <pubDate>Mon, 22 Feb 2010 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01064648?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Advanced Malignant Mesothelioma;   Epithelioid Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatoid Mesothelioma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cediranib Maleate;   Drug: Cisplatin;   Drug: Pemetrexed Disodium;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified February 2016</description>
      <guid isPermaLink="false">NCT01064648</guid>
      <pubDate>Fri, 05 Feb 2010 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01077154?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Placebo;   Drug: Denosumab&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Amgen;   Daiichi Sankyo Inc.&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01077154</guid>
      <pubDate>Thu, 04 Feb 2010 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Phase II Pazopanib Study in Advanced Dermatofibrosarcomas</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01059656?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Dermatofibrosarcomas of DARIER FERRAND(DFSP)&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Pazopanib&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Assistance Publique - Hôpitaux de Paris;   GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Terminated&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01059656</guid>
      <pubDate>Thu, 28 Jan 2010 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Formula PTX Renal Stent Clinical Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01057316?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Renal Artery Stenosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: Formula PTX Stent - Dose 1;   Device: Formula PTX Stent - Dose 2;   Device: Formula PTX Stent - Dose 3&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Cook&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01057316</guid>
      <pubDate>Mon, 25 Jan 2010 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Quality of Life in Food Allergic Families</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01054950?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Food Allergy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Counseling;   Behavioral: Placebo phone call&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Michigan&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01054950</guid>
      <pubDate>Thu, 21 Jan 2010 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Study to Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01031836?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Systemic Lupus Erythematosus&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: MEDI-545;   Drug: MEDI-545;   Drug: MEDI-545;   Drug: MEDI-545;   Drug: MEDI-545;   Drug: MEDI-545 600&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    AstraZeneca;   MedImmune LLC&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01031836</guid>
      <pubDate>Fri, 11 Dec 2009 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01020968?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Dilated Cardiomyopathy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Ixmyelocel-T;   Other: Standard of Care&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Vericel Corporation&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01020968</guid>
      <pubDate>Wed, 25 Nov 2009 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01013649?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Pancreatic Acinar Cell Carcinoma;   Pancreatic Ductal Adenocarcinoma;   Pancreatic Intraductal Papillary-Mucinous Neoplasm;   Stage IA Pancreatic Cancer;   Stage IB Pancreatic Cancer;   Stage IIA Pancreatic Cancer;   Stage IIB Pancreatic Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Radiation: 3-Dimensional Conformal Radiation Therapy;   Drug: Capecitabine;   Drug: Chemotherapy;   Drug: Erlotinib Hydrochloride;   Drug: Fluorouracil;   Drug: Gemcitabine Hydrochloride;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT01013649</guid>
      <pubDate>Fri, 13 Nov 2009 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Physician Perceptions About Parenteral Hydration in Latin America and Spain</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01011140?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Dehydration;   Advanced Cancers&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Survey&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    M.D. Anderson Cancer Center&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT01011140</guid>
      <pubDate>Tue, 10 Nov 2009 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT01004978?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Hepatocellular Carcinoma;   Non-Resectable Hepatocellular Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cisplatin;   Drug: Doxorubicin Hydrochloride;   Drug: Doxorubicin-Eluting Beads;   Other: Laboratory Biomarker Analysis;   Drug: Mitomycin;   Other: Pharmacological Study;   Other: Placebo;   Drug: Sorafenib Tosylate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT01004978</guid>
      <pubDate>Thu, 29 Oct 2009 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00989651?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Fallopian Tube Carcinosarcoma;   Fallopian Tube Clear Cell Adenocarcinoma;   Fallopian Tube Endometrioid Adenocarcinoma;   Fallopian Tube Mucinous Adenocarcinoma;   Fallopian Tube Serous Neoplasm;   Fallopian Tube Transitional Cell Carcinoma;   Ovarian Brenner Tumor;   Ovarian Carcinosarcoma;   Ovarian Clear Cell Adenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mucinous Adenocarcinoma;   Ovarian Seromucinous Tumor;   Ovarian Serous Adenocarcinoma;   Ovarian Transitional Cell Carcinoma;   Primary Peritoneal Serous Adenocarcinoma;   Stage IIA Fallopian Tube Cancer;   Stage IIA Ovarian Cancer;   Stage IIB Fallopian Tube Cancer;   Stage IIB Ovarian Cancer;   Stage IIC Fallopian Tube Cancer;   Stage IIC Ovarian Cancer;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIA Primary Peritoneal Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIB Primary Peritoneal Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Cancer;   Stage IIIC Primary Peritoneal Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Cancer;   Stage IV Primary Peritoneal Cancer;   Undifferentiated Fallopian Tube Carcinoma;   Undifferentiated Ovarian Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Bevacizumab;   Drug: Carboplatin;   Drug: Cisplatin;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Drug: Veliparib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00989651</guid>
      <pubDate>Fri, 02 Oct 2009 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00984997?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Lung Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Surgery;   Radiation: Chest Irradiation;   Drug: Cisplatin;   Drug: Etoposide;   Radiation: Prophylactic Cranial Irradiation&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    M.D. Anderson Cancer Center&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00984997</guid>
      <pubDate>Thu, 24 Sep 2009 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00980460?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    PRETEXT Stage 1 Hepatoblastoma;   PRETEXT Stage 2 Hepatoblastoma;   PRETEXT Stage 3 Hepatoblastoma;   PRETEXT Stage 4 Hepatoblastoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cisplatin;   Drug: Doxorubicin Hydrochloride;   Drug: Fluorouracil;   Drug: Irinotecan Hydrochloride;   Other: Laboratory Biomarker Analysis;   Procedure: Liver Transplantation;   Drug: Temsirolimus;   Procedure: Therapeutic Conventional Surgery;   Drug: Vincristine Sulfate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT00980460</guid>
      <pubDate>Fri, 18 Sep 2009 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Impact of Aerobic Exercise on Asthma Morbidity</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00953342?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Asthma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Behavioral: Aerobic exercise;   Behavioral: Usual care&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Hopital du Sacre-Coeur de Montreal;   McGill University Health Center;   Jewish General Hospital&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00953342</guid>
      <pubDate>Tue, 04 Aug 2009 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00942877?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Sarcoma, Alveolar Soft Part&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: AZD2171&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT00942877</guid>
      <pubDate>Sat, 18 Jul 2009 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00942331?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Bladder Urothelial Carcinoma;   Distal Urethral Carcinoma;   Infiltrating Bladder Urothelial Carcinoma Associated With Urethral Carcinoma;   Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;   Proximal Urethral Carcinoma;   Recurrent Bladder Carcinoma;   Recurrent Prostate Carcinoma;   Recurrent Urethra Carcinoma;   Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter;   Regional Urothelial Carcinoma of the Renal Pelvis and Ureter;   Stage IV Bladder Cancer;   Stage IV Prostate Cancer;   Stage IV Urethral Cancer;   Ureter Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Bevacizumab;   Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00942331</guid>
      <pubDate>Fri, 17 Jul 2009 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00923364?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    MDS;   Immunodeficiency;   GATA2&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Cyclophosphamide (CTX, Cytoxan);   Drug: Fludarabine(Fludara,Berlex Laboratories);   Procedure: Total Body Irradiation (TBI);   Procedure: Allogeneic HSC;   Drug: Equine Anti-Thymocyte Globulin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00923364</guid>
      <pubDate>Wed, 17 Jun 2009 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00923884?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Carcinoma, Non-Small Cell Lung;   Carcinoma, Small-Cell Lung&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00923884</guid>
      <pubDate>Wed, 17 Jun 2009 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Plasma and Urine Samples From Patients With Hormone-Refractory Prostate Cancer Enrolled on Clinical Trials CALGB-9480 or CALGB-9583</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00898833?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostate Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Other: laboratory biomarker analysis&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00898833</guid>
      <pubDate>Sat, 09 May 2009 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00892736?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Basal-Like Breast Carcinoma;   BRCA1 Mutation Carrier;   BRCA2 Mutation Carrier;   Breast Carcinoma;   Estrogen Receptor Negative;   HER2/Neu Negative;   Hereditary Breast and Ovarian Cancer Syndrome;   Ovarian Carcinoma;   Pancreatic Carcinoma;   Progesterone Receptor Negative;   Prostate Carcinoma;   Recurrent Breast Carcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Solid Neoplasm;   Triple-Negative Breast Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Veliparib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00892736</guid>
      <pubDate>Fri, 01 May 2009 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Phase 2 Multi-Center Study of Entinostat (SNDX-275) in Patient With Relapsed or Refractory Hodgkin's Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00866333?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hodgkin's Lymphoma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: entinostat (SNDX-275)&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Syndax Pharmaceuticals&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00866333</guid>
      <pubDate>Thu, 19 Mar 2009 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Parent Educational Program for Children With Sickle Cell Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00860782?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Hemoglobin SC Disease;   Anemia, Sickle Cell&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Parent Educational Support&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Miami;   National Heart, Lung, and Blood Institute (NHLBI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00860782</guid>
      <pubDate>Tue, 10 Mar 2009 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00858377?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Advanced Malignancy;   Advanced Solid Tumors;   Cancer;   Solid Tumors;   Tumors&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Arm 1- Dose Escalation;   Drug: Arm 1- Dose Expansion&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Amgen&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00858377</guid>
      <pubDate>Thu, 26 Feb 2009 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>rhBMP-2 Versus Autograft in Critical Size Tibial Defects</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00853489?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Tibial Fractures&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Device: recombinant bone morphogenetic protein 2;   Procedure: Autogenous iliac crest bone graft&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    St. Louis University;   Major Extremity Trauma Research Consortium&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00853489</guid>
      <pubDate>Tue, 24 Feb 2009 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00843882?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Anemia;   Chronic Myelomonocytic Leukemia;   de Novo Myelodysplastic Syndrome;   Previously Treated Myelodysplastic Syndrome&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Epoetin Alfa;   Other: Laboratory Biomarker Analysis;   Drug: Lenalidomide&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified May 2016</description>
      <guid isPermaLink="false">NCT00843882</guid>
      <pubDate>Thu, 12 Feb 2009 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00832702?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Cardiovascular Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: Cardiac MRI&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Cedars-Sinai Medical Center;   National Heart, Lung, and Blood Institute (NHLBI);   University of Florida;   University of Pittsburgh&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00832702</guid>
      <pubDate>Wed, 28 Jan 2009 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00809211?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: nilotinib;   Genetic: cytogenetic analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Other: pharmacological study&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Cancer Trials Ireland&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00809211</guid>
      <pubDate>Tue, 16 Dec 2008 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00769379?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Ductal Breast Carcinoma In Situ;   HER2/Neu Positive&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Laboratory Biomarker Analysis;   Biological: Trastuzumab;   Radiation: Whole Breast Irradiation&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00769379</guid>
      <pubDate>Wed, 08 Oct 2008 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00765518?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Dilated Cardiomyopathy&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Ixmyelocel-T;   Other: Standard of Care&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Vericel Corporation&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00765518</guid>
      <pubDate>Thu, 02 Oct 2008 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Refinement and Assessment of New Magnetic Resonance Imaging Technologies for Neurological Exams</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00739518?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Nervous System Diseases&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: MRI&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    University of Michigan;   General Electric;   Philips Medical Systems&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00739518</guid>
      <pubDate>Wed, 20 Aug 2008 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00708773?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Advanced Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Irinotecan&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Chicago&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00708773</guid>
      <pubDate>Fri, 27 Jun 2008 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00654836?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: bevacizumab;   Drug: carboplatin;   Drug: ABI-007l albumin-stabilized nanoparticle formulation&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Loyola University;   Genentech, Inc.&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00654836</guid>
      <pubDate>Tue, 08 Apr 2008 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00644228?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    DS Stage I Plasma Cell Myeloma;   DS Stage II Plasma Cell Myeloma;   DS Stage III Plasma Cell Myeloma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Bortezomib;   Drug: Dexamethasone;   Other: Laboratory Biomarker Analysis;   Drug: Lenalidomide&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00644228</guid>
      <pubDate>Sat, 22 Mar 2008 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Sorafenib Long Term Extension Program (STEP)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00625378?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Neoplasms&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Sorafenib (Nexavar, BAY43-9006)&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Bayer;   ICON Clinical Research&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00625378</guid>
      <pubDate>Wed, 20 Feb 2008 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00610415?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Head and Neck Cancer;   Head and Neck Cancers&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Procedure: tumor biopsy&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Stanford University&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00610415</guid>
      <pubDate>Fri, 25 Jan 2008 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00606346?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Crohn's Disease;   Ulcerative Colitis;   Indeterminate Colitis;   Inflammatory Bowel Diseases&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Anti TNF therapy including infliximab;   Drug: No Biologics&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Janssen Biotech, Inc.&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00606346</guid>
      <pubDate>Mon, 21 Jan 2008 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00588770?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Recurrent Hypopharyngeal Squamous Cell Carcinoma;   Recurrent Laryngeal Squamous Cell Carcinoma;   Recurrent Laryngeal Verrucous Carcinoma;   Recurrent Lip and Oral Cavity Squamous Cell Carcinoma;   Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary;   Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Recurrent Oral Cavity Verrucous Carcinoma;   Recurrent Oropharyngeal Squamous Cell Carcinoma;   Recurrent Salivary Gland Carcinoma;   Salivary Gland Squamous Cell Carcinoma;   Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary;   Stage IV Hypopharyngeal Squamous Cell Carcinoma;   Stage IV Major Salivary Gland Carcinoma;   Stage IVA Laryngeal Squamous Cell Carcinoma;   Stage IVA Laryngeal Verrucous Carcinoma;   Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma;   Stage IVA Major Salivary Gland Carcinoma;   Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage IVA Oral Cavity Verrucous Carcinoma;   Stage IVA Oropharyngeal Squamous Cell Carcinoma;   Stage IVB Laryngeal Squamous Cell Carcinoma;   Stage IVB Laryngeal Verrucous Carcinoma;   Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma;   Stage IVB Major Salivary Gland Carcinoma;   Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage IVB Oral Cavity Verrucous Carcinoma;   Stage IVB Oropharyngeal Squamous Cell Carcinoma;   Stage IVC Laryngeal Squamous Cell Carcinoma;   Stage IVC Laryngeal Verrucous Carcinoma;   Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma;   Stage IVC Major Salivary Gland Carcinoma;   Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage IVC Oral Cavity Verrucous Carcinoma;   Stage IVC Oropharyngeal Squamous Cell Carcinoma;   Tongue Carcinoma;   Untreated Metastatic Squamous Cell Carcinoma to Neck With Occult Primary&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Bevacizumab;   Drug: Carboplatin;   Drug: Cisplatin;   Other: Cytology Specimen Collection Procedure;   Drug: Docetaxel;   Drug: Fluorouracil;   Other: Laboratory Biomarker Analysis&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT00588770</guid>
      <pubDate>Fri, 28 Dec 2007 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Thyroid Disease Serum Repository</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00592605?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Thyroid Disease&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    University of Arkansas&lt;br/&gt;&lt;b&gt;Suspended&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00592605</guid>
      <pubDate>Thu, 27 Dec 2007 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00565851?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Clear Cell Adenocarcinoma;   Fallopian Tube Clear Cell Adenocarcinoma;   Fallopian Tube Endometrioid Adenocarcinoma;   Fallopian Tube Mucinous Adenocarcinoma;   Fallopian Tube Serous Adenocarcinoma;   Mucinous Adenocarcinoma;   Ovarian Brenner Tumor;   Ovarian Clear Cell Adenocarcinofibroma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Seromucinous Carcinoma;   Ovarian Serous Adenocarcinoma;   Primary Peritoneal Serous Adenocarcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Undifferentiated Carcinoma;   Undifferentiated Fallopian Tube Carcinoma;   Undifferentiated Ovarian Carcinoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Bevacizumab;   Drug: Carboplatin;   Drug: Docetaxel;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Other: Quality-of-Life Assessment&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT00565851</guid>
      <pubDate>Thu, 29 Nov 2007 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00505219?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Osteonecrosis&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Ixmyelocel-T;   Other: Standard of Care Only&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Vericel Corporation&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00505219</guid>
      <pubDate>Fri, 20 Jul 2007 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Inflammatory Breast Cancer (IBC) Registry</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00477100?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Other: Interview;   Procedure: Blood and Tissue Collection&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    M.D. Anderson Cancer Center;   Susan G. Komen Breast Cancer Foundation&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00477100</guid>
      <pubDate>Fri, 18 May 2007 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Use of Ixmyelocel-T (Formerly Vascular Repair Cells [VRC]) in Patients With Peripheral Arterial Disease to Treat Critical Limb Ischemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00468000?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Peripheral Arterial Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Ixmyelocel-T;   Biological: Placebo&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Vericel Corporation&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00468000</guid>
      <pubDate>Mon, 30 Apr 2007 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Transfusion-Associated Microchimerism in Previously Injured Individuals Who Received a Blood Transfusion</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00441779?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Chimerism;   Blood Transfusion;   Wounds and Injuries&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Heart, Lung, and Blood Institute (NHLBI)&lt;br/&gt;&lt;b&gt;Terminated&lt;/b&gt; - verified October 2014</description>
      <guid isPermaLink="false">NCT00441779</guid>
      <pubDate>Wed, 28 Feb 2007 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00433511?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Estrogen Receptor Negative;   Estrogen Receptor Positive;   HER2/Neu Negative;   Male Breast Carcinoma;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Bevacizumab;   Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Other: Placebo;   Other: Quality-of-Life Assessment&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Cancer Institute (NCI);   Cancer and Leukemia Group B;   Eastern Cooperative Oncology Group;   North Central Cancer Treatment Group&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00433511</guid>
      <pubDate>Thu, 08 Feb 2007 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00408005?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Adult T Acute Lymphoblastic Leukemia;   Childhood T Acute Lymphoblastic Leukemia;   Stage II Adult T-Cell Leukemia/Lymphoma;   Stage II Childhood Lymphoblastic Lymphoma;   Stage II Contiguous Adult Lymphoblastic Lymphoma;   Stage II Non-Contiguous Adult Lymphoblastic Lymphoma;   Stage III Adult Lymphoblastic Lymphoma;   Stage III Adult T-Cell Leukemia/Lymphoma;   Stage III Childhood Lymphoblastic Lymphoma;   Stage IV Adult Lymphoblastic Lymphoma;   Stage IV Adult T-Cell Leukemia/Lymphoma;   Stage IV Childhood Lymphoblastic Lymphoma;   Untreated Adult Acute Lymphoblastic Leukemia;   Untreated Childhood Acute Lymphoblastic Leukemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Asparaginase;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Dexamethasone;   Drug: Doxorubicin Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Nelarabine;   Drug: Pegaspargase;   Drug: Prednisone;   Radiation: Radiation Therapy;   Drug: Thioguanine;   Drug: Vincristine Sulfate&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00408005</guid>
      <pubDate>Mon, 04 Dec 2006 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00358657?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Immunodeficiency Syndrome;   Non-Cancer Diagnosis;   Severe Aplastic Anemia&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Procedure: Allogeneic Bone Marrow Transplantation;   Drug: Cyclophosphamide;   Drug: Fludarabine Phosphate;   Other: Laboratory Biomarker Analysis;   Drug: Mycophenolate Mofetil;   Procedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Sirolimus;   Drug: Tacrolimus;   Radiation: Total-Body Irradiation&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI);   National Heart, Lung, and Blood Institute (NHLBI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00358657</guid>
      <pubDate>Fri, 28 Jul 2006 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Phase I Study: Stop Smoking Therapy for Ontario Patients (STOP)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00356993?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Smoking&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Nicotine Replacement Therapy;   Behavioral: behavioural intervention&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Centre for Addiction and Mental Health;   Ontario Ministry of Health and Long Term Care&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00356993</guid>
      <pubDate>Tue, 25 Jul 2006 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00353522?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Coronary Heart Disease&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Placebo;   Drug: dalcetrapib&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Hoffmann-La Roche&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00353522</guid>
      <pubDate>Mon, 17 Jul 2006 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Organochlorine Exposure in Relation to Timing of Natural Menopause</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00353171?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Menopause&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Environmental Health Sciences (NIEHS)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00353171</guid>
      <pubDate>Mon, 17 Jul 2006 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00348595?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostate Cancer&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Revlimid&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Sidney Kimmel Comprehensive Cancer Center;   Celgene Corporation&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00348595</guid>
      <pubDate>Fri, 30 Jun 2006 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Family Studies of Eye Traits</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00342342?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Cataracts;   Glaucoma;   Myopia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Human Genome Research Institute (NHGRI)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00342342</guid>
      <pubDate>Mon, 19 Jun 2006 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00324805?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Stage IB Non-Small Cell Lung Carcinoma;   Stage IIA Non-Small Cell Lung Carcinoma;   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Bevacizumab;   Drug: Cisplatin;   Drug: Docetaxel;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Pemetrexed Disodium;   Other: Questionnaire Administration;   Drug: Vinorelbine Tartrate&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Cancer Institute (NCI);   Cancer and Leukemia Group B;   NCIC Clinical Trials Group;   North Central Cancer Treatment Group;   Southwest Oncology Group&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified February 2016</description>
      <guid isPermaLink="false">NCT00324805</guid>
      <pubDate>Wed, 10 May 2006 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>LMB-2 to Treat Hairy Cell Leukemia</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00321555?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hairy Cell Leukemia&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00321555</guid>
      <pubDate>Wed, 03 May 2006 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00310180?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Breast Adenocarcinoma;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Anastrozole;   Drug: Exemestane;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Quality-of-Life Assessment;   Radiation: Radiation Therapy;   Drug: Tamoxifen Citrate&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    National Cancer Institute (NCI);   American College of Surgeons;   Cancer and Leukemia Group B;   NSABP Foundation Inc;   NCIC Clinical Trials Group;   North Central Cancer Treatment Group;   Southwest Oncology Group&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified February 2016</description>
      <guid isPermaLink="false">NCT00310180</guid>
      <pubDate>Wed, 29 Mar 2006 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Center for Reducing Asthma Disparities - Northwestern University/Cook County Hospital Centers</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00281177?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Asthma;   Lung Diseases&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Behavioral: Asthma Disparity Reduction Strategy&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Heart, Lung, and Blood Institute (NHLBI)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2006</description>
      <guid isPermaLink="false">NCT00281177</guid>
      <pubDate>Fri, 20 Jan 2006 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Compassionate Use of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES)</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00244686?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Hypereosinophilic Syndrome&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: mepolizumab&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    GlaxoSmithKline&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00244686</guid>
      <pubDate>Tue, 25 Oct 2005 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00217737?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Colon Mucinous Adenocarcinoma;   Colon Signet Ring Cell Adenocarcinoma;   Lynch Syndrome;   Stage IIA Colon Cancer;   Stage IIB Colon Cancer;   Stage IIC Colon Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Bevacizumab;   Drug: Fluorouracil;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Oxaliplatin&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified March 2016</description>
      <guid isPermaLink="false">NCT00217737</guid>
      <pubDate>Tue, 20 Sep 2005 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Hypertension Education and Treatment Partnership for Reducing Ethnic Differences in the Risk of Cardiovascular Disease</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00101504?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Cardiovascular Diseases;   Hypertension;   Heart Diseases&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Heart, Lung, and Blood Institute (NHLBI)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified April 2006</description>
      <guid isPermaLink="false">NCT00101504</guid>
      <pubDate>Mon, 10 Jan 2005 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Genetic Studies in Difficult to Treat Asthma: TENOR</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00091767?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Asthma;   Lung Diseases&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Heart, Lung, and Blood Institute (NHLBI)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified July 2008</description>
      <guid isPermaLink="false">NCT00091767</guid>
      <pubDate>Thu, 16 Sep 2004 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00086801?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: doxorubicin hydrochloride;   Drug: gemcitabine hydrochloride;   Drug: vinblastine;   Procedure: fludeoxyglucose F 18 positron-emission tomography (PET) scan;   Procedure: CT scan&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00086801</guid>
      <pubDate>Thu, 08 Jul 2004 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Gene-Specific Responses to Exercise in Discordant Twins</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00083837?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Atherosclerosis;   Cardiovascular Diseases;   Heart Diseases&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Heart, Lung, and Blood Institute (NHLBI)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified April 2008</description>
      <guid isPermaLink="false">NCT00083837</guid>
      <pubDate>Wed, 02 Jun 2004 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Family Study of Affective and Anxiety Spectrum Disorders</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00071786?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Mood Disorders;   Anxiety Disorders&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Institute of Mental Health (NIMH)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00071786</guid>
      <pubDate>Thu, 30 Oct 2003 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00053885?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Malignant Mesothelioma&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    Drug: PTK787/ZK 222584&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00053885</guid>
      <pubDate>Wed, 05 Feb 2003 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00053196?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Leukemia;   Lymphoma;   Multiple Myeloma;   Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myeloproliferative Neoplasms&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: anti-thymocyte globulin;   Biological: G-CSF;   Drug: busulfan;   Drug: fludarabine phosphate;   Drug: methotrexate;   Drug: mycophenolate mofetil;   Drug: tacrolimus;   Procedure: allogeneic cell transplantation;   Drug: allopurinol&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00053196</guid>
      <pubDate>Mon, 27 Jan 2003 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00052845?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Prostate Cancer&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: docetaxel;   Drug: estramustine phosphate sodium;   Drug: exisulind&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00052845</guid>
      <pubDate>Fri, 24 Jan 2003 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00049010?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Melanoma (Skin)&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Genetic: comparative genomic hybridization;   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization;   Other: immunohistochemistry staining method&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00049010</guid>
      <pubDate>Tue, 12 Nov 2002 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Erlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid Tumors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00045201?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Adult Solid Neoplasm&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Drug: Erlotinib Hydrochloride;   Drug: Irinotecan Hydrochloride&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00045201</guid>
      <pubDate>Fri, 06 Sep 2002 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00026312?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Localized Resectable Neuroblastoma;   Localized Unresectable Neuroblastoma;   Recurrent Neuroblastoma;   Regional Neuroblastoma;   Stage 4 Neuroblastoma;   Stage 4S Neuroblastoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: Aldesleukin;   Biological: Dinutuximab;   Drug: Isotretinoin;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Other: Quality-of-Life Assessment;   Biological: Sargramostim&lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Active, not recruiting&lt;/b&gt; - verified April 2016</description>
      <guid isPermaLink="false">NCT00026312</guid>
      <pubDate>Fri, 09 Nov 2001 12:00:00 EST</pubDate>
    </item>
    <item>
      <title>Study of Adrenal Gland Tumors</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00005927?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Adrenal Gland Neoplasm&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)&lt;br/&gt;&lt;b&gt;Recruiting&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00005927</guid>
      <pubDate>Wed, 28 Jun 2000 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Genetics of Asthma and Bronchial Hyperresponsiveness</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00005359?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Conditions&lt;/b&gt;:    Asthma;   Lung Diseases&lt;br/&gt;&lt;b&gt;Intervention&lt;/b&gt;:    &lt;br/&gt;&lt;b&gt;Sponsor&lt;/b&gt;:    National Heart, Lung, and Blood Institute (NHLBI)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified July 2008</description>
      <guid isPermaLink="false">NCT00005359</guid>
      <pubDate>Thu, 25 May 2000 12:00:00 EDT</pubDate>
    </item>
    <item>
      <title>Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma</title>
      <link>https://clinicaltrials.gov/ct2/show/NCT00002501?lup_s=06%2F29%2F2016&amp;amp;lup_d=5&amp;amp;show_rss=Y</link>
      <description>&lt;b&gt;Condition&lt;/b&gt;:    Lymphoma&lt;br/&gt;&lt;b&gt;Interventions&lt;/b&gt;:    Biological: filgrastim;   Drug: cyclophosphamide&lt;br/&gt;&lt;b&gt;Sponsors&lt;/b&gt;:    Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI)&lt;br/&gt;&lt;b&gt;Completed&lt;/b&gt; - verified June 2016</description>
      <guid isPermaLink="false">NCT00002501</guid>
      <pubDate>Mon, 01 Nov 1999 12:00:00 EST</pubDate>
    </item>
  </channel>
</rss>
